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REPORT OF PROGRESS FOR RESEARCH CONTRACT NIEHS NO. NOl-ES-5-2135 
June 25, 1975 through December 2#, 1975 
The experiment proposed for the first year involved the determination of 
effect of a single mutagenic agent, administered in three different doses in 
addition to a negative control, upon three different germ cell stages, as re-





mice of inbred strain DBA/2J. In addition to thesecharacteristics, and for 
purposes of comparison with the results of other mutagenic studies, a dominant 
lethal test was planned for parental generation females mated with mutagenized 
(or control) parental males. The mutagenic agent selected for use in the first 
experiment was t -2iethylene melamine (TEM), and dosages selected for administra-
tion were .075, .15, .30 milligrams per kilogram of boby weight, in addition to 
an injection of carrier only to control males. The phenotypic traits selected 
for study included (1) number of young per female carried to weaning, (2) age 
of eruption of incisors, (3) age of development of the righting response, (4) 
mean and variance of body weight at weaning, (5) length of tail at seven weeks 
of age, (6) sex ratio, (7) hematocrit at seven weeks, and (8) serum cholestrol 
level at seven weeks. 
In general, the experiments have proceeded satisfactorily except for minor 
problems relating to delayed arrival of certain items of equipment and supplies 
and to a limited loss of mothers and litters, presumably due to disease, probably 
of a bacterial nature. The numbers of F
1 
generation young available for the es- 
tablishment of F_ crosses for all three mutagenized germ cell stages are adequate 
to provide useful information. The first F
1 
crosses are scheduled to be established 
shortly after the beginning of the second half year, in late December, 1975. 
Design. Parental females serving as parents for determination of the effects 
of different germ cell stages were termed groups A, B and C to indicate respectively 
those inseminated by spermatazoa which had been exposed to mutagenic action as sperma-
tozoa, spermatocytes and spermatogonia. According to the original plan a total or 
144 male mice would be treated at ten weeks of age and (1) would be mated immediately 
with group A females for a period of one week, then with females not involved in 
the experiment for a period of two weeks, at which point (2) the males would be mated 
with group B females for a period of two weeks followed by a period of two weeks 
again housed with females not involved in the experiment. (3) Matings would then 
be established between the same males and group C females, again for a period of 
two weeks. At this point, the parental generation males which had been mutagenized 
and those selected to serve as controls were to be destroyed. This constitutes in 
essence the portion of the experiment scheduled for completion within the first half 
year. 
Methods. Parental male and group A female mice were received from the Jackson 
Laboratory at eight weeks of age on September 16, 1975, as ordered. Both males and 
females were housed five to a box, the females fora period of two weeks until ini-
tial matings were established. Males were housed separately for the second week, 
immediately prior to establishment of matings. Triethylene melamine was administered 
by intraperitoneal injections in Hank's Balanced Salt Solution prepared immediately 
prior to injection. A series of male mice were weighed to determine average body 
weight, and all males within a dose group received the same quantity of carrier and 
TEM irrespective of individual variation in body weight. All mice received .25 cc 
of solution by injection, controls receiving the same quantity of carrier only. 
(2 ) 
Injections were carried out on September 30, 1975, and matings were established, 
three females to each male, immediately after injection. All males treated sur-
vived for a period of 24 hours, and, in fact, until all were destroyed at the 
completion of the portion of the experiment involving them. 
For purposes of recognition, Grotp A females were numbered from 1 to 436 
and were ear punched according to a numerical identification code. Males were 
similarly ear punched for identification and were numbered 501 through 645. Males 
were randomly assigned to one of the three experimental or control groups, each 
group thus containing 36 males. In similar manner, females were assigned randomly 
to males within the four different groups. Following establishment of group A 
crosses, cages were labeled in such a way as to preclude group identification. 
Group A matings were established on September 30, 1975; males were removed 
on October 7, 1975, and placed with females not involved in the experiment in an 
effort to maintain a normal level of sexual behavioral activity in the males. Ten 
days later, in expectation of production of litters, trios of mated females were 
separated one of a box. 
Group B females were received from the Jackson Laboratory on October 8, 1975, 
at eight weeks of age, 427 in number (5 fewer than had been ordered). These females 
were housed five to a box for the twelve days prior to the establishment of matings 
on October 20, 1975; females were ear punched to reflect numerical identification 
from 701 to 1130. As in group A matings, three females, randomly selected, were 
housed with each male until the males were removed on November 3, 1975. 
Unfortunately, delay in the arrival of double-compartment polycarbonate 
boxes required that these matings be established in stainless steel mouse boxes. 
However, all four groups were similarly housed, and this was judged to be the 
best of the alternative solutions available. 
Following removal from group B females on November 3, 1975, males were housed 
with females not involved in the experiment until the establishment of group C 
matings. The pressures of other demands of the project necessitated that the esta-
blishment of group C matings be handled on two successive days, November 19 and 20, 
1975. Again, because or the delayed arrival of polycarbonate boxes, it was necessary 
to employ stainless steel boxes of the same type used for group B matings. The 
females involved in these experiments had been received from the Jackson Laboratory 
on November 5, 1975, at eight weeks of age, ear punched for numerical identification 
from 1201 to 1636, and housed, five to a box, until matings were established. An 
excess of five mice in this shipment permitted the establishment involving random 
selection of individuals, of the full series of 144 matings (one male: three females). 
Males were removed from the matings established on November 19 and 20, respectively 
on December 3 and 4, 1975, and destroyed. Subsequently, females were isolated, one 
to a box, in anticipation of production of litters. 
The above summary deals with the establishment and maintenance of animals in-
volved in the matings. The section below will deal with the handling and maintenance 





young were assigned temporary numbers, within litter, at birth and this 
number was coded for identification by toe clippings. Subsequently, at weaning, 
a permanent number was assigned and the animals identified by ear punching. 
(3 ) 
For the Group A series a total of 187 litters were produced, based upon the 
observation of one or more young in a cage, between October 20, 1975 and October 27, 
1975. A total of 126 of these litters had some young surviving at weaning. The 
distribution of litter size at birth and at weaning is shown in Table 1. 
Table 1. Size distribution of Group A litters at birth and at weaning, including 
three experimental and one control group. Females producing these litters were 
mated for a period of seven days immediately following treatment. 
litter size 1 2 3 4 5 6 7 8 9 10 Total 
number of litters: 
at birth 6 32 44 35 28 22 10 8 1 1 187 
at weaning 1 16 31 26 24 16 8 2 1 1 126 
Of the 61 litters lost, 17, representing 95 young or about 41% of the total 
of 230 F1 losses, were incurred during the (apparent) disease epidemic that was 
limited to mothers nursing relatively large litters. The mean litter size at 
birth (4.10) is similar to that at weaning (4.26) while the mean litter size lost 
as a result of mothers dying prior to weaning was 5.6. Analysis of the numbers 
of young remaining in each of the four groups indicates that all of the 17 litters 
lost were in either the control group (9 litters) or the group receiving the lowest 
TEM dose, .075 mg/kg body weight (8 litters). 
In each of the four groups of Series A, control and experimental, more males 
survived to weaning than females. Accordingly, the number of females will probably 
determine the number of F
1 
pair crosses that may be established. As it turns out, 
the number of females presently surviving to weaning in the control, .075 mg/kg, .15 mg/ 
kg and .30 mg/kg groups are respectively 93, 82, 50 and 20. This suggests that we may 
expect to obtain relatively meaningful data for the F 2 generation for the control and 
.075 mg/kg body weight groups, perhaps something of interest from the .15 mg/kg body 
weight group, but little of significance from the .30 mg/kg body weight series. Never-
theless, we will establish as many crosses for each group as is possible for whatever 
information may be obtained. 
Autopsy of group A parental females has been completed, and preliminary results 
of uterine examinations will be outlined below. For the group A F 1 young, data have 
been recorded for all with respect to sex, time of development of righting response, 
time of incisor eruption, and weight at weaning. We are currently in the process of 
obtaining data on tail length, hematocrit and cholesterol level. The analysis of these 
date will be presented in the second semi-annual report. 
Group B series mothers produced a total of 309 litters, based upon the observa-
tion of one or more young in a box, between November 9 and November 24, 1975. This 
represents a great increase over the productivity of group A females, reflecting not 
(4) 
only the greater length of time the mated pairs were together but likely also a 
significant decrease in losses due to dominant lethality, in the progeny of mutagenized 
males. At weaning, 229 litters were still represented by surviving young. The dis-
tribution of litter sizes for this group at birth and at weaning is shown in Table 2. 
Table 2. Size distribution of Group B litters at birth and at weaning, including 
three experimental and one control group. Females producing these litters were 
mated for a period of fourteen days beginning twenty days after administration of 
mutagenic agent, to the male parent. 
litter size 	1 	2 	3 	4 	5 	6 	7 	8 	9 	10 	Total 
number of litters: 
at birth 	16 27 45 62 	55 45 30 26 	1 	2 	309 
at weaning 	0 	9 40 57 51 35 20 16 	0 	1 	229 
As was the case with group A series females a considerable part of the loss 
of young was due to the disease epidemic primarily affecting, again, mothers 
nursing relatively large litters. Of the total of 80 litters lost between birth 
and weaning 20, representing 142 young or 42% of the total of 336 F1 losses, were 
lost due to this cause. The mean litter size at birth for all group B females, 
4.68 was somewhat larger than for group A females but was, again, similar to their 
own mean litter size at weaning (4.84). As suggested above, the larger litter sizes 
probably reflect a reduction in dominant lethal losses, particularly among the two 
experimental groups receiving the highest mutagen doses. Mean litter size of diseased 
mothers dying prior to weaning (7.1) was much larger than that of surviving litters 
and somewhat larger than that of group A series females similarly lost. Unlike the 
situation in group A, the 20 litters lost were distributed over all four groups rather 
than being limited to females of the control and lowest mutagenic dose series. 
Again, in each of the three experimental and one control groups, more males 
survived to weaning than females. Thus, the number of females will determine for 
the group B series the number of F 1 pair crosses that may be established. At the 
present time, the number of females surviving in the control, .075 mg/kg, .15 mg/kg, 
and .30 mg/kg groups are respectively 135, 142, 122 and 108. These numbers obviously 
will provide the basis for a respectable number of crosses for each group. These 
groups will be established in January, 1976. 
The autopsy of group B parental females is being completed as this report is 
written, and time constraints prevent the presentation of these results. For these 
F1  young, data have been recorded with respect to sex, time of development of right- 
ing response, time of incisor eruption, and weight at weaning. Analysis of these 
data as well as those on tail length, hematocrit and cholesterol level at seven weeks, 
will be presented in the second semi-annual report. 
. itte,44, Submitted by:„ 
Yohn W. Crenshaw, Jr. 
;Proj6ct Director 
(5 ) 
Group C series mothers are still producing litters as this report is being 
prepared and will be treated in the next semi-annual report. An apparent disease 
epidemic similar to that in other groups is in progress, but numbers will probably 
be comparable to those in Group B. 
Results. A summary of the data on dominant lethality and related losses in Group 
A series females is given in Table 3. 
Table 3. Dominant lethality parameters of Group A series females and their F
1 young. Females belonging to the three experimental and single negative control 
group were mated for a period of seven days immediately following treatment. 
Dose of AM in mg/kg of body weight 
0 	.075 	.150 	.300 
% infertile 	of total mated (sample) 	32.4(108) 27.4(106) 34.9(106) 57.4(108) 
0/ "dead" scars of total (sample) 	 10.7(67) 18.6(73)** 21.3(69)** 20.4(46)** 
total scars ("live"+ "dead") per fertile 
(sample) 	 6.27(67) 5.88(73) 	5.10(69) 	4.37(46) 
live births based upon "live" scars, if 
known, or observed young per mated 	(sample)3.82(73) 3.49(77) 	2.61(69) 	1.47(46) 
% losses at birth (= "live" scars - 
observed live births) 	 32.3(67) 30.7(73) 	46.2(69) 	56.0(46) 
** P < .005 in comparisons with control 
The statistical results provided are based upon X
2 
contingency comparisons, 
and definitive conclusions must await more critical statistical evaluation. However, 
the primary value cf these data is that it is clear that effective administration of 
mutagenic agent has been effected. Further, there are several indications of increased 
response to increasing dose. Live births per mated female show a clear trend. It 
should be borne in mind that figures for the two highest doses are based entirely 
upon "live" scar counts. "Observed young per mated female" are included only in figures 
for the control and lowest dose groups in which some mothers were lost to disease 
prior to autopsy. The interpretation of increasing post-partum losses with increas-
ing dose is difficult for, as pointed out by Soares, (1972, Jour. Heredity 63(6):339), 
it is possible that there may be involved both the expression of dominant lethality 
at birth and the increased loss of young associated with small litters and, presumably, 
inadequate maternal care. 
• 	REPORT OF PROGRESS FOR RESEARCH CONTRACT NIEHS NO. NO1-ES-5-2135 6-31401/ 
December 25, 1975 through June 22, 1976 
The experiment proposed for the first year involved the determination of 
effect of a single mutagenic agent, administered in three different doses in 
addition to a negative control, upon three different male germ cell stages, as 
reflected by eight phenotypic characteristics in an F 1 and an F2 generation of 
mice of inbred strain DBA/2J. In addition to these characteristics, and for 
purposes of comparison with the results of other mutagenic studies, a dominant 
lethal test was planned for parental generation females mated with mutagenized 
(or control) parental males. The mutagenic agent selected for use in the first 
experiment was triethylene melamine (TEM), and dosages selected for administra-
tion were .075, .15, .30 milligrams per kilogram of body weight, in addition to 
an injection of carrier only to control males. The phenotypic traits selected 
for study included (1) number of young per female carried to weaning, (2) age 
of eruption of incisors, (3) age of development of the righting response, (4) 
mean and variance of body weight at weaning, (5) length of tail at seven weeks 
of age, (6) sex ratio, (7) hematocrit at seven weeks, and (8) serum cholesterol 
level at seven weeks. 
The experiments planned for the first year have been completed satisfactorily 
at this point except for the spectrophotometric analysis of cholesterol levels in 
plasma samples and for some specialized statistical analyses of data. Cholesterol 
determinations have required a greater time investment than anticipated. Of course, 
judgement as to whether this characteristic is worth the time investment required 
to employ it must await the final analysis of these data which should be completed 
during the summer. For all other traits it is felt that the number of young of 
both the F1 and Fp generations are satisfactory to provide at least the pilot 
indications to indicate the potential usefulness of the traits employed. 
Design. 	Parental females serving as parents for determination of the 
effects of different germ cell stages were termed groups A, B. and C to indicate 
respectively those inseminated by spermatozoa which had been exposed to mutagenic 
action as spermatozoa, spermatocytes and spermatogonia. According to the ori-
ginal plan a total of 144 male mice would be treated at ten weeks of age and (1) 
would be mated immediately with group A females for a period of one week, then 
with females not involved in the experiment for a period of two weeks, at which 
point (2) the males would be mated with group B females for a period of two weeks 
followed by a period of two weeks again housed with females not involved in the 
experiment. (3) Matings would then be established between the same males and 
group C females, again for a period of two weeks. At this point, the parental 
generation males were to be destroyed. 
For all groups, females were isolated from males and other females by 18 
days after initiation of matings so as to prevent postpartum matings and to avoid 
confusion of assignment of young to a particular litter, or a particular litter 
to a female. As detailed in the first semi-annual report, young were marked for 
identification and the sex recorded at birth. Subsequently, data on the time of 
development of the righting response and eruption of upper incisors were recorded. 
Approximately 22 days after males had been removed from contact with females in 
a given group, autopsy of unproductive females was initiated. 
Young were weaned at four weeks of age., At weaning the young were perma-
nently marked by ear punching, and the sex and body weight were recorded. At 
approximately seven weeks of age, tail length was recorded and a blood sample 
was obtained, hematocrit level recorded and the plasma frozen and stored for 
cholesterol level determination at a later date. 
F1 matings were established with individuals between 11 and 12 weeks of 
age, but full sibling pairs were precluded. F1 pairs remained together for a 
period of two weeks at which time males were removed and destroyed. The data 
acquired for F2 litters were the same and were taken at the same time intervals 
as for F1 young except that F1 females were not autopsied for intrauterine scar 
data. Unproductive females were destroyed about 21 days following the removal 
of males, and productive females were destroyed after their litters had been 
lost or weaned. 
Methods. 	The procedures involved in receiving mice, in mutagen administra- 
tion, maintaining mice and establishing crosses, handling young, and acquiring 
data on traits were detailed in the report of progress for the first half year. 
Summaries were provided of number of litters produced, surviving at weaning and 
distribution of litter size at birth and at weaning for groups A and B. A 
summary of these data for the remaining series follows. 
Group C series mothers produced a total of 269 litters, based upon the 
observation of one or more young in a box between December 6 and December 24, 1975. 
This is more comparable to the productivity of B series mothers (309 litters) than 
it is to the productivity of A series mothers (187 litters). It is likely that 
this reflects not only the greater length of time the mated pairs were together 
in both Groups B and C (two weeks) than in group A (one week), but, more impor-
tantly, there were significant decreases in losses due to dominant lethality in 
Groups B and C in the progeny of mutagenized males. At weaning, 192 litters were 
still represented by surviving young in Group C as compared with 126 in Group A 
and 229 in Group B. The distribution of litter sizes for Group C at birth and at 
weaning is shown in Table 1. 
Table 1. 	Size distribution of Group C litters at birth and at weaning, including 
three experimental and one control group. Females producing these litters were 
mated for a period of 14 days beginning 52 days after administration of mutagenic 
agent to the male parent. 
litter size 	1 	2 	3 	4 	5 	6 	7 	8 	Total 
number of litters: 
at birth 
	
9 35 	35 	49 	44 	42 	38 	17 	269 
at weaning 3 7 28 41 49 27 29 	8 	192 
As was the case in both Group A and Group B series, part of the loss of 
young was due to a disease epidemic primarily affecting mothers nursing relatively 
large litters. Of the total of 77 litters lost between birth and weaning six, 
representing 44 young or 14 per cent of the total of 315 F1 losses in this group, 
were lost for this reason. Percentage losses in Groups A and B were about three 
times as large as those of Group C, because productive Group C females were auto-
matically treated with antibiotic during the regularly scheduled box changes on 
the week following litter production. The mean litter sizes at birth and at wean-
ing are compared in Table 2. 
**-)HE* 
Table 2. 	Overall mean litter size of Groups A, B and C at birth and at weaning. 
mean litter size 
Group A 	Group B 	Group C 
At birth 	 4.10 4.68 4.66 
At weaning 	 4.26 	4.84 	4.89 
***** 
As is indicated in Table 2, litter sizes of Group B and Group C females 
were quite comparable and are larger than those of Group A both at birth and at 
weaning. As suggested earlier, the larger litter sizes of Groups B and C pro-
bably reflect a reduction in dominant lethal losses, particularly among the two 
experimental groups receiving the highest mutagen doses. Mean litter sizes of 
diseased mothers of Group C dying prior to weaning (7.3) was much larger than that 
of surviving litters, slightly larger than that of Group B females (7.1) and con-
siderably larger than that of Group A series females (5.6) similarly lost. 
* * * 
Table 3. 	Dominant lethality parameters with standard errors and sample sizes 
of Group A series females and their F 1 young. Females belonging to the three 
experimental and a single negative control group were mated for a period of seven 
days immediately following treatment, thus represent effects of mutagenic agent 
upon spermatozoa. (Live scar data were not tested statistically). 
0 
TEM dose, mg./kg. of body weight 
.075 	 .15 .30 
Live Scars/2 3.63 + .37(98 ) 3.32 + .28(97) 2.59 + .27(107) 1.47 + .22(108 
Dead Scars/2** .42 + .07(98) .78 + .11(99) .70 + .10(107) .39 + .08(108 
Total Scars/2* 4.01 + .36(98) 4.10 + .32(99) 3.29 + .30(107) 1.86 + .25(108 
Total Live Births/?** 4.50 + .27(52) 4.17 + .22(54) 3.47 + .27(43) 3.18 + .29(22) 
Total Weaned/2* 4.97 ± . 27(39) 4.20 + .25(41) 3.86 .32(28) 3.74 + .36(14) 
* Difference among groups, P < .05 
** Difference among groups, P < .01 
Results. 	Analyses of variance of data on dominant lethality and related losses 
confirm the significant nature of the tentative results summarized in the Report 
of Progress for the first half year on Group A series females and their F1 young. 
Table 3 summarizes these results. Data on dead scars, presented in the Table as 
mean scars per female were analyzed as percentage of total scars after arc sine 
transformation. Total scars were analyzed after square root transformation. 
Differences among the control and three experimental groups were found to be sig-
nificant for number of dead uterine scars per mated female, for total scars per 
mated female, for total number born per female bearing live young, and for total 
number weaned per female carrying young to weaning. The trends are in the direc-
tion expected with live scars, total born, and total weaned per female varying 
inversely with mutagenic dose. Total scars varied in a similar manner except 
that there was a nonsignificant increase in total scars from the control to the 
lowest mutagenic dose followed by a significant linear decrease in number of scars 
in the higher dose rates. The reduction in total scar numbers for the two higher 
doses are interpreted as resulting from preimplantation losses which would be ex-
pected to increase at high mutagenic agent exposures. As expected from earlier 
studies total number of dead scars increased from control to the two lower muta-
genic doses but dropped off in the highest dose to a level comparable with controls. 
The hypothetical relationship between live scars, dead scars and preimplantation 
losses in Group A series females is shown in Figure 1. 




losses for females of three experimental and a single negative 
showing the effects of mutagenic agent upon spermatozoa. 
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The simplest interpretation of the data from Group A females is that at 
the lowest dose of TEM, .075 mg./kg. of body weight, no significant preimplantation 
losses occur. However, at this dose there is an apparent although not significant 
increase in the number of dead scars precisely compensated for by a reduction in 
the number of live scars per female. On the assumption that the reduction in total 
scars at the higher TEM doses, .15 and .30 mg./kg., is due to preimplantation losses, 
the total number of losses due to mutagenic agent (the sum of preimplantation losses 
and postimplantation losses represented by dead scars) increases with a proportionate 
decrease in the total number of live scars per female at higher doses. This is con-
sistent with the results of earlier studies by Matter and Generoso (1974). 
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In Figure 2 are shown the dose response curves developed by Matter and 
Generoso (ibid) with data from the present study superimposed for comparison. These 
Figure 2. 	Effect of TEM dose on induction of dominant-lethal mutations in mouse 
spermatozoa and spermatids. The curves represent least-squares fits of the numbers 
of living embryos vs. the doses. Ninety-five percent confidence intervals are in-
dicated by vertical bars. Taken from Matter and Generoso (1974) with results of 
the present study added for comparison. 
curves are based upon living embryos as a percent of living embryos in the control 
group. So that our observations could be compared directly with theirs, we have 
calculated, as they did, live scars per mated female for the .3 mg./kg. group as 
a percent of controls, but for lower doses we have employed live scars among 
fertile females only as a percent of controls. Given the differences that exist 
between our method and theirs (i.e., our use of an inbred strain as opposed to an 
interstrain hybrid, and postpartum analysis of uterine scars in our study as 
opposed to uterine analysis at 12 to 15 days following plugging in the Matter-
Generoso study) our results are quite comparable. The slope of our curve would 
appear to result in a slightly lesser rate of reduction in living embryos with 
increasing dose than the Matter and Generoso curved. 
It was observed by Soares (1972) that the number of live scars observed 
was virtually always either equal to or more than the number of live young ob-
served at birth. Soares interpreted this difference as being due either to a 
late dominant lethal effect or to an increased loss of young associated with 
small litter sizes which would be more common at higher mutagen doses. We are 
carrying out an analysis of our data on this phenomenon based upon regression of 
number of losses-at-birth upon litter size for the control and treated series in- 
volved in our study. From these data it should be possible to determine the effect 
of litter size upon losses at birth. 
For females of the Group B series, the young of which developed from ova 
fertilized by spermatozoa subject to mutagenic treatment as spermatocytes, 
there were slight, though statistically significant evidences of an effect. These 
results are shown in Table 4. Significant variation was found among the three 
experimental and single control group in regard to total scars per female. These 
Table 4. 	Dominant lethal parameters with standard errors and sample sizes of 
Group B series females and their F1 young. Females belonging to the three ex-
perimental and single negative control group were mated for a period of 14 days 
beginning three weeks after treatment, thus representing effects of the muta-
genic agent upon spermatocytes. 
TEM dose, mg./kg. of body weight (sample size) 
0(98) .075(100) .15(95) .30(98) 
Live Scars/9 4.76 + .29 5.6o + .24 4.81 4 	.28 4.46 + .25 
Dead Scars/ 2 * .58 + .09 .66 + .08 .81 + .10 .73 + .10 
Total Scars $** 5.34 + .31 6.26 + .24 5.62 + .31 5.19 + .28 
*p = .052 
*p < .05 
conclusions are based upon an analysis of variance of number of total scars per 
female after square root transformation. Data on dead scars were analyzed by 
ANOVA after arc sine transformation of the dead scar percentage of total scars. 
Dead scars per female increased above control with increasing dose to fall slightly 
at the highest dose. This pattern would not be particularly unusual if there 
were reason to suppost that preimplantation losses had resulted in a reduction in 
total implantations at the highest dose. However, total scars increased from con-
trol to a peak at the lowest TEM dose from which they decreased with further in-
crease in dose so that total number of scars in the highest TEM dose is slightly 
lower than that of the control. A multiple range test indicated that the lowest 
TEM dose was associated with a significantly higher number of total scars than 
either the control or the highest TEM dose, and was responsible for the significant 
variation among the four groups. 
In the study by Matter and Generoso, no effects of mutagenic treatment on 
spermatocytes were reported below doses of .8 mg./kg. However, at .4 mg./kg. 
there were observed non-significant increases above controls in total implants 
in zygotes fertilized by spermatozoa mutagenized as late spermatocytes. This 
may indicate an interesting if paradoxical effect of a low dose TEM treatment 
causing an increase in total implants. 
It is difficult to account for the kind of variation observed in our study 
on any straightforward biological basis. If real, increased implants could be due 
to mobility or physiological activity. It is, of course, possible that the peak 
value in total scars for the lowest dose, .075 mg./kg. of body weight, represents 
chance variation of a relatively infrequent sort, and has led us to commit a Type 
I error. Certainly there are no other evidences in the spermatocyte treated series 
(Group B), either in the F1 or the F2 generation, to indicate that mutations have 
been induced by treatment at any dose level. 
With respect to dominant lethal measures for Group C series females, those 
producing young which were the products of fertilization by a spermatozoan ex-
posed to mutagenic treatment in the spermatogonial stage, there were no signifi-
cant differences observed among groups for any dominant lethal measure. For 
this group, however, there are other evidences that mutations were induced (see 
discussion of quantitative effects on spermatogonia, page 14). It seems likely 
that the kinds of mutations induced were limited to lesions with minor effects 
on fitness traits. 
Quantitative Traits. While the data above on dominant lethal measurements 
provide some confirmation of results by earlier workers (Matter and Generoso, 1974) 
and some new information, the primary thrust of the present study was directed 
toward the utilization of quantitative traits as indicators of mutagenic activity. 
Earlier studies have indicated that it is desirable to look not only at the effects 
of polygenic mutations, that is mutations of minor effect, on the means of quanti-
tative traits but also their effect upon the variances of such traits (Crenshaw, 
1970; Soares and Crenshaw, 1970). While information from either the F 1 or F2 
generation may be of interest in pointing out a deleterious effect resulting from 
treatment with a particular compound, in general it has been our assumption that 
effects observed in the F 2 generation were more surely attributable to a genetic 
basis than those of the F1 generation. However, genetic cause obviously cannot be 
excluded from F1 effects. 
Effect of Mutagen on Spermatozoa 
In young of the F1 generation significant effects of mutagen dose were ob-
served with respect to means for body weight, tail length and hematocrit. With 
respect to body weight an analysis of variance indicated that there were highly 
significant differences among doses and between sexes. The differences due to 
dose became even more impressive when litter size was considered (F = 4.13, P < .01). 
No evidence of a dose x sex interaction was found. 
It is evident from Table 5 that mean body weight of F1 progeny increases 
directly with dose. The results of a multiple range test show that the control is 
significantly different from both the low and the middle TEM dose, but that the 
three experimental groups do not differ significantly from one another. While the 
highest group (.30 mg./kg.) mean is the highest of the series in face value, 
Table 5. Means of body weight at weaning, and tail length and hematocrit levels 
at seven weeks in F1 and F2 generation progeny of three experimental groups and a 
single negative control showing effects of TEM upon spermatozoa. Sexes are com-
bined. Means over solid lines at the same level, whether continuous or connected 
by dashed line, are not significantly different by multiple range comparison. 
F1 F2 
Dose (mg./kg.) 0 .075 .15 .30 0 .075 .15 .30 
Body weight 13.06 13.54 13.94 14.05 12.79 13.19 10.87  13.00 
Tail Length 71.40 71.90 69.75 70.82 70.80 70.58 68.60  71.33 
Hematocrit 11.8.211. 48.42 48.67 48.79 
failure to attain significance of the difference from control was due to small 
sample size. The treatment effect of increasing body weight is unique among similar 
studies of the effects of (other) mutagenic agents upon body weight. In other 
studies, body weight of the F 1  young has been found to be reduced in some studies, 
and in some there has been no effect on mean. It is our feeling that the different 
kinds of responses which the particular experimental design employed in these studies 
makes possible, provides potential for differentiating between the effects of differ-
ent types of mutagenic agents. It is hoped that the importance of this kind of 
variation in response may be developed more fully in our experiment projected for 
a future year, which will compare the effects of different mutagenic agents. 
An analysis of the effects of sex and litter size on body weight reveals that 
the pattern of linear increase of body weight with increasing dose is characteristic 
of males, and that the variation in pattern among different litter sizes, particularly 
in the more numerous litter size categories, is negligible. Females of the F 1 
 generation show a slightly different pattern, involving a modest decrease in body 
weight from the middle to the highest TEM dose. However, this decrease is certainly 
not significant and seems to be characteristic of smaller litter sizes which are 
sufficiently numerous at the highest dose rate to have an appreciable effect on the 
mean. 
Mean tail length follows a similar pattern to that of body weight, with 
significant differences among the dose groups (F = 3.99, P < .01). While tail 
length does not appear to increase directly with increasing dose as was the case 
with body weight, the means for all experimental groups of the F 1 generation are greater 
than those of the control group. Inasmuch as tail length is a measurement that may 
be obtained with greater facility than body weight, some small economy might be 
achieved by employing this measurement in lieu of body weight. However, as will 
be discussed shortly, there are problems with the use of tail length variance that 
are not present in the body weight measurement. 
A comparison of the effect of sex and litter size upon tail length indicates 
that the experimental groups, both males and females, exhibit greater tail lengths 
than the control group. There is, however, considerable variation among litter 
sizes as well as among doses so that general patterns do not emerge. Most litter 
sizes, for both males and females, do show an increase in tail length from the 
control to the lowest TEM dose. 
Hematocrits of the F1 progeny follow the same pattern as those for body 
weight and tail length and, in fact, like body weight do appear to increase 
directly with increasing dose. P < .05 (F = 2.62) that the differences observed 
between groups could be due to chance alone. Only the middle TEM dose group is 
significantly different from the control, but the high dose group mean suffers 
from small sample size. 
In an analysis of the effect of sex and litter size on variation in hemato-
crit level, the patterns for males and females were found to be quite similar with 
the exception that in males all experimental groups show higher hematocrit levels 
than controls, while in females only the two highest TEM dose groups show hematocrit 
levels above the control group, with the lowest TEM dose group having hematocrit 
levels very slightly below that of controls. Relative to variation in body weight 
and tail length among litter size groups, that in hematocrit level is very limited. 
Examination of the effect of sex and litter size upon body weight in the 
F2 generation young reveals significant differences among dose groups (P < .001, 
F = 14.57) considering both sex and litter size. Significant reduction in body 
weight at the middle TEM dose (.15 mg./kg.) is responsible for this result and is 
particularly remarkable because it reflects a reduction in the mean body weight 
of individuals categorized by sex and litter size in the middle TEM dose, as com-
pared to all other dose groups. The significant increase in body weight from the 
middle to the highest TEM dose, while it is significant, does not reflect as con-
sistent a pattern among litters as the decrease from lowest to middle TEM dose 
group. Repetition. of this particular experiment in the coming year will be of 
great value as a test of the reality of the effect of induced variation upon the 
body weight of F2 progeny. 
In earlier studies of the effects of mutagenic agents on body weight in 
the F2 generation, the usual result has been no effect on mean. In a few instances, 
reductions in weight similar to that discussed above, have been reported. The 
present result suggests that dose may be critical in producing the precise quality 
and amount of damage that will lead to a reduction in body weight. 
As was the case with the F1 generation results, results of tail length 
comparisons among litter sizes and between sexes parallels very closely with 
variation patterns in body weight. An analysis of variances of differences among 
dose groups, considering both covariance with litter size and differences due to 
sex, reveal that the differences are significant (P < .05, F = 3.22). As shown 
in Table 5, there is a significant reduction in tail length, precisely paralleling 
the result with body weight, in the middle TEM dose group. In general both males 
and females exhibit similar patterns, with mean tail length for the low TEM 
dose in both males and females being very slightly greater than controls. For 
the high dose group, females exhibit slightly greater tail length than controls 
but males have slightly lesser tail lengths. Both males and females are charac-
terized by a fairly consistent reduction in tail length for the middle. TEM dose, 
with three of five of the litter sizes including females and four of five of the 
litter sizes including males exhibiting parallel tail length reductions from the 
low to the middle TEM dose. At the highest dose level there is remarkably little 
variation among litters in respect to tail length means. However, considering 
the small sample sizes involved, this may be a chance effect. 
Turning to a consideration of variances of the same traits considered 
above (body weight, tail length and hematocrit level) certain patterns emerge 
that are of interest. Table 6 presents in tabular form variances for male 
***-X-X- 
Table 6. Variances of body weight at weaning, and tail length and hematocrit 
levels at. seven weeks in F1 and F2 generation progeny of three experimental and 
a single negative control groups showing effects of TEM upon spermatozoa. Indi-
cations of statistical significance pertain to comparisons with appropriate con-
trols and are based upon variance ratios. 
F
l 
Dose (mg./kg.) 0 .075 .15 .30 0 .075 .15 .30 
Body Weight cr 7.62 4.45* 6.81 2.46** 5.95 8.01 8.58 14.29* 
5.34 3.50* 4.28 2.02** 7.24 7.90 11.56 8.41 
Tail Length e 9.67 9.99 12.18 4.o4** 4.84 9.12** 9.86 14.98** 
9 13.03 9.8o 9.24 6.71 6.92 9.61 46.51** 9.55 
Hematocrit (4, 1.74 1.64 3.20** 1.56 1.32 2.56** 1.85 1.61 
9 2.10 2.37 3.80* 2.16 1.96 2.34 4.75* 1.90 
* P < .05 
** P < .01 
and female groups in the F1 and F2 generation for the negative control and three 
TEM dose groups involved in our study. One of the hypotheses that has emerged 
from earlier studies of polygenic mutations is that there appears to be a charac-
teristic decrease in variance with respect to body weight in F1 generation young 
of a mutagenized male parent. Our own results from the present study provide 
strong confirmation of this effect. For all three TEM doses for both male and 
female samples there is a reduction in body weight variance among the progeny of 
treated males, and four of the six comparisons possible produce significant 
differences based upon F ratio comparisons. 
Tail length among females showed a similar pattern of reduced variance of 
the experimental groups as compared with the control group but only one comparison 
was significant. However, males exhibited a different pattern. In both the lower 
and middle TEM dose groups there were non-significant increases in variances over 
controls. Males of the highest TEM dose group did exhibit a highly significant 
reduction in variance relative to that of controls. 
With respect to variance differences among groups in regard to hematocrit 
level, the same group that exhibited a significant increase in mean hematocrit 
level, the 15 mg./kg. dose group, also exhibited a significantly increased variance 
with respect to hematocrit level for both sexes, which may be due in part to the 
direct relationship between mean and variance. 
Previous studies in our laboratory have developed evidence that, just as 
body weight variance is often decreased relative to control groups in the F1 pro-
geny of mutagenized males, so body weight variance is often increased in the F2 
generation progeny of offspring of mutagenized males. The prediction leading 
from this hypothesis is strongly confirmed in the results of the present study, not 
only in regard to body weight variances but also by tail length variances and in 
all except one of the possible hematocrit variance comparisons. To be precise, 
the variances in regard to both body weight and tail length in F2 generation young 
of all three TEM dose groups for both sexes (a total of 12 comparisons) are higher 
than the appropriate control variance. Only one-third of these variance ratio com-
parisons produce significant F values, however it is evident that the likelihood 
of having all twelve comparisons fall in the same direction by chance along is 
remote (P is approximately equal to .00024). In the hematocrit variance compari-
sons, all except one of the six experimental group variances is higher than the 
appropriate control, and two of these are significantly so. The effects of muta-
genic treatment on the F 1 and particularly the F 2 generation on the variance of 
quantitative traits support the hypotheses of earlier studies. 
In the discussion above of the effect of the mutagenic agent TEM upon sperma-
tozoa, we have limited the treatment to statistically significant results. There 
are interesting implication in some of the other aspects of our data, for example 
with respect to sex ratio, the time of development of the righting response and 
the time of emergence of upper incisors. Our analyses of these data are continuing 
and, if results of interest do develop, these will be reported in the next semi-
annual report. 
Effect of Mutagen on Spermatocytes 
There are no strongly persuasive evidence in either F1 or F2 generation 
data that indicate an effect from mutagen induced polygenic mutations. In a 
single trait, tail length, there were highly significant differences in means 
due to dose when the effects of both litter size and sex were partitioned out 
(Table 7). The fact that such differences were observed for both the F1 and F2 
generations lends strength to the likelihood that they are real, even in the 
absence of differences in means of other traits involved in the study. 
Table 7. 	Means of tail length at seven weeks, corrected for sex and litter 
size, in F1 and F2 generation progeny of three experimental groups and a single 
negative control showing effects of TEM upon spermatocytes. Sexes are combined. 
Means over solid lines at the same level, whether continuous or connected by dashed 
line, are not significantly different by multiple range comparison. 
F1  F2  
Dose (mg./kg.) 0 .075 .15 .30 0 .075 .15 .30 
Tail Length 70.91 70.24 71.37 71.02 68.26 68.54 67.26 68.60 
***-X--* 
In the F1 generation it is in the lowest mutagen dose group that tail 
lengths were significantly different from (less than) those of the control group 
and, in fact, lower than the means for the two higher mutagen dose groups, although 
significantly different only from the middle dose. In the F 2 generation again one 
of the experimental groups exhibits a lower mean than that of the control and the 
other experimental groups, but in this case it is the middle TEM dose (.15 mg./kg.) 
that shows the lowest tail length mean. 
It has been shown by Favor (1976) that the mean number of mutations in the 
F1 and F2 generations of progeny using the present design are not appreciably 
different. Accordingly, explanation for the kind of result observed here in re- 
spect to tail length is most simply attributable to maternal x progeny interaction. 
The F1 generation progeny, which themselves may carry induced mutations, will be 
reared by a mother having no genetic damage. On the other hand, progeny of the F2 
generation will be reared by a mother that has approximately the same number of 
mutations as they themselves have. At this time, it would be somewhat speculative 
to attempt to account precisely for the mean differences observed here, but it would 
seem to be most worthwhile to seek answers in the differences between maternal effects 
of the two generations involved. It is worth noting that body weight means differ-
ences parallel very closely the differences found in tail lengths in both the F1 
and F2 generations. These differences, however, do not approach significance when 
litter size and sex are considered. 
With respect to differences in variance, only one pattern of interest was 
noted. With regard to time of incisor emergence, there was observed a consistent 
reduction in variance in the F1  generation young of all three experimental groups 
relative to the control (Table 8). In two of the six comparisons possible, the 
differences were significant. 
Table 8. 	Variances associated with time of emergence of incisors in F 1 and F2 
generation progeny of three experimental and a single negative control groups 
showing effects of TEM upon spermatocytes. Indications of statistical significance 





0 	.075 .15 	.30 	0 	.075 	.15 	.30 
Incisor 	d 	.7396 	.6400 	.6889 	.6241 .9409 .7056* 	.8281 	.9801 
Emergence Time 	? .9025 .6400* .7225 .5776** .9801 .7744 .8649 .8100 
* P < .05 
** P < .01 
Variances for incisor emergence time are also shown for the F2 generation 
in Table 8. The pattern suggested is the reverse of that when treated spermatozoa 
are involved, with evidences of a tendency for reduction of variance in experimental 
groups relative to that of controls in the F2 generation just as there was in the 
Fl . The consistency of this directional difference is not complete, with one of 
tne six comparisons possible showing an increase, albeit not significant, in the 
variance of incisor emergence time in an experimental group relative to that of con-
trols. This apparent exception to the general trend is that for males in the high 
mutagen dose group. Only one of the other five differences proved to be significant 
by variance ratio comparison. 
Since there were some indications of a mutagenic effect based upon dominant 
lethal parameters, it seems likely that the effects of dose on mean tail length 
and on variance of incisor emergence may be real. However, for practical purposes, 
the general insensitivity of spermatocytes to the mutagenic agent employed does not 
argue strongly for continued investigation of a treated spermatocyte stage in future 
experiments. 
Effect of Mutagen on Spermatogonia 
Even though there were no conclusive evidences of a dominant lethal effect 
in the F1 young of males in which the spermatogonia had been exposed to the muta-
gen TEM, a number of evidences emerge from the quantitative traits analyzed to 
indicate that there were indeed polygenic mutations induced by TEM treatment, and 
that these were effective not only in modifying means but also variances of several 
traits, especially in the F2 generation. Table 9 outlines the effects on trait 
means where differences among groups were found to be statistically significant. 
Table 9. 	Means of (1) time of development of righting response and (2) hematocrit 
level at seven weeks in the F1 generation, and of (3) time of righting response, 
(4) time of incisor emergence, (5) body weight at weaning and (6) tail length at 
seven weeks in the F2 generation progeny of three experimental groups and a single 
negative control showing effects of TEM upon spermatogonia. Means over solid lines 
at the same level, whether continuous or connected by dashed line, are not signi-
ficantly different by multiple range comparison. Means have been corrected for 
sex and litter size. 
F1 F2 
Dose (mg./kg.) 0 .075 .15 .30 0 .075 .15 .30 
Righting Response 7.67 7.93  7.74 7.98 8.37 8.30 8.08  8.18 
Incisor Emergence Time 12.19 12.15 11.96  12.04 
Body Weight 13.35 13.54 13.19 13.82 
Tail Length 73.94 74.59 74.50 74.81 
Hematocrit 47.39 47.13 46.80 47.36 
With respect to the righting response, there were effects on the mean time 
of development of this behavioral trait due to treatment in both the F1 ( F = 2.71, 
P < .05) and F2 (F = 2.89, P < .05) generations. In the F1 generation the time 
of development of the righting response was delayed in all experimental groups rela-
tive to that of the control. However, the delay was significant only for the lowest 
and the highest TEM doses. In the F2 generation, the effect appears to be reversed 
with the experimental groups all having shortened developmental times relative to 
the control. However, only the middle TEM dose is significantly different from the 
control, and it is not significantly different from the other experimental groups. 
The simplest interpretation of these data, assuming a negative correlation between 
fitness and developmental time, is that induced polygenic mutations showed a dele-
terious effect in F1 generation progeny, but that reassortment of induced mutations, 
and perhaps selection against the more deleterious variants (and for any heterozygous 
- 1 5- 
advantage) resulted in a reduced developmental time in the F2 generation. 
The only other trait to show a significant mean effect in the F1 generation 
was hematocrit level ( F = 20.47, P < .01), the general effect being one of re-
duced hematocrit in the three experimental groups. However, only in the case of 
the middle TEM dose was there a significant reduction, and this mean was signifi-
cantly different from the control and the other experimental groups. Both sexes 
showed parallel reductions at the middle TEM dose, but males exhibited greater 
differences among means that females. Differences between sexes were reinforced 
by similar performances of different litter size groups within sex. Hematocrit 
means did not exhibit significant variation in the F2 generation. However, differ-
ences among dose groups were sufficiently great so that repetition of the experi-
ment with the same results would result in significant differences upon the combined 
factorial analysis of the two experimental data sets. The order of the computed 
hematocrit means was more or less linear, ranging from a low for the control group 
to a higher level for the lowest TEM dose and even higher values for the middle 
and highest TEM doses, which were themselves quite similar. It is difficult to 
interpret a given change in hematocrit level as "good" or "bad", but it is probably 
well to bear in mind that different traits might very well respond in different 
directions to induced genetic variance. 
Of the traits showing an effect only in the F 2 generation the time of incisor 
emergence showed significant differences among groups (F = 3.15, P < .05). There 
was a shorter time to emergence for experimental groups than for the control, parallel-
ing that found for development of the righting response. However, only the emer- 
gence time for the middle TEM dose group proved to be significantly different from 
control. 
The body weight and tail length traits showed similar effects of treatment 
in the F2 generation of the spermatogonial treated groups. For tail length, highly 
significant differences were found among groups (F = 5.82, P < .01), and all three 
experimental groups exhibited significantly greater tail lengths than were found for 
controls. Body weight also showed highly significant variation (F = 5.29, P < .01), 
but only the highest TEM dose was associated with a body weight mean significantly 
higher than that of controls. Only one of the other two experimental group means, 
that for the lowest TEM dose, was higher at face value than the control. Both body 
weight and tail length were characterized by erratic variation among litter size 
means with general tendency to parallelism in response to dose over all litter sizes. 
An analysis of the effects of TEM dose on variances revealed interesting pat-
terns for a number of traits. Those that confirm predictions based on earlier work 
(or that directly refute such predictions) are illustrated in Table 10..  
One of the most interesting patterns is that illustrated by variance about 
the time of development of the righting response. In the F1 generation the variance 
pattern for males follows that predicted on the basis of earlier work with body 
weight in that it shows a reduction in variance for the three experimental groups 
relative to that of the male control. None of these differences is significant, 
however. Remarkably, females show precisely the reverse pattern with all three ex-
perimental groups showing a higher variance than that of controls. Two of these 
comparisons are significantly different based upon variance ratio comparisons. 
The pattern in the F2 generation is precisely reversed with males, again, follow-
ing the pattern predicted on the basis of body weight variation, with an increase 
in all experimental groups relative to the variance of controls, and one compari-
son producing a highly significant F value. The remarkable pattern continues in 
that females are precisely the reverse of males and of what they exhibited in the 
F1 generation, with the control variance being greater than any experimental variance 
and with two of the three comparisons possible showing statistical significance. 
While it is possible that this peculiar pattern is a matter of chance, it is also 
possible that it is real, in which case the potential as a diagnostic trait is very 
great for righting response development. 
***E* 
Table 10. 	Variances of (1) time of development of the righting response and (2) 
body weight at weaning in the F 1 generation, and of the (3) time of development of 
righting response and (4) incisor emergence, (5) of body weight at weaning and 
(6) tail length at seven weeks in F2 generation progeny of three experimental and 
a single negative control group showing effects of TEM upon spermatogonia. Indi-
cations of statistical significance pertain to comparisons with appropriate con-




	 o 	.075 	.15 	.3o 	0 	.075 	.15 	.3o 
Righting Response d' 1.93 	1.80 	1.88 	1.44 	1.49 	1.74 	2.25** 	1.72 
	
1.61 2.22* 	1.71 2.34* 2.25 1.88 	1.42** 	1.54* 
Incisor Emergence cr 	 1.17 	.88* 1.17 	.90 
2 	 1.21 1.06 	.86* 	.96 
Body Weight 	e 6.05 	3.39** 	4.54 	4.12* 5.81 	5.76 	4.67 	4.45 
5.43 	2.99** 	4.88 4.45 	5.38 	3.53* 3.92* 	3.46** 
Tail Length 	dr 11.22 13.47 	10.05 	10.11 	6.45 	6.20 	5.34 	6.00 
? 12.39 11.22 16.73 	16.16 8.53 	5.06** 5.62* 7.67 
* P < .05 
** P < .01 
Data for the other developmental trait, time of emergence of upper incisors, 
appears to parallel the variance pattern of females for righting response development 
and other F2 generation responses in spermatogonial treatment. While not completely 
consistent, in the F2 generation all experimental variance except one are lower 
than controls for both males and females, and two of these differences are significant. 
In the one exception, that for males in the middle dose TEM group, the variances 
of control and experimental are equal. 
The data on variances of body weight are particularly interesting in that 
they offer confirmation for the prediction that mutagenic agents tend to produce 
a reduction in body weight variance in F1 progeny of mutagenized males. In all 
comparisons between experimental groups and controls, for both males and females, 
body weight variances are lower than appropriate controls, and three of the differ-
ences are significant. 
In the F2 generation, the patterns predicted from work with ethyl methanesul-
fonate and x-ray as mutagenic agents, are precisely reversed for TEM. Experimental 
groups show uniformly reduced variances with respect to their controls, and all 
of these differences are significant in the female comparisons. The present most 
acceptable hypothesis to account for F2 generation increases in variance in experi-
mental groups following mutagen treatment of spermatozoa is that interaction between 
mutagenized F2 progeny genotypes and mutagenized F1 maternal genotypes produces 
an increase in variance. Reductions in variance in F 1 generation progeny of muta-
genized males, under this hypothesis, would result from the buffering effect of 
mutagen induced polygenic heterozygosity in the F1 young in the absence of inter-
action of mutagenized maternal and progeny genotypes. The simplest hypothesis to 
account for the results of spermatogonial treatment in our TEM study is that the 
mutations induced by TEM in spermatogonia may be sufficiently minor in effect so 
that a deleterious interaction does not occur between experimental series F1 females 
and their F2 progeny. Thus, the buffering effect of mutagen induced polygenic 
variation may be sufficient to reduce variance in both F1 and F2 generations. If 
this hypothesis is correct, the usefulness of this particular tool in the charac-
terization of the effects of mutagenic agents is great. 
It will be recalled that variance distribution patterns for TEM induced poly-
genic mutations in spermatozoa exhibited the predicted reduction in body weight 
variance in the F1 generation followed by a variance increase in the F 2 progeny. 
This result is consistent with the present hypothesis and suggests that the muta-
tions produced and remaining unrepaired in spermatozoa include an array of greater 
magnitude and of more deleterious effect than those induced in spermatogonia, the 
more serious of which are likely to be eliminated or repaired. 
The variance patterns found for tail length in the F1 generation, which usually 
appear to parallel very closely body weight patterns, do not do so here. Two of 
the three experimental variance values in females and one of three in males exceed 
those for controls. However, none of the differences was significant. 
In the F2 generation, the effects of treatment on the variance on tail length 
were similar to the effects observed for body weight. The variance values for all 
experimental groups were less than those of appropriate controls. In two of these 
comparisons, both in females, the differences were significant. Tail length did 
not appear to be as broadly useful as body weight in the overall. However, the 
parallelism between the pattern of change for tail length and body weight in both 
means and variances offers additional evidence of the reality of the differences 
found in body weight mean and variance patterns, if any were needed. 
Discussion. The most surprising negative result obtained in view of the 
results from earlier studies is the absence of any significant effects of mutagenic 
agent on sex ratio. In some cases the sex ratio data approached significance. 
However, the patterns emerging made very little sense. We will continue to study 
these patterns for implications that may have eluded us to the present. 
Another surprising result is the lack of an effect on number carried to 
weaning, which has been a very good indicator in F2 generation litters particularly 
in x-ray studies. We will also continue to study these data for other indications 
of an effect. 
Of the traits studied for the first time, incisor emergence time shows the 
least promise, and it will be recommended below that a trait be substituted for 
this in the experiments of the coming year. 
We will continue to carry out the spectrophotometric analysis of cholesterol 
levels and to analyze the resulting data so that they may be reported in the next 
semi -annual report. 
In regard to plans for the coming year, following discussions with the project 
officer, it is proposed that the mutagenized spermatocyte experimental group be 
eliminated, and that the numbers of mice employed in this group in the past year 
be redistributed over other groups, particularly the treated spermatozoa group in 
order to increase the numbers of F1 young, which were quite seriously depleted in 
the high TEM dose groups by dominant lethality. It is felt that the increase in 
the numbers of F1 young available will be necessary to establish statistically 
some of the important results implied by our data in the past year. 
It is also proposed that the antibiotic terramycin be administered uniformly 
to all females rearing young, control and experimental, F1 and F2 generation, nine 
days after the birth of a litter. It is our experience that the addition of anti-
biotic to the water of females rearing young counteracts virtually completely the 
effects of a disease, presumably bacterial in origin, that caused the death of sig-
nificant numbers of females in our studies. While the possible mutagenic action 
of the terramycin itself is a concern, it would be administered well after the birth 
of litters and therefore could not affect the gametes from which they develop. 
Further, the small quantity and limited duration of administration of antibiotic 
could hardly lead to significant mutagenic effects. Finally, antibiotic would be 
administered to control and experimental groups alike, and any effects could be 
partitioned out as error variance in our statistical analyses. 
It is suggested that the substitution of new traits for those which proved to 
be not too promising in studies of the past year be considered. It is recommended 
that brain weight after maturity be substituted for time of incisor emergence which 
proved to be of relatively little diagnostic value. 
It is further recommended that the substitution of a behavioral trait, perhaps 
-1 
some measure of physical activity, be considered in lieu of the righting response 
trait which showed little of interest in the study of treated spermatozoa in 
either generation. Inasmuch as this trait proved to be of considerable interest 
potentially in the mutagenized spermatogonia group, it might be well to continue 
to employ it for this group only. This possibility will be explored with the con-
tract officer before decision. 
Finally, the question as to the usefulness of cholesterol level as a quanti-
tative trait in this particular kind of study should be reserved until the data 
are in and analyzed. It is recommended that, should cholesterol level prove to 
be of little value, white blood cell count be substituted as a trait in the coming 
year's experiment. Dr. John B. Favor, Research Associate on the project, has had 
prior experience with the white blood cell count as a quantitative trait and, in 
fact, has found differences due to the action of a mutagenic agent. 
Everything considered, it is felt that the results of the first year's ex-
periments provide strong support for the continued effort to develop a mutagenic 
assay based upon polygenic mutations involving the use of quantitative traits \. 
In particular, the body weight trait has been shown to be reliable and to have 
considerable potential as an indication of mutagenic effect. Both tail length and 
hematocrit level have been found to show statistically significant variation due 
to mutagenic action, and both may prove to be quite useful in detecting genetic 
damage. Finally, the unusual patterns of sexually dimorphic variance differences 
in the righting response trait, in experiments involving treated spermatogonial 
cells, introduce a new and exciting possibility which should be explored. 
Data from dominant lethal parameters have clearly indicated a consistent 
dose response effect as expected for spermatozoan treatment, and have failed to 
show an effect where one would not be expected in spermatogonia. Our results with 
treated spermatocytes were equivocal, but very probably reflect the mutagenic/toxic 
action of the mutagenic agent employed. Perhaps the most significant overall ob-
servation is that, while the dominant lethal effect of TEM at all doses on sperma-
togonia was undetectable, effects on quantitative trait means and variances have 
indicated for a number of traits, the mutagenic action, of TEM upon spermatogonia. 
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The experiment proposed for the second year involved a repetition of those 
aspects of the experiment of the first year that appeared to require verifica-
tion or substantiation. It had been proposed that traits that appeared to be 
without merit be omitted and that additional prospectively valuable traits be 
tested. It was also anticipated that sample sizes might be altered if dictated 
by statistical analyses of the results of the experiment of the first year, 
and that the mutagenic agent itself might be replaced if desirable. 
Following discussions with the Project Officer, Dr. Eugene Soares, tri-
ethylene melamine (TEM) was selected as the mutagenic agent and the same agent 
has been employed in the experiments of the second year. Dosages selected for 
administration, .075, .15 and .30 milligrams per kilogram of body weight, were 
also employed in the experiments of the present year. As anticipated, sample 
sizes have been altered somewhat as dictated by the results of the first year, 
and there has been some substitution of traits based upon initial results. 
Finally, one of the germ cell stages tested (spermatocyte) in the first year 
has been eliminated from the present year's experiments in the interest of 
increasing the sample size for the other groups. It was possible to eliminate' 
this group because there was negligible, to slight response of all traits to 
all treatments at this stage. Treatment of both spermatozoan and spermato-
gonial stages revealed promising results, and treatment of both stages is con-
tinued in the experiments of the present year. 
In the experiments of the first year, the effect of TEM on F1 and F2 genera-
tion progeny was analyzed for eight specified traits. One of these, age of 
eruption of incisors, showed little promise and has been eliminated from the 
present experiment. Another of the original traits, serum cholesterol level 
at seven weeks of age, proved to be very time consuming, and a decision has 
not yet been made whether analyses will be continued in the present year's ex-
periment. We are still in the process of completing the spectrophotometric 
analyses of samples taken last year. However, analyses run to date for Fl 
generation progeny have revealed no significant differences. We are continuing 
to take serum samples (which are deep frozen for future analysis) should it be 
determined that the trait is, in fact, worth the effort. The remaining six 
traits of the initial experiment are being analyzed again in the present year. 
These include (1) young per female carried to weaning, (2) age of development 
of the righting response, (3) mean and variance of body weight at weaning, 
(4) length of tail at seven weeks of age, (5) sex ratio, and (6) hematocrit at 
seven weeks. In addition, we have added a seventh trait, which would be cate-
gorized as behavioral in nature, number of fecal pellets deposited in a five 
minute period, and (8) a morphological trait of high heritability, brain weight 
at 13 1/2 or more weeks of age. (For males and unproductive females, brains 
will be weighed at between 13 1/2 and 14 1/2 weeks of age. However, for pro-
ductive females brains will be weighed after litters have been weaned at about 
18 to 20 weeks of age.) 
The experiments of the present year have proceeded satisfactorily with 
(2) 
a minor problem relating to an unknown presumably bacterial illness, in the 
first shipment of mice, which reduced productivity of the first replicate 
males in both spermatozoan and spermatogonial F1 matings. While males were 
affected primarily in regard to fertility, there was some lethality among 
females. It is felt that the numbers of F1 generation young available for 
the establishment of F 1 crosses for mutagenized germ cell stages is adequate 
to provide useful information. The first F1 crosses for both replicates of 
the young of spermatozoan treated germ cell stages have been established. 
For the first replicate the matings have already been separated and for the 
second, mates are due to be separated prior to submission of this report. 
Design. In the experiments of the present year, parental females serving 
as parents for determination of the effects of different germ cell stages were 
assigned to temporally separated replicates A and B, which were mated to males 
which had been exposed to mutagenic action immediately prior to mating, thus 
involving mutagenized spermatozoa, while groups C and D represent groups of 
females mated to males which had been exposed to mutagenic action over seven 
weeks prior to establishment of matings, thus involving germ cells mutagenized 
as spermatogonia. According to original plan a total of 216 male mice were 
treated at about 11 weeks of age and mated immediately with 648 females for 
a period of one week. These matings were carried out in two separate repli-
cates, A and B, involving equal numbers of females, conducted approximately 
three weeks apart. Upon separation of the sexes, males were housed with fe-
males not involved in the experiment for a period of 6 1/2 weeks. Males 
which had been involved in the group A matings were then mated with replicate 
Cl females for a period of one week then with group C2 females for a second 
week. Similarly males which had been involved with group B matings were then 
mated with replicate Dl females for a period of one week followed in immediate 
succession by mating with group D2 females for a second week. 
The spermatogonial replicates were subdivided into two mating periods due 
to the unequal numbers of males in the different treatment doses. The adjust-
ment of male numbers in the different doses was designed to compensate for 
dominant lethal effects with increasing dose in the spermatozoan stage matings. 
Since there is inappreciable dominant lethal effects in the spermatogonial 
stages, equal numbers of females should be mated in the treatment doses. In 
order that all treatment groups be handled the same, the number of males in 
each of the dose groups was reduced to the number treated in the smallest 
dose group (control). To mate all females, this group of males was required 
to service approximately six females each. Therefore, spermatogonial groups 
C and D matings were separated into two one week mating periods in which each 
was mated to three females. When parental generation males were removed from 
the last matings in which they were to be involved, they were destroyed. 
As in the experiments of the first year, females were isolated from males 
and other females eighteen days after initiation of matings to prevent post 
partum matings and to avoid confusion of assignment of young to a particular 
litter or a litter to a specific female. Young were marked for identification 
and the sex recorded at birth. Subsequently data on the time of development 
of the righting response was recorded. Approximately 22 days after males had 
been removed from contact with females in a given group, autopsy of unproduc-
tive females for uterine scar data was initiated. 
(3) 
Young were weaned at four weeks of age. At weaning the young were per-
manently marked by ear punching, and the sex and body weight were recorded. 
The fecal count portion of the open field test was conducted on mice at five 
weeks of age. At approximately seven weeks of age, tail length was recorded 
and a blood sample was obtained, hematocrit level recorded and the plasma frozen 
and stored for cholesterol level determination, should that be determined to 
be desirable, at a later date. 
F1 matings for the spermatozoan treatment groups were established with 
individuals between eleven and twelve weeks of age; sibling pairs were pre-
cluded. The design calls for F1 pairs to remain together for two weeks at 
which time males are to be removed and their brain weights recorded prior to 
discarding. At the present time, males involved in the A replicate crosses 
have been separated from females and their brain weights recorded. Males in-
volved in replicate B crosses are scheduled to be separated and their brain 
weights recorded prior to the completion of this report. 
Methods. Parental males and females of replicate A were received from 
the Jackson Laboratory at ten weeks of age on August 4, 1976, as ordered. 
Males and females were housed five to a box, sexes separate until matings were 
established nine days later. Triethylene melamine was administered by intra-
peritoneal injections in Hank's Balanced Salt Solution prepared immediately 
prior to injection. As in the first experiment, a series of male mice were 
weighed to determine body weight, and all males within a dose group received 
the same quantity of carrier and TEM irrespective of individual variation in 
body weight. All mice received .25 cc of solution by injection, controls re-
ceiving the same quantity of carrier only. Injections were administered to 
replicate A males on August 13, 1976, and matings were established, three fe-
males to each male, immediately after injection. 
Replicate B males and females were received from the Jackson Laboratory 
on August 13, 1976. Males were treated on September 1, 1976 and matings esta-
blished immediately afterwards. This replicate was handled in precisely the 
same manner as the first. All males treated survived for a period of 24 hours 
and until the completion of the portions of the experiment involving them. 
For purposes of recognition males of replicates A and B were numbered 
respectively 1 through 109 and 501 through 609. Females were similarly ear 
punched for identification and were numbered for groups A and B respectively 
110 through 437 and 610 through 937. 
As indicated earlier, the numbers of pairs in each of the treatment groups 
were adjusted to compensate for the reductions in number of young expected for 
the higher dose rates. Employing the results of the first year, it was deter-
mined that the total number of males assigned respectively to the control, .075, 
.15, and .30 mg/kg groups would be 30, 30, 50 and 106. Males to be assigned to 
each of these groups were selected at random, and approximately equal numbers 
of males were included in A and B replicates. Similarly, females were assigned 
randomly to the different treatment groups in appropriate numbers. Following 
establishment of replicate A and B crosses, cages were labeled in such a way 
as to preclude group identification. 
(4) 
Replicate A matings were established on August 13, 1976; males were re-
moved on August 20, 1976, and placed with females not involved in the experi-
ment in an effort to maintain a normal level of sexual behavioral activity in 
the males. Approximately ten days later, in expectation of production of 
litters, trios of mated females were separated, one to a box. Replicate B 
matings were established on September 1, 1976; males were removed on September 
8, 1976. Approximately ten days later, trios of mated females were separated, 
one to a box. 
Females which were to be involved in matings to test the effects of 
treated spermatogonia were also handled in two replicates of 324 females 
each. The same males that had been involved in replicate A of the spermatozoa 
testing matings were assigned to replicate C in the spermatogonial matings. 
Similarly, males which had been involved in replicate B spermatozoan matings 
were assigned to replicate D of the spermatogonial matings. As described above, 
because of the small number of males involved in the control and lowest TEM 
dose groups of the spermatozoa test matings, it was necessary to divide the 
females within replicates into two groups of equal size to be mated in sequence, 
three females per male. 
Females of replicate C were received from the Jackson Laboratory on 
September 22, 1976, at 10 weeks of age and numbered 1001 to 1332 by ear punch 
and housed five to a box until matings were established. Half of these fe-
males were paired with males on October 4, 1976. After one week, on October 
11, 1976, these males were transferred to matings involving the remainder of 
the group C females. One week later, these second matings were terminated on 
October 18, 1976. Using identical procedures, females involved in the replicate 
D matings were received from the Jackson Laboratory on October 6, 1976 and 
numbered 1401 to 1726 by ear punch. These were divided into two groups of equal 
size, one of which was mated with males which had been involved in the replicate 
B matings on October 18, 1976. These matings were terminated one week later 
on October 25, 1976, at which time the males were transferred to matings in-
volving the balance of the replicate D females. These matings continued from 
October 25, 1976, until November 1, 1976. 
Each of the four treatment groups was represented by fourteen males in 
each of the replicates, C and D, for a total of 112 males. The 324 females of 
each of the two replicates were assigned randomly to males of the different 
groups, three females per male. For each treatment group one male was assigned 
only two females to compensate for the lack of sufficient females to provide 
three for every male. Following termination of the final matings, males of the 
parental generation were destroyed. Subsequently, females were isolated, one 
to a box, in anticipation of production of litters. 
As F1 young were produced, they were assigned temporary numbers, within 
litters, and this number was coded for identification by toe clipping. Subse-
quently, the young were weaned at four weeks of age, a permanent number was 
assigned, and the animals were identified by coded ear punching. Sex was 
recorded at birth and again at weaning (four weeks) along with body weight, 
the fecal count portion of the open field test was done at five weeks, and at 
approximately seven weeks the tail length was recorded and the blood sample 
was obtained. Hematocrit level was determined and the plasma frozen and stored 
in the event cholesterol level determinations were desirable. 
(5) 
F 1 matings were established with individuals between 11 and 12 weeks of 
age. Males and females of a pair were randomly selected except that sibling 
pairs were precluded. Experimental design calls for pairs to remain together 
for two weeks at which time, the brain weights of the F 1 male parents will be 
recorded before they are discarded. A total of 108 females were mated in F1 
generation crosses of replicate A. These matings were established on November 
22, 1976 and were terminated on December 6, 1976. In replicate B, 170 F1 females 
were mated on December 9, 1976. These matings were terminated on December 23, 
1976. 
In spite of our effort to compensate for dominant lethality the number 
of young produced by the replicate A females mated to males which had received 
a .30 mg/kg TEM dose was very low. Replicate A males continued to be of rather 
low productivity in group C matings. Fortunately replicate B males were not 
similarly affected, and efforts to compensate for dominant lethality in high 
dose groups was effective. The high productivity of replicate B matings appears 
to have been maintained in replicate D matings. The simplest hypothesis to 
account for this low productivity of replicates A and C males is that the ill-
ness which destroyed some females in the replicate A shipment, may have inter-
acted with the high TEM dose in males to bring about reduced fertility. 
A summary of litter production of different treatment groups of replicates 
A and B is shown in Table 1. A total of 174 litters were produced, based upon 
the observation of one or more young in a cage. A total of 130 of these litters 
had some young surviving at weaning. Of the 44 litters lost, about half were 
incurred in the high dose group. Interestingly, replicate A suffered a loss 
of five of the total of nine litters produced, the lowered total productivity 
possibly a result of the sickness observed in this group and alluded to above. 
By contrast, the females of replicate B lost about four times as many litters, 
24, but this constituted a considerably lesser portion of the 52 litters pro-
duced. In all but one of the four dose groups of replicates A and B, control 
and experimental, more males survived to weaning than females. 
Autopsy of the females of replicates A and B have been completed and 
preliminary results of uterine examinations will be outlined below. For the 
replicate A F 1 young, data have been recorded for all with respect to sex, 
time of development of righting response, weight at weaning, tail length and 
hematocrit. Brain weights have been recorded for males only. For replicate 
B F1 young the same data have been recorded except for brain weights. Cholesterol 
samples are available for all should analysis be indicated. Analyses of these 
data will be presented in the second semi-annual report. 
Replicate C and D series mothers produced a total of 141 litters, based 
upon the observation of one or more young in a cage. This represents an im-
pressive reduction in the total number of litters produced. However, the 
number of young surviving to weaning in the C and D replicates, (4.4 young per 
fertile female) was more than sufficient to offset the greater productivity 
of litters of replicates A and B in which only 3.5 young per fertile female 
survived to weaning. Thus, at weaning, 621 young were available for F1 crosses 
in the C and D replicate test of spermatogonial effect as compared with 606 young 
available for crosses in the F 1 young of the replicates A and B spermatozoan 
effect test. 
(6) 
Table 1. Size distribution of litters of Replicates A and B at birth and 
at weaning, including three experimental and one control group. Females 
producing these litters were mated for a period of seven days immediately 
following administration of treatment to male parents, and involving germ 
cells treated as spermatozoa. 
0 1 2 3 4 5 6 7 8 
52 .0 2 3 7 9 8 3 3 
55 0 2 2 8 9 5 4 2 
54 0 4 3 13 7 3 3 
57 0 2 4 11 7 4 2 1 
101 6 7 10 7 6 5 2 1 
113 0 2 10 7 6 4 2 1 
244 5 14 8 8 7 14. 5 0 
263 0 2' 5 8 10 5 5 0 
451 11 27 24 -35 29 30 13 5 
488 0 8 21 34 32 18 13 
control 
Litter size 
















Table 2. Size distribution of litters of Replicates C and D at birth and 
at weaning, including three experimental and one control group. Females 
producing these litters were mated for a period of one week seven and one-
half or eight and one-half weeks following administration of treatment to 











0 1 2 3 4 5 6 7 8 9 
120 4 1 2 3 9 4 10 4 0 
127 0 1 1 7 6 7 4 4 0 
117 0 3 1 4 3 7 4 4 
122 0 1 0 5 4 6 3 2 • 0 
134 1 1 4 7 12 4 6 3 0 
140 0 1 4 6 11 4 5 1 0 
133 0 2 4 9 6 9 3 4 2 
140 0 0 • 1 10 5 7 3 4 2 
504 5 7 11 23 30 24 23 15 3 
529 0 3 6 28 26 24 15 11 2 
Litter size 








Results. Compilations of the data on dominant lethality and related 
losses for the A and B replicates are shown in Table 3. While these data have 
not yet been submitted to statistical analysis, it is evident that the trends 
shown parallel very closely the results of the experiments of the first year. 
For both replicates the mean number of live scars per female decreases with in-
creasing dose, generally, as would be expected. This trend is the more consist-
ent if the results of both replicates are combined. In similar manner, total 
number born per female bearing young and the total number weaned per female 
carrying young to weaning show general trends in the direction of decreasing 
numbers with increasing dose. Reversals in this trend for the highest dose group 
in replicate B are not likely significant. Again, if the replicates are combined, 
the trends are consistent. With respect to total scars it is generally expected 
that slight decreases (if any) for lower mutagen doses will be followed by more 
dramatic decreases at higher doses. The data from the results of replicates A 
and B combined are consistent with this expectation. Such reductions in scar 
numbers at higher mutagenic agent doses are interpreted as resulting from pre-
implantation losses, which would be expected to increase at high mutagenic ex-
posures. The results of the experiments of the first year showed slight, non-
significant, increases in total scars from the control to the lowest mutagenic 
dose group followed by more striking decreases in total scars successively for 
the two higher dose groups (Fig. 1). The results of the present year's study, 
however, show slight decreases in total scars from the control to the lowest 
dose group followed by more appreciable decreases in total scars successively 
for the two higher dose groups. There appears to be a general reduction in total 
scars for all dose groups as compared with comparable dose groups in the studies 
of the first year. This reduction is due partly, though not entirely, to the 
reduction in fertility believed to be associated with the, illness discussed 
above. In Figure 1, our estimate of preimplantation losses is based upon the 
assumption that for a given dose, this may be computed as total scars minus to-
tal scars of the dose group being considered. On this assumption, it is evident 
that the total number of losses due to mutagenic agent (i.e., the sum of preim-
plantation losses and postimplantation losses represented by dead scars) in-
creases (with a proportionate decrease in live scars per female) with increasing 
mutagenic agent dose. 
In Figure 2, the dose response curves developed by Matter and Generoso 
(1974) are shown with data points from our own studies superimposed for compari-
son. These curves are based upon living embryos in each dose group as a percent 
of living embryos in the control group. So that our observations are precisely 
comparable to theirs, we have calculated, as did Matter and Generoso, live scars 
per mated female for the .3 mg/kg group as a percent of controls, but for lower 
doses we have employed live scars among fertile females only as a percent of 
controls. As pointed out in the final report of the first year, given the differ-
ences that exist between our methods and theirs (i.e., our use of an inbred strain 
as opposed to an interstrain hybrid, and postpartum analysis of uterine scars in 
our study as opposed to uterine analysis at twelve to fifteen days following plug-
ging in the Matter-Generoso study) our results are quite comparable. The slope 
of the dose response curve for the experiments of both the first and the second 
year being reported here represents a lesser rate of reduction in living embryos 
with increasing dose than was the case with the Matter and Generoso curves. 
As was reported for the first year's experiments, we have again observed an 
increasing number of losses at birth with increasing dose as reflected by the differ- 
-9- 
Table 3. Dominant lethality parameters with standard errors and sample sizes 
of Replicate A and B series females and their F1 young. Females belonging to 
the three experimental and a single negative control group were mated for a 
period of seven days immediately following treatment, thus represent effects 
of mutagenic agent upon spermatozoa. 
Replicate A 
Live Scars/9 	2.48 
Dead Scars/9 	.30 
Total Scars/ 9 	2.78 
Total Live Births/9 3.73 
Total Weaned/ 9 	4.65 
Replicate B 
Live Scars/ 9 	3.35 
Dead Scars/ 9 	.17 
Total Scars/ 9 	3.52 
Total Live Births/9 4.85 












TEM dose, mg./kg. of body weight 
.075 	 .15 
2.37 + 	.42(38) 	1.92 ± .26(75) 
	
.29 + .09(38) 	.57 + .12(75) _ 
2.66 + .46(38) 	2.57 + .31(75) _ 
2.95 + .47(20) 	2.02 + .36(45) _ 
3.27 + .54(15) 	3.25 + .55(24) _ 
2.83 + .45(47) 	1.44 + .27(72) 
.09 + .04(47) 	.25 + 	.07(72) _ 
2.91 + .46(47) 	1.69 + .31(72) 
3.65 + .19(26) 	2.92 + 	.39(24) 
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Figure 1. Relationship between per female live scars, dead scars and estimated 
preimplantation losses for females of three experimental and a single negative 
control group showing the effects of mutagenic agent upon spermatozoa. 
TEM dose, mg./kg. body weight 
Figure 2. Effect of TEM dose on induction of dominant-lethal mutations in mouse 
spermatozoa and spermatids. The curves represent least-squares fits of the numbers 
of living embryos vs. the doses. Ninety-five percent confidence intervals are in-
dicated by vertical bars. Taken from Matter and Generoso (1974) with results or 
the present study added for comparison. 
ence between the number of live scars and the number of live young actually ob-
served at birth. We have completed analyses of data for the experiments of the 
first year that indicate that these losses are clearly due to higher mutagen 
doses rather than to a litter size effect. Results of the present year will be 
similarly analyzed and included in a paper currently being prepared for publica-
tion reporting this interesting example of late dominant lethality. 
Other analyses of data already collected and of those to be collected in 




John W. Crenshaw, Jr. 
Project Director 
REPORT OF PROGRESS FOR RESEARCH CONTRACT NIEHS NO. NOI-ES-5-2135 
December 25, 1976 through June 22, 1977 
This document includes preliminary analysis of data acquired in the ex-
periment of the second year of the referenced research research contract, and 
involved repetition of the first year's experiment so that observations could 
be confirmed and new prospectively valuable traits could substitute for traits 
which appeared to be poor indicators of the mutagenic effects of treatment. 
As in the first experiment, triethylene melamine (TEM) was the mutagenic agent 
employed. Dosages remained the same: 0.0, 0.075, 0.15 and 0.30 milligrams 
per kilogram of body weight. However, the number of matings set in each dose 
group was altered to compensate for the dominant lethal effects of treatment 
in the high dose groups. The number of matings in the higher doses was in-
creased to produce a similar number of F1 progeny in all dose groups. TEM 
treatment effects were tested on spermatozoa and spermatogonial stages of 
spermatogenesis. 
In the first year the effects of mutagenic agent on spermatozoan, sperma-
tocyte and spermatogonial stages were tested. Results of this experiment 
suggested that little of interest would be gained by repeating investigation 
of the effect of mutagenic agent upon the spermatocyte germ cell stage. Re-
sponse of all traits to all treatments at this stage was negligible. However, 
treatment of both spermatozoan and spermatogonial stages revealed promising 
results, and treatment of both stages was continued in the experiments of the 
second year. 
The quantitative traits studied to determine the effect of mutagenic 
treatment on F1 and F2 progeny included (1) age of development of the righting 
response, (2) body weight at weaning, (3) the defecation portion of the open 
field test, (4) tail length at seven weeks, (5) hematocrit at seven weeks, 
and (6) brain weight at 13 1/2 or more weeks of age. In addition, producti-
vity traits were studied to determine if treatment was effective. These traits 
include (1) per cent dead implantation scars, (2) total implantation scars, 
(3) per cent females born, (4) total born, (5) per cent females weaned, and 
(6) total weaned. The productivity traits (1) and (2) determined by inspection 
of uterine scars were collected in the F1 generation only (inspection of parental 
generation females) while the,remaining productivity traits (3) through (6) 
were collected in the Fl and F2 generations (inspection of parental and F1 
generation females). Two of the traits investigated in the first year, age of 
eruption of incisors and serum cholesterol levels, showed little promise and 
were not included in the experiments of the second year. 
In using a technique to estimate induced dominant lethals which allows 
progeny to be born and weaned, an estimate of late losses can be made (from 
the difference between the number of scars indicative of live embryos and the 
number of live born). In a number of past experiments (Crenshaw and Favor, 
1976; Favor, unpublished; Soares, 1972) it has been observed that there was 
a treatment effect on the number of late losses. Therefore, since the data 
are readily available, we routinely estimate for this effect. As far as we 
are aware, all past dominant lethal studies have shown preimplantation and 
early post-implantation dominant lethal effects, but never a late post-implan-
tation effect due to mutagenic treatment. 
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Finally, in response to an hypothesis suggesting that the genetic 
effects on quantitative traits we observe are due to induced translocations, we 
tested the F2 male progeny descended from the replicate B spermatozoa treated 
parental males. 
The experiment of the second year has been completed including all initial 
statistical comparisons. With the exception of an unknown health problem in 
the first shipment of mice, which affected male productivity in both spermatozoa 
and spermatogonial F1 (replicates A and C matings), no problems arose. 
Design. The experiment of the second year was conducted to determine the 
effects of mut:agenic treatment in the spermatozoan and spermatogonial stages 
of spermatogenesis on quantitative traits. Each spermatogenic stage was repre-
sented by two temporally separated replicates of equal size. These replicates 
were designated A and B for the spermatozoan stage and C and D for the sperma-
togonial stage. Within each replicate, four dose groups were included 0.0, 
0.075, 0.15, 0.30 milligrams per kilogram of body weight of TEM. Parental males 
were treated and immediately paired for one week to three females to produce 
the spermatozoan stage treated groups. Males were subsequently housed with 
females not involved in the experiment for 6 1/2 weeks at which time the males 
were mated to females to produce spermatogonial stage treated groups. Thus, 
the spermatozoan stage group A and the spermatogonial stage group C were pro-
duced by the same parental males. Groups B and D are similarly related. Pre- 
cise timing of replicate matings is shown in Table 1. 
Females were isolated from each other eighteen days after initiation of 
matings and checked daily for the presence of a litter through day twenty-one 
after the termination of matings. Young were sexed and marked by toe clipping 
for identification at birth. Starting on day five, progeny were checked for 
the ability to right (righting response) and were checked daily until the trait 
appeared. All animals were weaned at four weeks of age, at which time body 
weight and sex were recorded and individuals were permanently marked by ear 
punching. The defecation portion of the open field test was conducted on mice 
at five weeks of age while tail length and hematocrit measures were taken on 
mice at approximately seven weeks of age. 
Matings of F1 individuals to produce F2 progeny were established when F1 
individuals were between eleven and twelve weeks of age. Crosses were set by 
randomly mating individuals within a dose and a replicate except that sibling 
crosses were precluded. Thus, four replicates were produced in the F2 genera-
tion each represented by four dose groups. The four replicates were designated 
A, B, C, and D, and correspond to the F1 replicates. (That is, F2A includes the 
F2 progeny of :replicate 1 spermatozoa treated males. F2B is the F2 progeny of 
repliCate 2 spermatozoa treated males. F2C and F2D are the F2 progeny re-
spectively of replicates 1 and 2 spermatogonia treated males). F1 matings were 
set for two weeks. Males were separated from females of the F1 matings, and 
brain weights recorded. Brain weights of females were recorded when litters 
of the group had been weaned. 
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Methods. A time course of the second year experiment is given in Tables 
1 and 2. 
Table 1. Time course of parental generation matings. 
Replicate 
A C D 
Mice received 8/4 8/13 9/22 10/6 
Matings set 8/13 9/1 10/4;10/11 10/18;10/25 
Matings separated 8/20 9/8 10/24;10/30 11/7;11/14 
Mice weaned 9/30-10/6 10/19-10/26 11/22-11/26; 12/6-12/13; 
11/29-12/6 12/13-12/20 









Matings set 11/22 12/9 1/12 2/3 
Matings separated 12/6 12/23 1/26 2/17 
Mice weaned 1/10-1/17 1/27-2/8 3/1-3/11 3/24-4/5 
Treatment consisted of intraperitoneal injection of triethylene melamine 
carried in .25 cc Hank's balanced salt solution. Doses were based upon the mean 
body weight of a random sample of the mice to be treated. The numbers of mat-
ings set in each dose were adjusted to compensate for dominant lethal effects 
in, the higher doses so as to produce similar numbers of F1 progeny. The total 
number of males treated in replicates A and B combined in the dose groups 0.0, 
0.075, 0.15, and 0.30 mg/kg of body weight was respectively 30, 30, 50, and 106. 
All animals were identified by a coded number so that all observations were 
blind with respect to dose. 
Since there are no substantial dominant lethal effects in spermatogonial 
treatment, replicate C and D dose groups were established with equal numbers of 
matings. With unequal numbers of males in the dose groups established for re-
plicates A and 13, the number of males mated in each dose group of replicates C 
and D was equal to the number of males in the smallest dose group (0.0 mg/kg 
with 30 males). To mate all females, each male had to service 6 females. Thus, 
replicates C and D matings were subdivided into two one week mating periods. 
A summary of productivity data for each replicate and dose in the F1 and 
F2 generations is given in Tables 3 and 4. In replicate A parental matings, 
treatment produced the expected effects on productivity data. Per cent fertile 
matings was reduced at the highest dose, litters born as a per cent of fertile 
matings was reduced at the two highest doses, and litter size at birth, litters 
weaned as a per cent of litters born, and litter size at weaning all decreased 
as dose increased. 
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For replicate B parental matings, treatment appeared to have reduced the 
per cent fertile matings at the 0.15 as well as the 0.30 doses. The number 
of litters born as a per cent of fertile females appears to have been affected 
only slightly by dose. Both litter size at birth and at weaning decreased as 
dose increased up to a dose of 0.15 but then increased slightly at the highest 
dose. Litters weaned as a per cent of litters born appeared to be reduced at 
the highest dose. 
As expected, no differences in productivity were found among spermatogonial 
treated parental matings (replicates C and D). In general, per cent fertile 
matings was low and was probably due to the large number of females each male 
was required to service. 
In the F1 matings, per cent fertile matings, the per cent of litters weaned 
that were born and litter size at birth is reduced as dose increased in the 
spermatozoa treated groups (replicates A and B) but not in the spermatogonial 
treated groups. Finally, with the exception of replicate A in which there was 
the possibility of an illness affecting productivity (see semi-annual Report 
of Progress June 76-Dec. 76), we were successful in producing similar numbers 




3. 	Productivity data of Parental matings. 
Dose 
	
0.0 	 0.075 
Females mated 	 46 	 38 
Females fertile 22(.48) 	20(.53) 
Litters born 	 17(.77) 15(.75) 











Litters weaned 16 12(.80) 16(.66) 4(.44) 
Litter size weaned 4.65 3.27 3.25 1.78 
Females mated 40 47 72 159 
Females fertile 20(.50) 26(.55) 24(.33) 62(.39) 
B Litters born 18(.90) 19(.73) 20(.83) 47(.75) 
Litter size birth 4.85 3.65 2.92 3.06 
Litters weaned 16(.89) 19(1.00) 15(.75) 31(.66) 
Litter size weaned 4.56 4.84 2.90 3.19 
Females mated 80 66 89 88 
Females fertile 15(.19) 16(.24) 32(.36) 19(.22) 
C 
Litters born 









Litters weaned 10(.83) 8(.88) 22(.81) 12(.70) 
Litter size weaned 4.92 5.22 4.15 4.18 
Females mated 78 77 83 83 
Females fertile 29(.37) 21(.27) 15(.18) 26(.31) 
D Litters born 25(.86) 18(.85) 12(.80) 22(.85) 
Litter size birth 4.52 4.52 4.27 4.62 
Litters weaned 20(.80) 12(.66) 10(.83) 20(.91) 
Litter size weaned 4.24 4.28 4.00 5.00 
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Table 4. 	Productivity data of F 1 matings. 
Rep. 
0.0 
Females mated 	 35 
Females fertile 30(.85) 
A 	Litter size birth/mated 	4.27 
Litters weaned 	 14(.46) 
Litter size weaned/ 




















Females mated 34 39 24 70 
Females fertile 31(.91) 31(.79) 19(.79) 51(.73) 
B Litter size birth 4.21 3.41 3.46 2.97 
Litters weaned 16(.52) 16(.52) 8(.42) 22(.43) 
Litter size weaned 2.45 2.16 2.26 1.94 
Females mated 31 17 54 32 
Females fertile 26(.84) 13(.76) 42(.77) 25(.78) 
C Litter size birth 3.68 2.47 3.48 3.69 
Litters weaned 12(.46) 4(.31) 24(.57) 17(.68) 
Litter size weaned 2.36 1.23 2.56 3.60 
Females mated 56 34 23 46 
Females fertile 45(.80) 27(.79) 17(.74) 39(.85) 
D Litter size birth 3.64 3.44 3.35 3.76 
Litters weaned 24(.53) 17(.63) 12(.70) 25(.64) 
Litter size weaned 2.58 2.85 3.47 3.31 
Results. Data on parameters associated with dominant lethality in fe-
males mated to males receiving spermatozoan treatment were provided in the 
Report of Progress submitted for the period ending December 24, 1976, as Table 
3. Means, standard errors and sample sizes were shown separately for replicates 
A and B for the following measures: live scars per female, dead scars per fe-
male, total scars per female, total live births per female and total weaned per 
female. Data had not been submitted to statistical analysis at that time, but 
it was pointed out that they paralleled very closely the results of experiments 
of the first year. From that report, "for both replicates the mean number of 
live scars per female decreases with increasing dose, generally, as would be 
expected." Replicates were combined in Figure 1 of the previous Report of Pro-
gress to show the similarity and trend of data from the first year's experiment. 
As has been reported total live births for replicates A and B showed parallel 
results, with numbers of live births per pregnant female being inversely re-
lated to dose. These same data, in modified form, are included in this report 
as Table 3. Subjected to statistical analysis, it was found that there were 
highly significant differences (P < .001) in live births per fertile female 
between dose groups and between replicates. Variance due to interaction proved 
to be not significant. The numbers of live births found for each dose group in 
replicate B was higher than in the comparable group of replicate A. Replicate 
and dose mean litter size at birth is shown in Table 3. 
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Young weaned per fertile female showed highly significant differences due 
to dose (P < .001), but the difference between replicates was not significant 
nor was interaction between replicate and dose. Data for replicates A and B 
have been combined in Table 5. Comparable data from the experiment of the 
first year are included for comparison. The close similarities are evident. 
Analysis of the results of variation in total scars must take into con-
sideration the likelihood that reductions in total scar numbers may be very 
slight, if any, for lower mutagen doses but will be followed by more dramatic 
increases at higher doses, presumably due to preimplantation losses, which 
would be expected to increase at very high mutagenic doses. Thus when we 
analyze our results based upon pregnant females only, those females that 
suffered complete loss of litter due to preimplantation loss are excluded. 
These expectations are consistent with our findings. In Table 3 of the last 
Report of Progress, total scars per mated female were shown to decrease rather 
regularly with increasing dose for both replicates A and B, except that the 
highest dose group of replicate B showed a reversal of the trend, i.e., total 
scars were slightly greater than for the next highest dose. Statistical analy-
sis of these results based upon square root transformation of total scars per 
mated female revealed that differences due to dose are significant (P < .05) 
while differences between replicates are not so. Interactions between group and 
dose were highly significant (P < .01), presumably due to the increase in repli-
cate B of scars per female for the highest dose group over the next highest. 
An analysis of square root transformation of total scars per fertile female  
eliminates the significant interaction variance as well as differences due to 
dose, however differences between replicates remain significant. This suggests 
that the interaction observed was likely due to the inclusion of large numbers 
of females with zero scars in the "per mated female" analysis (perhaps combined 
with the effect of an illness in replicate A which may have affected these mean 
values). While total scars per mated female for replicates A and B may not be 
combined for statistical purposes, we have included combined weighted means for 
descriptive purposes in' Table 5. Comparable values for the experiments of 
the first year are included to show the similarity. The decreases in total 
scars with increasing mutagen dose in the experiments of both first and second 
years were significant, and it is clear that the dose response curves are very 
similar, involving inappreciable differences between the control and lowest 
mutagen dose, modest reductions in total scars at the next highest dose and 
striking reductions at the highest mutagen dose. 
In Table 3 of the last Report of Progress, dead scars per mated female  
revealed a pattern involving little difference between the control and lowest 
mutagen dose groups followed by an increase in the next highest dose group and 
contrasting responses in replicates A and B with respect to the highest dose 
group, with a remarkable drop in numbers in replicate A and a negligible in-
crease in numbers in replicate B. However, these figures, based upon dead scars 
per mated female may have been affected inordinately, as were analyses of total 
scar variation, by the very low fertility of females in the highest dose group 
of replicate A. 
A more useful measurement of variation in dead scars is percent dead  
scars of total scars, which may be analyzed either on a "per fertile female" 
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or a "per mated female" basis. We have carried out statistical analyses on 
both bases. The per mated female analysis has the disadvantage that a decision 
has to be made as to whether infertile females should be treated as having 
lost all their young prior to implantation. Either approach is patently in 
error, but the evidence indicates that preimplantation loss may be very high 
for high mutagen dose groups and not very important for low dose and control 
groups. 
Table 5. Dose responses of selected indications of dominant lethality with 
standard errors and sample sizes of parental series females and their F1 
young comparing results of experiments conducted in 1975-76 (I) with those 
carried out in 1976-77 
Trait 
(II). 
Year TEM dose in mg./kg. of body weight 
0 	.075 	.15 	 .30 
Total weaned/fertile I 7.97 + .27 4.20 + .25 3.86 + .32 3.74 + .36 
**II 4.60 T .35 4.51 T .32 3.09 + .36 _ 2.96 + .34 
Total scars/mated *I 4.01 + .36 4.10 + .32 3.29 + .30 1.86 + .25 
*11 3.13 T .45 2.80 -1  .33 2.14 + .22 1.46 + .14 
Dead scars per cent **I 10.4 19.0 21.3 20.9 
of total scars **II 7.8 6.3 19.4 17.0 
Late losses per cent I 21.86 + 4.59 26.27 + 5.02 44.29 + 5.52 54.50 + 7.10 
of total scars II 25.44 IT 5.27 36.33 T 6.02 39.45 T 5.36 41.90 + 4.42 
* P < .05 
** P < .01 
In any event, the statistical analyses, carried out after arc sine transforma-
tion of per cent dead scars of total, per mated female, were not very satis-
factory even though effects due to variation in mutagenic dose are highly sig-
nigicant. However, variance due to interaction between replicate and dose, 
probably due to the same factors discussed above, is also highly significant. 
Analysis on a per fertile female basis is more satisfactory, with differences 
due to dose and replicate each being highly significant, but differences due to 
group X dose interactions negligible. 
Data on per cent dead scars of total are the most meaningful and therefore 
persuasive of the data in the study that the mutagenic agent administered has 
been effective. While, again, we have submitted our data to factorial ANOVA 
after arc sine transformation by replicate and dosage froups, for descriptive 
purposes it is useful to combine the two replicates to produce weighted group 
mean values for the separate dose responses. These are shown in Table 5 with 
the results of the study of the first year also shown for comparison. Indica-
tions of statistical significance are based upon ANOVA of arc sine transformed 
percentage values. 
As noted in the last semi-annual report, in the results of both the first 
and the second year's experiments, we observed an increasing number of losses 
at birth with increasing mutagen dose. This loss was computed as the difference 
between the number of uterine of live scars and the number of live young actually 
8 
observed at birth. We have now completed analyses of the data for the experi-
ments for both years. The results of the first year's experiment, as reported, 
revealed significant differences between dose groups, and are supported by the 
mean distribution of the experiments of the second year. A factorial analysis 
of variance of the differences between dose groups with respect to percentage 
late dominant lethal losses of total scars for both years reveal that the differ-
ences were highly significant (p < .001). Similarly the differences between 
the experiments of the first and second year were highly significant (P < .001); 
interaction between experiment and dose was not significant. Results of an 
ANOVA after arc sine transformation of data resulted in similar conclusions 
except that the probability of chance error was increased (P - .03). In order 
to reduce the chances of committing a Type I Error, our data were modified 
by a correction factor to determine if misclassifications of dead scars as live 
scars could account for the differences observed. Although, differences be-
tween dose groups were no longer significant, it was found that the correction 
factor could not account for the variation observed, and that the basic pattern 
of increase in late dominant lethal losses as a function of increasing mutagen 
dose was still evident. Late dominant lethal loss means are shown (Table 5) 
as a percent of total scars for the separate dose groups for the experiments 
of the first and second year. 
All group B F2 males (154) were tested for semi-sterility to determine 
if they included translocation heterozygotes. A stock of randomly mated females 
with high productivity (CD-1, Charles River Breeding Laboratories) was used to 
test males. Each male was paired to two females. Eighteen days after matings 
were set, females were sacrificed and their uterine horns examined for live 
and dead embryos. Matings were set on 4/15/77 and 4/18/77 and females dissected 
on 5/2/77, 5/3/77, and 5/4/77. In those cases where the results indicated the 
possibility that the male (12) might be a translocation heterozygote, additional 
matings (two females) were set on 5/6/77 and females dissected on 5/23/77. No 
male had fertility data which would classify it as a translocation heterozy-
gote. One male proved to be sterile in all matings and is being retained for 
chromosomal examination. However, it is unlikely that a translocation causing 
such infertility could have survived to the F2 generation. 
With respect to dominant lethal parameters for females producing young 
which were the products of fertilization by spermatozoa exposed to mutagenic 
treatment in the spermatogonial state, there were significant differences be-
tween dose groups in replicate C (P < .05) only with respect to percent dead 
scars of total. The high variance between groups was due largely to relatively 
high dead scar percent (14.3%) in the lowest mutagen dose and a relatively low 
percent dead scars (4.6%) in the highest mutagen dose. Replicate D exhibited 
no significant differences with respect to this trait, nor was there any simi-
larity in general to the pattern exhibited by replicate C. Since there is no 
simple biological explanation to account for the pattern in replicate C it is 
felt that unusually great chance variation may be involved. In the experiments 
of the first year, there were no significant differences observed among com-
parable groups for any dominant lethal measure. 
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Quantitative traits. The primary purpose of the experiments conducted 
over the past two years has been to determine the usefulness of quantitative 
traits as indicators of mutagenic activity. In studies of the first year 
and in earlier experiments our results have indicated that mutagen induced 
polygenic mutations, that is mutations of minor effect, may have effects both 
upon the means and the variances of some quantitative traits. Our results 
of the first year indicated that some traits were particularly useful while 
others were not, and that differences due to mutagenic treatment might be 
detected in either the F 1 or F2 generation progeny of mutagenized males. 
While information from either generation may be of interest as an indicator of 
genetic damage following mutagenic treatment, in general effects observed in 
the F2 generation are more certainly attributable to a genetic basis than those 
of the F1 generation. Nevertheless, genetic causation is likely even if it 
cannot be conclusively demonstrated to be a cause of observed F 1 generation 
effects. 
Our results of the second year have, in some cases, supported conclusions 
arrived at in the first year. In other cases, traits were not found to be so 
broadly useful as might have been hoped. In still others, traits which did 
not appear to be particularly useful in the first year's experiment proved to 
be of potentially greater usefulness than had been anticipated. In general, 
our decision to divide the total experiment into two successive replicates re- 
duced the potential to demonstrate significant differences within each replicate. 
Unfortunately, this potential was even more adversely affected by an illness 
which affected our replicate A. Even so, this experience can be useful in 
providing some idea as to the extent of environmental variation acting upon 
the traits investigated. Finally, sexual dimorphism was found with respect to 
every trait investigated thus necessitating factorial analyses or comparisons 
within a given sex. 
In the analyses to follow, we will first deal with the effects of mutagenic 
treatment upon the spermatozoan stage of spermatogenesis in the F1 and F2 genera-
tions. Subsequently we will consider the effects of mutagen treatment upon the 
spermatogonial stage of spermatogenesis in the F 1 and F2 progeny. 
Effects of Mutagen on Spermatozoa: F 1 Generation 
In broad overview, results of the second year's experiments (Experiment II) 
were similar to and support those of the first year (Experiment I) with respect 
to hematocrit where it was evident that increases with increasing dose occur 
in a roughly linear manner. Differences between the two replicates of Experiment 
II are not significant so that they may be combined. 
With respect to body weight and tail length, results tended to be in the 
same direction in Experiment II as in Experiment I. However, differences due 
to dose were not significant, and individual experimental face value means 
were not always greater than those of their controls as predicted. 
Data were obtained for the time of development of the righting response  
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in Experiment II primarily because of data suggesting an interesting effect 
in the F2 generation of Experiment I. However, data obtained for F1 genera- 
tion young in Experiment II proved to be quite interesting in their own right. 
When the effects of litter size were partitioned out, there remained highly 
significant differences due to both dose and sex. Since there were no sig-
nificant interactions between group and dose effects, the two replicates 
could be combined for analysis. In general, there appeared to be a decrease 
in rate of development with increasing mutagen dose. 
With respect to two new traits analyzed, the defecation portion of the open  
field test and brain weight at 13 1/2 or more weeks of age, no significant 
differences were found due to mutagen dose. With respect to the defecation por-
tion of the open field test it was found that there was significant variation 
in this trait due to litter size (p < .05) and there was a highly significant 
difference between sexes (p < .01). However mean differences between dose 
groups were very slight and showed no suggestion of any of the several types 
of patterns that have been evident in data with respect to other traits. 
Accordingly, we will eliminate the defecation portion of the open field test 
from future experiments. 
The situation with respect to brain weight is more interesting. While 
differences due to dose were not significant (P - .21), a modest increase in 
the sample size with similar variances and distribution of means might well 
lead to a demonstration of significant differences. An interesting pattern 
of mean distribution also emerged in that, without exception, the brain weights 
of all progeny of treated males was greater than the appropriate control. These 
results will be treated in greater detail below, and it is planned that future 
experiments will continue to explore the usefulness of mutagen effects upon 
brain weight. 
In final analysis, hematocrit appears to be a most useful trait for 
detection of mutagenic effect in F1 generation progeny involving mutagenized 
spermatozoa. Although the magnitude of the differences is not as great as has 
been found for some traits, relatively low variation within groups would 
seem to make mean differences very useful as indicators of genetic effect. 
Whether hematocrit variance will prove to be of usefulness or not will de-
pend upon additional evidence. Very likely it will be necessary to employ 
much larger sample sizes than have been employed to date to detect effect 
upon variance. 
Body weight. The exciting results of Experiment I were not uniformly con-
firmed in Experiment II. As expected, litter size was shown to have a highly 
significant effect upon body weight. After partitioning the effect of litter 
size, highly significant differences were found to exist between replicates and 
between sexes. While differences between dose groups were not significant 
(p 	.16), in general the mean body weight of progeny of mutagenized males 
were greater than those of controls as in Experiment I. The only exception to 
this was the high mutagen dose group of replicate B. Mean body weights for 
Experiments I and II sexes (and replicates of Experiment II) combined, are 
shown in Table 6. 
The distribution of variances in Experiment II is in remarkable contrast 
with those of Experiment I. In the latter experiment variances of the progeny 
of mutagenized males were uniformly lower than those of controls, more often 
than not significantly so. By contrast, in the experiments of the present year 
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Table 6. Means of hematocrit at seven weeks, body weight at weaning, tail 
length at seven weeks, time of development of righting response, and brain 
weight at 13 1/2 or more weeks of age in F1 generation progeny of three ex-
perimental groups and a single negative control for two experiments showing 
effects of TEM upon spermatozoa. Replicates for Experiment II are combined. 
Means over solid lines at the same level, whether continuous or connected by 
dashed line, are not significantly different by multiple range comparison. 
Experiment Dose (mg./kg.) 0 .075 .15 .30 
I 	Hematocrit 	e & ? 48.24 48.42 48.67  	48.79 
II 46.05 46.27 46.28 46.53 
cr 
46.79 46.97 47.26 47.16 
*********** 
I 	Body weight cr & ? 13.06 13.54 13.94 14.05 
II 	 & 14.46 14.66 14.84 14.44 
*********** 
I 	Tail Length e & ? 69.75 70.82 70.80 70.58 
II 	 e & ? 73.99 74.26 74.30 74.42 
********* 
I 	Righting Response 
8.10 8.33 8.20 8.30 
8.03 7.89 7.86 8.74 
II 	 (11 7.52 7.20 7.81 7.96 
? 7.28 7.23 7.44 7.31 
*********** 
II Brain size 	d & ? 419.86 	422.59 422.03 422.16 
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Table 7. 	Variances of hematocrit at seven weeks, body weight at weaning, tail 
length at seven weeks and time of development of righting response in F 1 genera-
tion progeny of three experimental and a single negative control group showing 
effects of TEM upon spermatozoa. 	Indications of statistical significance per- 
tain to variance ratio comparisons with appropriate controls. 
Experiment Dose (mg./kg.) 	0 	.075 	.15 	.30 
I 	Hematocrit 1.74 1.64 3.20** 1.56 
2.10 2.37 3.80** 2.16 
II 	 9 2.65 2.90 2.67 3.09 
2.34 2.32 1.90 1.49* 
I 	Body weight 5.34 3.50* 4.28 2.02** 
7.62 4.45* 6.81 2.46** 
HA 1.77 2.43 3.06 1.56 
2.34 3.92 2.43 1.30 
IIB 	 9 2.01 2.25 3.50 3.42 
2.82 2.82 3.06 3.92 
I 	Tail length 	9 13.03 9.80 9.24 6.71 
9.67 9.99 12.18 4.04** 
IIA 	 9 4.37 3.88 5.52 2.56 
5.34 7.24 7.40 2.50* 
IIB 	 2 9.00 4.38* 4.20* 4.28* 
4.45 4.54 4.37 4.16 
I 	Righting response 
9 1.66 2.28 2.82* 2.10 
e 2.46 2.59 2.72 1.74 
II 	 9 .95 1.47* 1.09 1.04 
.82 1.05 1.11 1.01 
* p < .05 
** p < .01 
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the reverse is generally true, the only exception being the high dose group 
of replicate A in which variances for both males and females were below those 
of controls. However, no significant differences were observed between any 
experimental group and its appropriate control. Perhaps the reduction in num-
bers associated with splitting the total sample into two replicates has made 
it difficult to reveal meaningful variation in body weight variances. 
Hematocrit. Variation in hematocrit was analyzed by factorial ANCOVA 
by mutagen dose, replicate, and sex with litter size. Effects due to litter 
size and replicate were not significant. Effects of mutagen dose were signifi-
cant (P < .05) and highly significant sexual dimorphism was found (P < .001). 
This latter result is in contrast with those of the results of the first year 
where differences between sexes (in the same direction as in Experiment II) 
were not significant. Mean values for males and females combined in Experiment 
I and tabulated separately for Experiment II are shown in Table 6. It is evi-
dent that F1 progeny of mutagenized males invariably show higher hematocrit 
values than their appropriate controls. In the experiment of the first year 
it was found that the middle mutagen dose only was significantly higher than 
control, but the small sample size of the highest mutagen dose may have pre-
vented demonstration of significance which for the highest mean value ob-
served in the comparison. In the experiments just completed, while our analy-
sis of variance indicates that there are significant differences between dose 
groups, a multiple range test, which considers the number of comparisons being 
made, does not lead to conclusions of significance for any comparison. How-
ever, the values that most closely approach significance are those for the 
highest mutagen dose in comparison with control for females, and the two highest 
mutagen doses as compared with control for males. 
With respect to variance comparisons of hematocrit, patterns that emerge 
are not really convincing although certain points of interest remain. In 
Experiment I the two significant differences that occurred were between the 
(high) variances of males and females of the middle mutagen dose and the (low) 
controls. In other comparisons with controls male progeny of mutagenized males 
exhibited higher variances, females lower. In Experiment II precisely the 
reverse trend is evident. Experimental variances for female F1 progeny are 
uniformly higher than those of controls, and experimental variances for F1 male 
progeny are without exception lower. Only one of these comparisons is signifi-
cant, that for the high dose male group in comparison with the male control. 
Tail length. Analysis of variation in tail length by factorial ANCOVA 
indicates that there is highly significant variation associated with litter 
size, between replicates and between sexes, but differences among dose groups 
are not significant. After correcting for litter size, there is a roughly 
linear increase in tail length with increasing mutagen dose as in Experiment I. 
However these differences are not significant as they were in Experiment I. 
Means corrected for litter size for Experiment I and Experiment II, sexes and 
replicates combined, are shown in Table 6. 
Variances with respect to tail length in Experiment I showed, in general, 
reductions among female progeny of mutagenized males relative to controls (Table 
7), but increases among male progeny of mutagenized males relative to controls 
(except for the high dose group where small sample size was a problem). In 
Experiment II, considering replicates and sexes separately, all female progeny 
of mutagenized males except one (of six groups) exhibited tail length variances 
of lesser magnitude than controls, and three of these were significant. Tail 
14 
length variances for male progeny exhibited no pattern in comparisons of con-
trol and experimentals, although the replicate A, high mutagen dose group was 
significantly lower than its control. Small sample size (N = 11) could be 
the responsible factor. 
Righting response. As indicated above, in Experiment II, data obtained 
with respect to the effect of mutagenic agent on the time of development of 
the righting response proved to be more interesting than anticipated. It 
was found that there was highly significant variation associated with litter 
size and with sex. Differences between dose groups were also highly significant 
(P < .001). A significant dose x sex interaction was also found. Since there 
was no suggestion of a difference between replicates,of significant group x 
dose or group x sex interactions, replicates were combined for purposes of 
this analysis. 
In the experiments of the present year, there is a general trend in both 
replicates for an increase in the time of development of righting response with 
increasing mutagen dose. Interestingly, the lowest mutagen dose appears to 
have no effect on the effect of reducing developmental time, but in both sexes 
of both replicates the high mutagen dose is associated with a longer develop-
mental time than that of the control (and the low mutagen dose groups). The 
phenomenon is especially evident in females where a multiple range test in-
dicates that the high mutagen dose is associated with a significantly longer 
time to development of righting response than the control group, and both high 
and middle mutagen dose groups have significantly longer times to develop- 
ment of the righting response than the low mutagen dose. Interestingly the 
increase in rate of development, i.e. reduction in time of development to the 
righting response, associated with the low mutagen dose group approaches sig-
nificance in comparisons with the control. We have observed this pattern be-
fore in respect to other traits, and it may well be real. 
A reexamination of the results of the first year's experiment reveals cer-
tain similarities of these patterns except that the males showed a more pro-
nounced effect in that experiment than the females,in contrast with those of 
the present year. However, face value means for both males and females for 
the high mutagen dose groups were greater than for their respective controls. 
For the male group there was also observed a reduction in time of development 
to righting response for the low and middle mutagen dose groups below that of 
control. The probability that the differences between dose groups were real 
was sufficiently high (p 	.25) so that these results were not singled out for 
critical discussion. The means for Experiment I and II are shown in Table 6 
with replicates combined for Experiment II. 
With respect to variation in variance of the righting response, there is 
limited variation between doses,and male variances are generally lower than 
those of females. In a comparison of variances with sex, replicates combined, 
those of progeny of mutagenized males are uniformly higher than those of con-
trols and one of these differences is significant (Table 7). A similar trend 
was seen in the first year's experiment, the only exception being the variance 
for the high mutagen dose male group. One of the increases in variance in an 
experimental group over that of control is significant. 
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Brain weight. Brain weight was one of the traits introduced for the first 
time in the present year's experiment and would seem to have some promise in 
spite of the fact that the difference between dose groups was not significant 
(P 	.21). It will be evident that similar differences and variance with 
twice the number of experimental subjects employed would produce an impressive 
level of significance. Of greater importance is the fact that a pattern emerges 
from these results that would be of interest as an indicator of mutagenic 
activity, if the differences observed approximate reality. Our analysis of 
variance indicates that brain size is not significantly associated with 
litter size. However, there are highly significant differences between re-
plicates and between sexes. Interactions between group, dose and sex were 
not significant. 
Examining the distribution of means for both replicates, sexes considered 
separately, the generalization that emerges is that with two exceptions (out 
of 12 comparisons possible) progeny of mutagenized males exhibited larger 
brain size than did their appropriate controls. The difference between brain 
size of sexes is likely due in large part to the fact that females were approxi-
mately one month older than males when their brains were weighed, in order to 
permit rearing of litters. Since there were no significant interactions be-
tween dose and group or dose and sex , for simplification, we have shown 
dose means adjusted for litter size with sexes and replicates combined, in Table 
6. Variance with respect to brain weight showed no patterns of interest and 
rather limited variation. 
Effects of Mutagen on Spermatozoa: F 2 Generation 
The traits that stand out as being of interest in effects in the F2 
generation following treatment of spermatozoa include the righting response  
in which the pattern of distribution of means was strikingly similar to differ-
ences observed in the F1 generation with reduction in developmental time at 
low doses but increase at higher doses. Again, following the partitioning of 
litter size effects, there remain highly significant differences due to dose. 
Reexamination of the results of the first year's experiments fail to reveal 
any similarity with the results obtained in the present year's study. 
Brain weight proved to be a particularly exciting possibility for F2 
generation analysis. It was found that effects due to litter size and repli-
cates were highly significant (P < .001) as were those due to dose (P < .003). 
The most evident difference was the increase in brain size associated with the 
lowest mutagen dose over control brain size, followed by a more or less linear 
reduction in size with increasing dose. Means for all of the experimental 
series groups remained above the control means. 
While differences associated with dose in regard to tail length were not 
significant, they were nearly so, and patterns that emerged resembled rather 
closely patterns of the first year's experiments. These will not be reported 
upon in further detail here but it is planned that more detailed analyses will 
be carried out in the future to investigate the possibility of repeatable 
patterns that could be of usefulness. 
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With respect to the other traits examined, there was little of interest. 
The defecation portion of the open field test showed no significant differences 
due to dose, nor was the pattern of mean distribution particularly interesting. 
Similarly, differences due to dose in regard to body weight were not signifi-
cant. Although, as would have been predicted from the first year's experiments, 
body weights for all three experimental series groups when adjusted for litter 
size were greater than the mean body weight of the control group. The pre-
diction of an increase in body weight variance for experimental groups over 
those of controls was not confirmed by the present year's experiments. Of 
the ten comparisons possible, only six were in the predicted direction. Differ-
ences among dose groups with respect to hematocrit variation also proved not 
to be significant, nor was there any pattern of interest in the distribution 
of means. 
In summary the time of development of righting response and brain weight 
would appear to be the most useful characters for F2 generation analysis of 
mutagen effect upon spermatozoa. The consistency of increase in body weight 
in the F2 progeny of mutagenized males over that of controls also suggests that 
this trait would be a useful indicator, particularly in dose response analyses. 
Table 8. Means of time of development of righting response, brain weight 
at about 13 1/2 weeks and body weight at weaning in F2 generation progeny 
of three experimental groups and a single negative control for two experi-
ments showing effects of TEM upon spermatozoa. Replicates of Experiment II 
are combined. Means over solid lines at the same level, whether continuous or 
connected by dotted line, are not significantly different by multiple range 
comparison. 
	
Experiment Dose (mg./kg.) 	0 	.075 	.15 	.30 
II Righting response 	8.53 	7.88 	9.05 	8.24 
II Brain weight 	411.97 	419.32 	413.95 	414.45  
408.99 	417.10 	412.50 	416.36 
I Body weight 12.79 	13.19 10.87 	13.00 
   






Righting response. An analysis of variance of variation in time of de-
velopment of the righting response revealed that there were highly significant 
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effects associated with litter size (P < .001), but differences between repli-
cates and due to sex only approached significance (P < .10). Differences 
among dose groups were highly significant (P < .01). For males and females 
and replicates A and B there was a consistent reduction in time of development 
of the righting response in the lowest mutagen dose group below that of con-
trols followed generally by a slowly increasing time of development with in-
creasing mutagen dose. Replicates and sexes have been combined in Table 8. 
Had the means been adjusted for variation in litter size, linearity of the 
response would be more evident. The simplest interpretation of these results 
is that the slightest amount of mutagen induced variation has the effect of 
shortening developmental time appreciably. With increasing mutagen effect, 
i.e., genetic damage, developmental times are not so strikingly reduced. 
Comparing these results with those of the F 1 generation (Table 6) it may be 
seen that the same pattern was present except that developmental time was not 
shortened so noticeably at comparable doses and, at the highest mutagen doses, 
experimental means exceeded control group means. This interpretation is based 
upon the assumption that a very limited amount of mutagen induced polygenic 
variance may provide a buffering effect that permits more rapid development. 
With increasing mutagenic damage, however, the cumulative effects of deleterious 
mutations will gradually mask the buffering effects of those polygenic muta-
tions with effects in the normal range of variation. Rate cf development is a 
phenomenon closely related to fitness, and it might be predicted that other 
fitness traits would show a similar pattern where the direction of "bad" or 
"good" effect can be determined in a relatively straightforward manner. 
Variance in regard to righting response showed no particular pattern. Of 
ten comparisons possible, exactly five experimental variances proved to be 
greater than their controls, but only one of these was significantly so. 
Brain weight. An analysis of variance of the variation in regard to brain 
weight showed that there was highly significant variation (P < .001) associated 
with litter size and between replicates. Differences between the sexes were 
not significant. It is worth noting that brain weights were taken from males 
and females at the same age in the F2 generation. Differences among dose groups 
were highly significant (P - .003) and interactions between group, dose and 
sex were not significant. 
The pattern of distribution of means that emerges is very interesting, 
almost the mirror image of the pattern of distribution of means for the 
righting response, and the interpretation may well have a similar basis. In 
brain weight, the lowest mutagen dose produces the greatest increase in brain 
weight over that of controls followed by a slow more or less linear decrease 
in the brain size which however never falls to the level of controls. Our 
interpretation is that a modest increase in genetic variance induced by a re-
latively slight mutagen dose will permit the inbred experimental animal to 
develop a larger brain. With increasing amounts of variance, and the cumulative 
effects of deleterious mutants, these effects are masked increasingly with 
increasing mutagen dose. From examination of the results of the F1 generation, 
where total amounts of mutagen induced variation would have been greater than 
in the F2 generation (Table 6), it can be observed that the difference between 
the control and the lowest mutagen dose group is not as great as that between 
the same groups in the F2 generation. The subsequent decrease in brain size 
with increasing dose falls to approximately the same level, relative to controls, 
as that in the F2 generation. 
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It should be noted that there is the very exciting possibility that using 
these two traits, righting response and brain weight, the sensitivity of the 
test for very low mutagen doses is quite high. 
With respect to variation in regard to brain weight variance, experimental 
variances in all six comparisons (two sexes, three doses), replicates combined, 
are lower than those of their appropriate controls, and two of these differences 
are significant. 
Table 9. Variances of brain weight at about 13 1/2 weeks in F2 generation 
progeny of three experimental and a single negative control group showing 
effects of TEM upon spermatozoa. Replicates are combined. Indications of 
statistical significance pertain to variance ratio comparisons with appropriate 
controls. 
Dose (mg./kg.) 0 .075 .15 .30 
Females 248.00 220.09 156.02* 198.53 
Males 249.19 173.18 140.23* 184.96 
* P < .05 
Effects of Mutagen on Spermatogonia: F
1 
Generation 
As in the experiments of the first year there were very few strongly per-
suasive evidences of quantitative effects in F 1 progeny of mutagenized males 
where treatment was administered to spermatogonial stages. Brain weight stands 
out as an exception to this generalization. Dose was found to have a highly 
significant effect upon brain weight, with the progeny of mutagenized males in 
all except one of the sex-dose groups exhibiting greater brain weights than 
its appropriate control. An interesting difference in dose response between 
the sexes necessitates that dose comparisons be made separately for males and 
females. 
With respect to tail length there were highly significant differences due 
to dose, but the pattern of mean distribution does not make a great deal of 
sense at this stage of analysis. There were also highly significant differences 
between groups, between sexes, and the dose by sex interaction was sufficiently 
great to approach significance. Analyses of this trait will continue in the 
future. 
Analysis of the defecation portion of the open field test indicated that 
there were differences among dose groups of borderline significance, the general 
pattern of distribution suggesting an increase in mean value with increasing 
dose in a roughly linear fashion. These means, with sexes and replicates com-
bined and adjusted for variation in litter size (which was not however signi-
ficant), are presented in Table 10. Inasmuch as this trait was examined for 
the first time in the present year's experiments, it will be desirable to seek 
confirmation of this result in future experiments. 
Differences due to dose with respect to hematocrit and body weight were 
not significant, although there were the expected highly significant differ- 
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ences between replicates and sexes. Variation in body weight variance in 
the first year's experiment showed a pattern of uniformly reduced variances 
among experimental groups relative to controls, and half of the six comparisons 
possible were significant reductions. In the results of the present year's 
experiment, this pattern is not seen. Of the twelve comparisons possible (two 
replicates, two sexes, three mutagen doses) only five experimental variances 
are lower than their appropriate controls. 
Table 10. Means for brain weight at 13 1/2 weeks or more, tail length at 
seven weeks and defecation rate in F1 generation progeny of three experimental 
groups and a single negative control for two experiments showing the effects 
of TEM upon spermatogonia. 
Experiment Dose (mg./kg.) 	0 	.075 	.15 	.30 
II Brain weight 	? 	424.53 	426.70 	430.05 	426.79 
409.27 	413.60 	411.57 	417.05 
I Tail Length 	 63.5 	65.33 	55.87 	67.79 
II 	 75.26 	75.69 	74.54 	75.46 
II Defecation 	 3.28 	3.54 	3.80 	3.83 
Brain weight. Brain weight was not found to vary significantly with 
variation in litter size. However, there were highly significant differences 
(P < .001) between replicates and between sexes. There was also a significant 
dose x sex interaction (P - .02). Accordingly dose group comparisons were 
made within sexes. Examination of the general effect of dose suggests an in-
crease in brain size that is more or less linear with increasing dose. The 
interpretation that has been Suggested above for other brain weight effects 
would seem to apply equally well in this case. Variation in brain weight 
means is shown in Table 10 separately for males and females, but with repli-
cates combined. 
Tail length. As indicated above variation in tail length among dose groups 
was highly significant (P < .001), however the pattern that emerges is not so 
easily subject to interpretation. Since there are also highly significant 
differences (P < .001) between groups and sexes, comparisons must be made with 
considerable care. There does exist a parallel of some interest between the 
distribution of means in the present year and that of the first year's experi-
ments, where the results were not cited because the pattern of distribution of 
means did not make much sense. Nevertheless, there was a significant differ-
ence among dose group means (P 	.02). Means for the experiments of the first 
and second year, adjusted for litter size, are shown in Table 10 for comparison. 
In each experiment the mean associated with the middle mutagen dose is reduced 
20 
below the others, and that there tends to be an increase from control to the 
lowest mutagen dose followed by a significant drop at the middle mutagen dose 
and a subsequent increase to a maximum for the high mutagen dose. This unusual 
distribution is further supported by the observation that each of the replicates 
showed a parallel distribution of means. 
Defecation. Distribution of means for the defecation portion of the open 
field test is provided for interest in Table 10. While the difference between 
dose groups only approaches significance (P - .06), the pattern that emerges 
is of interest. Differences between replicates and sexes approached signifi-
cance (P 	.10), but there were no significant interactions between dose, re- 
plicate, and sex, nor was there significant effect of litter size variation. 
The pattern that is evident is one of a more or less linear increase in defeca-
tion rate with increasing mutagen dose. 
Effect of Mutagen on Spermatogonia: F2 Generation 
Again in contrast with the results of the first year where several traits 
exhibited interesting mean distributions associated with significant differences, 
in the present year only one trait, brain weight, showed strong evidence of po-
tential usefulness. There was a highly significant difference among dose groups 
(P < .01), and the pattern of mean distribution paralleled that found in the 
F2 generation of spermatozoa treatment groups. Analysis of data on hematocrit  
indicated that there were significant effects of dose, with means for experimental 
groups generally being lower than the control. 
The analyses of data with respect to time of development of righting re-
sponse, the defecation portion of the open field test, body weight at weaning 
and tail length at seven weeks failed to show either significant differences 
due to dose or variance distributions that would be of interest. With re-
spect to body weight, but for males only, there was the predicted increase in 
variance for all experimental groups relative to appropriate controls, but 
this pattern, which had been evident for females also in the first year's ex-
periment, was not extended to females in the present year's experiment. 
Table 11. Means for brain weight at about 13 1/2 weeks and hematocrit in 
F2 generation progeny of three experimental groups and a single negative 
control for two experiments showing the effects of TEM upon spermatogonia. 
Experiment 	Dose (mg./kg.) 0 .075 .15 .30 
II Brain weight C 419.27 414.95 416.35 418.67 
D 416.70 424.24 421.09 423.66 
II Hematocrit 46.23 45.96 46.40 46.53 
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Brain weight. Analysis of variation in brain weight revealed that there 
was a highly significant association with litter size (P < .001), and highly 
significant differences between replicates (P 	.003) and sexes (P < .001). 
Differences among groups were also highly significant (P 	.006), but a highly 
significant replicate x dose interaction necessitated that comparisons be 
carried out separately for each replicate. Experimental groups in replicate 
D exhibited brain sizes significantly greater than the control. However, 
differences among means in replicate C were not significant (Table 11). 
Hematocr:Lt. The analysis of results for variation in hematocrit indicated 
that there was not significant association with litter size, although there were 
highly significant differences (P < .001) between replicates and sexes. There 
were also significant differences (P < .05) due to dose. The pattern of mean 
distribution :Ls in striking contrast with that of the first year's experiment 
which was not, however, associated with statistically significant differences. 
In the present year's experiment, the three experimental group means show a 
reduction in hematocrit below that of control, with the middle mutagen dose 
group showing the greatest depression relative to control. Dose means adjusted 
for litter size, with sexes and replicates combined, are shown in Table 11. 
Discussion. Negative results observed in the first year with respect to 
effects of mutagenic agent on sex ratio were found again in the present year. 
As we reported in the results of the first year, reduced numbers of young 
carried to weaning by female progeny of mutagenized males, which had been a 
good indicator of mutagenic damage in X-ray studies, proved not to be so in 
our TEM studies. Similarly, in the second year's results there were no evi-
dences to support such an effect. 
While the general usefulness of body weight as a trait appeared to be much 
diminished in the results of the present study, especially the variance 
patterns which had appeared quite exciting in last year's study and in earlier 
work, effects on body weight means resulting from mutagenized spermatozoa still 
appear to be of usefulness. However, the very interesting effects associated 
with the F1 and F2 generation of mutagenized spermatogonia were not substantiated 
in the present year's study. The results for tail length parallel the body 
weight conclusions as they did in the prior year's study. Apparently useful-
ness of tail length is much diminished, but for mutagenized spermatozoa, es-
pecially in the F1 generation, increases in tail length do appear to be indi-
cative of mutagenic damage. Similarly decreases in variance both with respect 
to body weight and tail length in the F1 generation appear to be indicative 
of mutagenic damage. 
In contrast to the reduced usefulness of body weight and tail length, the 
time of development of the righting response appeared to be particularly use-
ful as a diagnostic trait. The results of the present year's experiment are 
supported, in retrospect, by the results of the past year's experiment which 
were not in themselves significant, but which did parallel the results found 
in the present year. This mutagenic effect may be summarized as one of decrease 
or unaffected developmental time with very low mutagen dose, followed by in-
creasing developmental times, i.e. reduced developmental rates, with increasing 
mutagen dose. This same pattern was found for F 1 and F2 generation groups alike, 
with the F2 generation low mutagen dose response being particularly interesting 
as a sensitive indicator of mutagenic damage. 
All of the above traits have the prognosis for being useful and also have 
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the advantage of being relatively easily obtained. By contrast, brain weight 
at 13 1/2 or more weeks of age, a trait tried for the first time in the pre-
sent year's experiments, proved to be very broadly useful, having considerable 
potential as an indicator of mutagenic damage for spermatogonia and spermatozoa 
alike and for F1 as well as F 2 generation groups. 
With respect to plans for the coming year, it is proposed employing the 
same design employed in the present year and including all of the traits em-
ployed in the present year, that we examine the effects of TEM on two addi-
tional strains of inbred mice, BALB/cby and C3H/HeJ, each in comparison with 
strain DBA/2J, the strain upon which our studies have been conducted to date. 
It is also our plan to eliminate one of the dose groups in order to increase 
numbers per group as much as is possible. The current plan is to employ mutagen 
doses of 0, .1 and .2 milligrams of TEM per kilogram of body weight. 
We plan to administer the antibiotic terramycin uniformly to all females 
rearing young, control and experimental, F1 and F2 generation of all three 
strains, nine days after the birth of the litter. 
During the past year we investigated the possibility of employing a trait, 
variation in red blood cell volume, which had been proposed in a research con-
ference earlier. It was found that the equipment necessary to accumulate 
satisfactory quantities of data with respect to red blood cell volume was 
rather expensive, approximating $25,000.00 for the Coulter Counter and asso-
ciated computer. At that time, we could not seriously consider the possibility 
of obtaining the equipment in the short time available. At this point, we 
have made arrangements with the Coulter Company to use a demonstration Counter 
for a limited period during which it is expected that we could acquire suffi-
cient data to determine the potential usefulness of the trait. Should the 
trait prove to be useful, we would make efforts to obtain equipment for future 
studies. 
It is our feeling that results of the first two years provide strong support 
for the continued development of a mutagenic assay based upon the use of quan-
titative traits in the detection of polygenic mutation damage such as would be 
expected to result from a wide variety of mutagenic agents. In particular, we 
feel that body weight, hematocrit level, righting response and brain size have 
demonstrated great potential as indicators of mutagenic effects. Others, in-
cluding tail length, the defecation portion of the open field test, survival 
of young to weaning and sex ratio may also prove to be of some usefulness in 
detecting certain kinds of genetic damage. 
Finally, we have developed in these two experiments substantial evidence 
that a late dominant lethal effect, originally observed by Soares (1972) pro-
duces a significant number of deaths at parturition. These deaths cannot be 
accounted for either by covariation with litter size or by upper estimates 
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The experiments proposed for the third year were devoted to explora-
tion of the effect of strain of experimental animal (mouse) on the genetic 
system, particularly with respect to quantitative traits. Traits proposed 
for study were those that appeared to be promising based upon the results 
of the experiments of the first and second years. 
In accord with discussions held with the Project Officer, Dr. Eugene 
Soares, it was agreed that triethylene melamine (TEM) would continue to be 
employed as the mutagenic agent as in the experiments of the first and 
second year. In order to compensate for the effects of increased numbers 
of groups required to compare strains, doses were modified somewhat from 
previous experiments. It was determined that only two doses would be em-
ployed in addition to the control; these were .1 and .2 mg TEM per kilogram 
of body weight. In previous years doses of .075, .15 and .30 mg per kilo-
gram of body weight had been used. Sample sizes were altered somewhat in 
order to compensate for greater losses due to dominant lethality with in-
creasing mutagen dose. As in the experiment of the second year, the germ 
cell stages tested included only spermatozoa and spermatogonia. 
Experiments of the first year had indicated that some traits did not 
appear to be particularly useful. One of these was time of eruption of 
incisors and this has been eliminated from subsequent experiments. During 
the second year, completion of the analysis of the serum cholesterol level 
data indicated that this also should be discarded. Of two new traits 
analyzed for the first time in the second year, one, brain weight at 13 1/2 
or more weeks of age, appeared to be very useful, and the other, number of 
fecal pellets deposited in a five minute period, proved to be of borderline 
usefulness, but is rather easily taken. Accordingly it is planned that 
these two in addition to the six traits remaining from the experiments of 
the first year will be continued. These include: 1) young per female 
carried to weaning, 2) age of development of the righting response, 3) body 
weight at weaning, 4) length of tail at seven weeks of age, 5) sex ratio, 
6) hematocrit at seven weeks, 7) number of fecal pellets deposited in five 
minutes, and 8) brain weight at 13 1/2 or more weeks of age. 
It was planned that two strains of mice would be compared with the 
performance of the strain employed in previous experiments, DBA/2J. The 
strains selected were C3H/HeJ and BALB/cby. These two strains were selected 
primarily because of their distant relationship to DBA/2J strain and because 
of their acceptable productivity records. 
It appears that in the experiments of each year at least one significant 
problem developed to prevent the achievement of anticipated numbers of 
progeny animals which are so important to the determination of effect in 
quantitative genetic studies. In the present year a faulty light switch, one 
which failed to turn off lights to produce a twelve-hour-on and twelve-hour-
off daily cycle, was not discovered until it had already led to seriously 
(2) 
decreased productivity of both replicates of matings involving sperm-
atozoan treated males. In fact, it was the significantly reduced produc-
tivity of our D]3A/2J and C3H/HeJ crosses that led to the discovery of 
the defective equipment. Interestingly, the BALB/cby crosses were reason-
ably productive in spite of their constantly lighted environment. These 
mutagenized males will be retained for crosses involving spermatogonial 
treatment. However, it is also planned that the spermatozoan experiments 
will be repeated in the spring with a separate set of mice which have 
already been ordered from the Jackson Laboratory. Precise timing of this 
will depend upon the time at which these animals become available, and 
the complete analysis of data may not be completed until early in the final 
contract year. However, it is felt that it will be of great importance to 
acquire this information for the strains in the present contract year. 
There has been none of the illness in the present year that plagued our 
experiments in the first two years. As of the present date, the parental 
crosses for both replicates of the spermatozoan and spermatogonial treated 
germ cell stages have been carried out. 
Design. In the experiments underway, parental females serving as 
parents for determination of the effects of different germ cell stages were 
assigned to temporally separated replicates A and B, which were mated to 
males which had been exposed to mutagenic treatment immediately prior to 
mating, thus involving mutagenized spermatozoa. Replicates C and D repre-
sent groups of females which were mated to males which had been exposed 
to mutagenic treatment over eight weeks prior to establishment of matings, 
thus the germ cells involved were mutagenized as spermatogonia. According 
to original plan, a total of 116 male mice of each strain were treated 
at about 11 weeks of age and mated immediately with 226 females for a 
period of one week. These matings were carried out in two separate repli-
cates, A and B, involving equal numbers of females, and were conducted two 
weeks apart. After separation of the A and B matings, males were housed 
with females not involved in the experiment and remained so until spermato-
gonial stage matings are established. Males which had been involved in the 
group A matings were each mated with three replicate C females for a period 
of two weeks. Similarly males which had been involved with group B matings 
were each mated with replicate D female trios for a period of two weeks. 
Methods. Parental males and females of replicate A were received from 
the Jackson Laboratory at ten weeks of age on October 31, 1977, as ordered. 
Males and females were housed five to a box, sexes separate until matings 
were established two weeks later. Triethylene melamine was administered by 
intraperitoneal injections in Hank's Balanced Salt Solution prepared imme-
diately prior to injection. As in the previous experiments, a series of 
male mice were weighed to determine body weight, and all males within a 
dose group received the same quantity of carrier and TEM irrespective of 
individual variation in body weight. All mice received .25 cc of solution 
by injection, controls receiving the same quantity of carrier only. Injec-
tions were administered to replicate A males on November 14, 1977, and 
matings were established, two females to each male, two days after administra-
tion of injections. 
Replicate B males and females were received from the Jackson Laboratory 
on November 15, 1977. Males were treated on November 28, 1977, and matings 
established two days later. This replicate was handled in precisely the 
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same manner as the first. All males treated survived for a period of 
24 hours and until the completion of the portions of the experiment involving 
them. 
For purposes of recognition, males of each strain of replicates A and 
B were numbered respectively 115 through 172 and 415 through 475. Females 
were similarly ear punched for identification and were numbered for groups 
A and B of each strain respectively 1 through 114 and 301 through 414. 
As indicated earlier, the numbers of pairs in each of the treatment 
groups were adjusted to compensate for the reductions in number of young 
expected for the higher dose rates. Employing the results of the first year, 
it was determined that the total number of males assigned respectively to 
the control, 0.1 and 0.2 mg/kg groups would be 24, 30 and 60. Males to be 
assigned to each of these groups were selected at random, and equal numbers 
of males were included in A and B replicates. Similarly, females were assigned 
randomly to the different treatment groups in appropriate numbers. Following 
establishment of replicate A and B crosses, cages were labeled in such a way 
as to preclude group identification. 
Replicate A matings were established on November 16, 1977; males were 
removed on November 23, 1977, and placed with females not involved in the 
experiment in an effort to maintain a normal level of sexual behavioral ac-
tivity in the males. Approximately ten days later, in expectation of produc-
tion of litters, females were separated, one to a box. Replicate B matings 
were established on November 30, 1977; males were removed on December 7, 1977. 
Approximately ten days later, females were separated, one to a box. 
Females which were to be involved in matings to test the effects of 
treated spermatogonia were also handled in two replicates of 113 females of 
each strain in each replicate. The same males that had been involved in 
replicate A of the spermatozoa testing matings were assigned to replicate C 
in the spermatogonial matings. Similarly, males which had been involved in 
replicate B spermatozoan matings were assigned to replicate D of the spermato-
gonial matings. As described above, because of the small number of males 
involved in the control and lowest TEM dose groups of the spermatozoa test 
matings, it was necessary to mate three females to each male. 
Females of replicate C were received from the Jackson Laboratory on 
December 20, 1977, at 10 weeks of age and numbered 601 to 714 by ear punch 
and housed five to a box until matings were established. Females were paired 
with males on January 10, 1978 for a two week mating period and were separated 
on January 24, 1978. Using identical procedures, females involved in the 
replicate D matings were received from the Jackson Laboratory on January 4, 
1978 and numbered 901 to 1014 by ear punch. Replicate D matings were set on 
January 24, 1978 and were terminated two weeks later on February 7, 1978. 
Each of the three treatment groups in each strain was represented by 
twelve males in each of the replicates, C and D, for a total of 216 males. 
The 339 females of each of the two replicates were assigned randomly to 
males of their own strain of the different groups, three females per male. 
Following termination of the final matings, males of the parental generation 
were removed, and females were isolated, one to a box, in anticipation of the 
production of litters. 
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As F1 young were produced, they were assigned temporary numbers by toe 
clipping within litters. Using this identification, offspring were tested for 
the ability to right (righting response). Subsequently, the young were weaned 
at four weeks of age, a permanent number was assigned, and the animals were iden-
tified by coded ear punching. Sex was recorded at birth and again at weaning 
(four weeks) along with body weight. The fecal count portion of the open field 
test was done at five weeks, and at approximately seven weeks the tail length 
was recorded and the hematocrit determined. 
A summary of litter production in Replicates A and B is given in Table 1. 
Strain DBA/2J appears to be the worst producer, particularly in higher TEM dose 
groups. Strain C3H/HeJ is better than DBA/2J because of a lower rate of litter 
destruction. Strain BLAB/cby is a strong producer due to a higher fertility rate 
and a lower rate of litter destruction than in strains DBA/2J and C3H/HeJ. In 
strain DBA/2J, a total of 46 litters were produced based upon observation at birth. 
Of these litters 20 (43.5%) had some young which survived to weaning. In comparison, 
strain C3H/HeJ produced a total of 45 litters at birth of which 37 (82.2%) had some 
young surviving to weaning, and strain BALB/cby produced 96 litters at birth of 
which 90 (93.8%) had some young which survived to weaning. Although total produc-
tion was somewhat low, strains C3H/HeJ and BALB/cby produced an adequate number of 
young in each of the three dose groups. Strain DBA/2J however, had very poor pro-
duction in the highest dose group (.2 mg. TEM/kg.). 
Autopsy of the replicate A and B parental females has been completed and 
preliminary results of the uterine examinations will be given in the next section. 
Replicate C matings have just finished producing litters, and replicate D matings 
are just beginning to produce litters. Data from F1 young in replicates A and 
B have been recorded for righting response, tail length, body weight at weaning, 
the fecal portion of the open field test, and hematocrit. In replicate C, data 
are being obtained on the righting response of the F1 progeny. 
Results. Compilations of the data on dominant lethality and related losses 
for the A and B replicates for the three inbred strains examined are shown in Tables 
2, 3, and 4 respectively for strains DBA/2J, BALB/cby, and C3H/HeJ. While these 
data have not yet been submitted to statistical analysis, it is evident that the 
trends shown parallel the results of the experiments of the first and second years 
carried out for DBA/2J strain. For both replicates of the BALB/cby a decrease 
in the number of live scars with increasing dose of TEM is clearly indicated. The 
same effect, on the average, obtains with strain DBA/2J although average replicate 
performance is not precisely reflected in within replicate trends. For example, 
in replicate A, the .10 mg. TEM/kg. dose group showed slightly higher live scar 
counts than the control group. The difference, however, is not likely significant. 
The situation with respect to the C3H/HeJ strain is interesting in that the number 
of live scars increases in both replicates in the .10 mg. TEM/kg. dose group over 
controls, and the differences are appreciable. A drop in live scars per female in 
the .20 mg. TEM/kg. dose group to below the control means is of even greater magni-
tude. 
The three strains show parallel trends with respect to total live births per 
pregnant female. In each replicate of all three strains there is a consistent de-
crease in number of live births with increasing TEM dose. The same trend is evi-
dent with respect to total number of young weaned per female weaning young with the 
exception that for the C3H/HeJ strain there is essentially no difference between 
total young weaned per female for the .10 and .20 mg. TEM/kg. dose groups. 
(5) 
Table 1. Litter sizes at birth and at weaning for the three mouse strains em-
ployed as experimental animals with the three doses of TEM. Results from Replicates 
A and B (parental animals mated for seven days immediately following male treat-
ment) were combined. 
DBA Litter size 0 1 2 3 4 5 6 7 8 9 10 11 12 13 
birth 35 1 3 6 - 3 4 2 1 
0 
wean 42 - - 3 1 3 3 2 1 
birth 50 2 3 7 2 2 - 1 
.1 
wean 61 - 2 1 2 1 1 
birth 112 1 5 4 
.2 
wean 121 - 1 - 
C3H birth 31 - 1 - 2 2 2 - 1 1 1 
0 
wean 31 - 1 - 2 2 2 - 1 1 1 
birth 44 2 1 2 3 5 3 2 1 
.1 
wean 49 - 2 1 4 4 2 1 
birth 106 2 2 3 3 4 2 
.2 
wean 110 1 2 3 4 2 
BALB birth 3 - 1 3 3 3 5 3 6 1 3 1 
0 
wean 3 - 1 4 4 5 4 1 6 1 3 1 
birth 32 - 7 3 3 7 5 3 1 
.1 
wean 32 - 7 2 2 8 4 3 1 
birth 89 9 11 5 2 1 
.2 
wean 92 7 10 6 1 2 1 
(6) 
Table 2. Dominant lethality parameters with standard errors and sample sizes 
of Replicate A and B series (DBA/2J strain) females and their Fl young. Females 
belonging to the two experimental and a single negative control group were mated 
for a period of seven days immediately following treatment, thus represent effects 
of mutagenic agent upon spermatozoa. 
Replicate A 
0 
TEM dose, mg./kg. of body weight 
.10 	 .20 
Live Scars/2 2.09 + .49(31) 2.20 ± .41(35) .61 + .16(61) 
Dead Scars/ ? .13 + .06(31) .60 + .15(35) .20 + .07(61) 
Total Scars/ ? 2.23 + .52(31) 2.80 + .49(35) .80 + .18(61) 
Total Live Births/ ? 3.07 + .63(15) 2.25 + .49(20) .95 + .30(19) 
Total Weaned/ ? 4.86 + .67( 7) 3.60 + .74( 5) 2(1) 
Percent Dead Scars 
of Total 5.8 21.4 24.5 
Percent Perinatal 
Losses 29.2 44.1 51.4 
Replicate B 
Live Scars/ ? 2.29 + .65(24) .47 + .19(32) .38 + .12(61) 
Dead Scars!? .29 + .11(24) .13 + .07(32) _ .07 + .03(61) _ 
Total Scars/ ? 2.58 + .70(24) .59 + .21(32) .44 + .14(61) 
Total Live Births/ ? 4.00 + .84(10) _ 1.57 + .48( 7) .45 + .25(11) 
Total Weaned!? 5.67 + .61( 6) 3(1) 0 
Percent Dead Scars 
of Total 11.3 21.1 14.8 
Percent Perinatal 
Losses 27.3 26.7 78.3 
(7) 
Table 3. Dominant lethality parameters with standard errors and sample sizes of 
Replicate A and B series BALB/cby females and their F 1 young. Females belonging 
to the two experimental and a single negative control group were mated for a period 
of seven days immediately following treatment, thus represent effects of mutagenic 
agent upon spermatozoa. 
TEM dose, mg./kg. of body weight 
0 	 .10 .20 
Replicate A 
Live Scars/ ? 8.19 + .84(21) 3.50 + .63(32) _ 1.37 + .29(59) _ 
Dead Scars/ 9 .19 + .09(21) .69 + .25(32) .71 + .19(59) 
Total Scars/ 8.38 + .84(21) 4.19 + .68(32) 2.08 + .39(59) 
Total Live Births/ 9 6.74 + .74(19) 3.75 + .55(20) 1.38 + .27(24) 
Total Weaned/ 6.94 + .68(18) 4.29 + .50(17) 2.14 + .25(14) _ 
Percent Dead Scars 
of Total 2.3 16.4 46.7 
Percent Perinatal Losses 25.6 33.0 59.3 
Replicate B 
Live Scars/ 9 8.71 + .87(14) 2.69 + .64(29) 1.27 + .31(59) 
Dead Scars/ 2 .07 + .07(14) .62 + .22(29) .78 + .16(59) 
Total Scars/ 2 8.78 + .87(14) 3.31 + .72(29) 2.05 + .41(59) 
Total Live Births/ 2 7.46 + .60(13) 3.86 + .58(14) 1.58 + .39(24) 
Total Weaned/ 2 7.46 + .60(13) 4.42 + .50(12) 2.69 + .46(13) 
Percent Dead Scars 
of Total .8 18.8 38.0 
Percent Perinatal Losses 20.5 30.8 50.7 
(8) 
Table 4. Dominant lethality parameters with standard errors and sample sizes of 
Replicate A and B series C3H/HeJ females and their F1 young. Females belonging to 
the two experimental and a single negative control group were mated for a period of 
seven days immediately following treatment, thus represent effects of mutagenic 
agent upon spermatozoa. 
Replicate A 
TEM dose, mg./kg. of body weight 
0 	 .10 .20 
Live Scars/ 1.86 + .78(22) 2.65 + .62(31) 1.62 + .34(60) 
Dead Scars/ ? .18 + .18(22) .03 + .03(31) .10 + .06(60) 
Total Scars!? 2.05 + .82(22) 2.68 + .62(31) 1.72 + .35(60) 
Total Live Births/ ? 6.60 + 1.78(5) 3.75 + .85(12) 1.74 + .52(19) 
Total Weaned/p 8.25 + 	.85(4) 5.20 + .37( 5) 4.43 + .48( 7) 
Percent Dead Scars 
of Total 8.9 2.6 5.8 
Percent Perinatal Losses 19.5 45.1 66.0 
Replicate B 
Live Scars/? 2.32 + .76(19) 2.77 + .62(31) 2.06 + .37(64) 
Dead Scars!? .11 + .11(19) .16 + .08(31) .05 + .03(64) 
Total Scars/? 2.42 + .78(19) 2.94 + .66(31) 2.11 + .38(64) 
Total Live Births/? 3.71 + .78( 7) 2.92 + .69(13) 1.42 + .40(24) 
Total Weaned!? 4.33 + .56( 6) 4.13 + .69( 8) 4.14 + .40( 7) 
Percent Dead Scars 
of Total 4.3 5.5 2.2 
Percent Perinatal Losses 	40.9 
	
55.8 	 74.2 
Of particular interest is variation in percent dead scars of total scars and 
percent perinatal losses, which has been defined as: live scars - live young 
observed at birth/live scars. With respect to percent dead scars of total, the 
BALB/cby strain shows a classical increase from a very low control value of a 
few percent to a value somewhere between 1/3 and 1/2. Data for strain DBA/2J 
also shows an increase from a control value (which is however somewhat higher than 
the control value for BALB/cby) to a figure somewhat less than 1/4. As in experi-
ments of previous years the difference between high and low TEM dose groups in 
percent dead scars of total is not as great as that between control and the low 
TEM dose group. Our data for strain C3H/HeJ are particularly interesting in that 
they suggest that the classical dominant lethal test would be of very little useful-
ness in determining the effects of mutagenic action. There is, in effect, no 
difference between treated groups and control with respect to percent dead scars 
of total. With respect to percent perinatal losses, however, there is a clear and 
consistent increase with increasing TEM dose from a very high control value to values 
two or three times as great as control for the .20 mg. TEM/kg. dose group. Perina-
tal losses were equally clearly shown to increase for the BALB/cby strain and the 
DBA/2J strains. 
With respect to total scars, as has been discussed in earlier reports, it is 
generally expected that slight decreases, if any, for lower mutagen doses will be 
followed by more dramatic decreases at higher doses. The data from the results of 
experiments of previous years with strain DBA/2J were consistent with this expec-
tation as are the current results with strain DBA/2J. Such reductions in scar num-
bers at higher mutagen doses are interpreted as resulting from preimplantation 
losses, which would be expected to increase at high mutagenic exposures. Results 
with respect to strain BALB/cby are in interesting contrast in that preimplantation 
losses are appreciable at the lowest TEM dose and increase again appreciably at 
the highest dose. By contrast, total scars actually seem to increase for strain 
C3H/HeJ followed by an appreciable decrease at the highest mutagen dose. 
As reported in our last Annual Report (for the period December 25, 1976 through 
June 22, 1977) the experiments of the first two years resulted in the development 
of substantial evidence that a late dominant lethal effect produces a significant 
number of deaths at parturition. In a collaborative effort based upon data compiled 
independently by Dr. J. Favor and Dr. E. Soares, a manuscript has been prepared and 
submitted for publication to Mutation Research that demonstrates that these late 
dominant lethal, or perinatal losses as we have termed them, cannot be accounted for 
either by covariation with litter size or by upper estimates of misclassified "dead" 
uterine scars. Data from the experiments of the present year offer additional con-
firmation of this effect. 
Also as reported in the cited Annual Report, we investigated the possibility 
of employing a trait, variation in red blood cell volume, which had been proposed 
in a research conference earlier. The equipment required to produce satisfactory 
quantities of data with respect to red blood cell volume would require an outlay 
of approximately $25,000. We reported that an arrangement had been made with the 
Coulter Company to use a demonstration piece of equipment for a limited period to 
determine if we could acquire sufficient data to determine the potential useful-
ness of the trait. At the present time the Coulter Counter and associated computer 
are on loan in our laboratory, and we hope to be able to run a sufficient number 
of samples to obtain a rough idea as to the potential usefulness of this trait. 
John/ 	Crenshaw, Jr. 
Project Director 
(10) 
As indicated above, the productivity of spermatozoan stage crosses particularly 
for strains DBA/2J and C3H/HeJ were significantly reduced, probably as the result 
of a faulty light switch, to such an extent that it was judged desirable to attempt 
to repeat these crosses in the present year. Inasmuch as the light switch was 
repaired prior to spermatogonial stage crosses, the originally treated males have 
been employed as planned in the matings and no repetition of these matings is planned. 
However, we have ordered numbers of animals of all three strains sufficient to 
repeat the spermatozoan stage matings with the expectation of accumulating data from 
their F1 progeny and from an F2 generation. In view of the significant delay in 
repeating this experiment, it is likely that data for the F2 generation will not 
be available for analysis at the time of the December 24, 1978 Annual Report pre-
paration. Any such analyses will be carried over and provided in the report for 
the period ending December 24, 1978. 
There is an additional advantage to be gained by the repetition of spermatozoan 
stage crosses. At the present moment, the BALB/cby strain would appear to be a 
strain of choice, other things remaining the same, for the kinds of experiments being 
conducted. However, we do not yet have data on the reaction of the BALB/cby strain 
to effects upon quantitative traits. It will be of considerable importance, there-
fore,to have two replicates of BALB/cby strain spermatozoan cross results to deter-
mine the usefulness of the strain with respect to quantitative traits. (It will 
be recalled that this was the only strain to produce sufficient numbers of sperma-
tozoan stage progeny to justify setting up F 1 matings). Should our analyses be 
positive, we would propose that the BALB/cby strain be used in the experiments of 
the final year in place of the DBA/2J strain for purposes of comparison with two 
new strains to be tested as proposed in the original research contract proposal. 
Respectfully submitted, 
REPORT OF PROGRESS FOR RESEARCH CONTRACT NIEHS NO. NO1-ES-5-2135 
December 25, 1977 through June 25, 1978 
This report includes preliminary analysis of data acquired to date in 
the experiment of the third year of the referenced research contract, and 
involved an exploration of the effect of strain of experimental animal in-
bred (mouse) on the effect of mutagenic agent in affecting the expression 
of quantitative traits. As in earlier experiments, triethylene melamine 
(TEM) was the mutagenic agent employed. In order to maximize the number 
of animals in each group only two doses (.1 and .2 mg TEM per kilogram of 
body weight) were employed in addition to a control group, instead of the 
three doses (.075, .15 and .30 mg per kilogram of body weight) which had 
been employed in prior experiments. The number of matings set in each 
dose group was adjusted to compensate for dominant lethal effects of treat-
ment in the high dose groups in such a way that similar numbers of F 1 
progeny would be produced in all groups. TEM treatment effects were tested 
on spermatozoa and spermatogonial stages of spermatogenesis. 
The quantitative traits analyzed in the experiment reported here to 
determine the effect of mutagenic treatment on F i and F2  progeny of treated 
males included 1) age of development of the righting response, 2) body weight 
at weaning, 3) the defecation portion of the open field test, 4) tail length 
at seven weeks of age, 5) hematocrit at seven weeks of age, and 6) brain 
weight at 13 1/2 or more weeks of age. In addition to these quantitative 
traits, productivity traits were also investigated to determine if treatment 
was effective. These traits included 1) per cent dead implantation scars 
of total scars, 2) total implantation scars, 3) per cent females born, 
4) total born, 5) per cent females weaned and 6) total weaned. As in prior 
experiments, the productivity traits 1) and 2), determined by inspection of 
uterine scars in parental generation females, were collected for F1 genera-
tion young only while the remaining productivity traits, 3) through 6), were 
collected in both F1 and F2 generations. 
The major thrust of the experiment reported here involved a comparison 
of the performance of the strain employed in previous experiments, DBA/2J, 
with two untested strains, C3H/HeJ and BALB/cByJ. These strains were 
selected for this experiment because of their distant relationship to DBA/2J 
and because of their acceptable productivity records. As indicated in the 
Report of Progress for the period ending December 24, 1977, relatively low 
productivity was realized for the strains ABA/2J and C3H/HeJ which led to 
the discovery of defective light timing equipment. As will be seen below, 
correction of the faulty light switch did not improve the productivity of 
these strains significantly in subsequent crosses, suggesting that other 
factors (e.g. time of year, intrinsic changes in strain or unsuspected 
disease) may have also been of importance. By contrast with the two above 
strains, the BALB/cByJ crosses were highly productive. Realizing that the 
low productivity of the first two strains would leave our facilities relatively 
(2) 
uncrowded later in the year, a decision was made to attempt a second re-
plicate of BALB/cByJ to repeat the experiments at least for F1 young, to 
whatever extent might be possible in the present year. This decision, 
which has been effected in crosses now well under way, turned out to be 
particularly advantageous inasmuch as discussions between the principal 
investigator and contract officer have resulted in a decision to devote 
total efforts to the testing of strain BALB/cByJ in the final contract year. 
Thus, all that can be learned at the present time with respect to the 
response of this strain will be particularly useful in the final year. 
Design of Experiment. In the experiments of the past year, female 
parents employed to determine the effects of spermatozoa treated at differ-
ent germ cell stages were assigned to one of four replicates. Replicates 
A and B, carried out two weeks apart, were made up of females mated to 
males which had been exposed to mutagenic treatment immediately prior to 
mating, thus involving mutagenized spermatozoa. These matings involved 
mated trios of two females with each male. Replicates C and D were tem-
porally separated replicate groups of females which were mated ( in a 
ratio of 3 ? :1 e) to males which had been exposed to mutagenic treatment 
over eight weeks prior to establishment of mating. Thus the germ cells 
involved were mutagenized as spermatogonial cells. In Replicates A and B, 
a total of 116 male mice of each of the three strains tested were treated 
at about 11 weeks of age and mated immediately with 226 females of each 
strain for a period of one week. These matings were divided into two 
replicates involving equal numbers of females as described above. 
After separation of the matings in Replicates A and B, males were 
housed with females not involved in the experiment until spermatogonial 
stage matings had been established. Males which had been involved in 
the Replicate A matings were each mated with three Replicate C females 
for a period of two weeks. A total of 114 males and 342 females, evenly 
divided among the three strains, were involved in these matings. Two 
weeks later Replicate D matings were similarly established involving the 
same males that had been parents in the Replicate .B crosses and were main-
tained for two weeks. Again 114 males and 342 females, evenly divided 
among the three strains, were involved. 
Females were isolated from each other 10 days after the initiation of 
matings and checked daily for the presence of a litter through day 21 after 
the termination of matings. Young were sexed and marked by toe clipping 
for identification at birth. Starting on day 5, progeny were checked for 
the ability to right (righting response) and were checked daily until the 
trait appeared. All animals were weaned at four weeks of age, at which time 
body weight and sex were recorded and individuals were permanently marked 
by coded ear punching. The defecation portion of the open field test was 
conducted on mice at 5 weeks of age while tail length and hematocrit measures 
were taken on mice at approximately 7 weeks of age. 
Matings of F1 individuals to produce F2 progeny were established at 
between 11 and 12 weeks of age. Pair crosses (19 :l d) were established 
between individuals taken randomly, except that sibling crosses were pre-
cluded, within a dose, a replicate, and a strain. Two replicates, A and 
(3) 
B, were produced by the F1 young in the spermatozoan treatment group, the 
progeny respectively of Replicates A and B of parental crosses. A total 
of 116 Replicate A pairs and 111 Replicate B pairs were established, em-
ploying BALB/cByJ strain animals only. It was decided that there were too 
few F1 animals in the other strains to produce meaningful results. Facili-
ties were strained by the establishment of Replicate C F1 crosses to the 
extent that Replicate D F1 crosses could not be set. Accordingly, the 
prospective Replicate D F1 parents were held pending the availability of 
sufficient cages to house them. A total of 336 BALB/cByE pairs, 40 C3H/ 
HeJ pairs, and 35 DBA/2J pairs were established in Replicate C F1 crosses. 
These figures reflect the relative productivity of the different strains 
quite accurately. All F1 matings were single pair crosses and were main-
tained for a period of two weeks. Males were separated from females of 
the F1 matings and brain weights were recorded as early as possible after 
about 13 1/2 weeks. For females, brain weights were recorded when litters 
of the group had been weaned. 
As indicated above the relatively high productivity of BALB/cByJ 
strain as contrasted with the relatively low productivity of the other 
two strains led to a decision to repeat Experiment III for the BALB/cByJ 
strain only. Accordingly, Experiment IV Replicates A and B, involving a 
total of 119 males and 238 females, approximately evenly divided between 
the two replicates, were established in a precise repetition of Experiment 
III, except that the effects of mutagenic action on spermatozoa only were 
tested. Effects of spermatogonia were not investigated. Thus, there were 
no Experiment IV Replicates C and D. Table 1 details the scheduling of 
parental and Fi generation matings. 
Table 1. Schedule of matings 
A. Parental generation 
Replicate 
IIIA IIIB IVA IVB IIIC IIID 
Mice received 10/31/77 11/15/77 5/9/78 5/23/78 12/20/77 1/4/78 
Matings 11/16 11/30 5/25 6/8 1/10 1/24 
Matings separated 11/23 12/7 6/1 6/15 1/24 2/7 




1IIB 	 IIIC 
Matings set 2/24/78 3/13/78 5/1/78-5/3/78 
Matings separated 3/10 3/27 5/15 - 5/17 
(4) 
The mutagenic treatment itself consisted of intraperitoneal injection 
of triethylene melamine carried in .25 cc Hank's balanced salt solution 
prepared immediately prior to injection. Control males received the same 
quantity of carrier only. Doses were based on the mean body weight of a 
random sample of the mice to be treated. The numbers of matings set in 
each dose were adjusted to compensate for dominant lethal effects in the 
higher doses so as to produce similar numbers of F1 progeny. The total 
number of males treated in Replicates A and B combined, in the dose groups, 
0.0, .1 and .2 mg/kg of body weight were respectively 24, 30 and 60. All 
animals were identified by a coded number so that observations were blind 
with respect to dose. Since dominant lethal effects in spermatogonial 
treatment groups are very slight, if present, Replicates C and D dose 
groups were established with approximately equal numbers of matings. 
With unequal numbers of males in the dose groups established for Replicates 
A and B, the number of males mated in each dose group of Replicate C and 
D was equal to the number of males in the control dose group, which had 
the smallest number of males involved. In order to mate all females each 
male had to service three females. Thus, quartets in the ratio of 3 :1 
were established for Replicates C and D. 
As of the present moment data are available for Replicates A and B 
parental crosses with respect to productivity and quantitative traits, 
except that brain weights for a few males which were involved in transloca-
tion studies will not be included. With respect to Replicates C and D, 
data are available on quantitative traits except for brain weights in Re-
plicate D and females still weaning young in Replicate C. For F2 progeny 
of F1 crosses in Replicates A and B data on all quantitative traits except 
brain weight are available. F2 young of Replicate C F1 crosses have just 
been weaned and Replicate D matings have not been established. Accordingly, 
quantitative traits will not be discussed for these two groups. Similarly, 
Experiment IV Replicates A and B parental crosses have respectively just 
had litters or are ready to have litters and the data available would not 
be meaningful. Accordingly discussions under results will be limited to 
those for which available data are reasonably complete, Replicates A and B, 
parental crosses only. 
Results: Dominant Lethality. Data on dominant lethality and related 
losses for the A and B replicates of all three inbred strains were discussed 
in the Report of Progress for the period ending December 24, 1977. Tables 
2, 3, and 4, respectively for strains DBA/2J, BALB/cByJ, and C3H/HeJ, are 
taken from that document and included in the present for completeness. As 
pointed out earlier, the results parallel the results of experiments of the 
first and second years carried out with DBA/2J strain. With respect to 
strain comparisons, certain interesting differences are apparent. While 
total live scars tend to decrease with increasing dose for both DBA/2J 
and BALB/cByJ, strain C3H/H3J showed an increase in live scars between 
controls and the lowest mutagen dose followed by a drop to a level below 
that of controls for the highest mutagen dose. These trends were evident 
in both replicates. All three strains parallel one another closely with 
respect to live births per female which decreases uniformly in both repli-
cates of all three strains with increasing dose. Similarly total young 
(5) 
weaned per female carrying young to weaning decreases with increasing dose 
in all three strains. However the C3H/HeJ strain shows very slight differ- 
ences in one replicate. In the traditional measurement of dominant lethality, 
per cent dead scars of total scars, DBA/2J strain exhibited the expected 
trend of an increase with increasing dose, although there is some irregu-
larity between replicates. By contrast, the BALB/cByJ strain exhibits a 
clear increase from a very low control value to a very high value with the 
highest mutagen dose supported by closely parallel and regular replicate 
responses. Strain C3H/HeJ is remarkable in that clear evidence of dominant 
lethality by the traditional measure is lacking. In both replicates the 
highest mutagen dose shows a face value decrease in per cent dead scars of 
total, but all differences between experimental groups and control are slight 
and show no evidence of a dominant lethal effect. 
Finally, of particular interest is variation in perinatal dominant 
lethality. Investigators on this project (Crenshaw and Favor) in collabora-
tion with Dr. Eugene Soares have recently determined that per cent perinatal 
losses, defined as live scars minus live young observed at birth/live scars, 
increase with increasing mutagen dose in experiments involving three strains 
of mice and three mutagenic agents. Results of the present study support 
this observation. In the DBA/2J strain there is a general increase in 
perinatal losses with increasing mutagen dose although, as might be expected, 
there is some variation between replicates within strain. In strain BALB/ 
cByJ, also as might be expected, there is a clear increase in perinatal 
losses with increasing mutagenic dose in each replicate. The C3H/HeJ strain 
is interesting in that per cent perinatal losses increase in both replicates 
with increasing dose in striking contrast to the lack of a dominant lethal 
effect using the standard measure. 
Detailed statistical analyses of the above results have not yet been 
carried out. The late start of these experiments, necessitated by a delay 
in arrival of the mice employed, has not left time for computer analysis. 
These analyses are being conducted, however, and significant results will 
be summarized in the next semi-annual report. Standard errors have been 
computed for those parameters for which such a computation is appropriate 
and do provide an indivation of significance. It might also be noted 
that the magnitude of the differences with respect to per cent dead scars 
of total and per cent perinatal losses would suggest clearly significant 
differences among both groups for BALB/cByJ strain and an approach to 
significant differences among groups for DBA/2J strain. 
Quantitative Traits. The primary goal of the series of experiments 
conducted over the past three years has been to determine the possible use-
fulness of quantitative traits in mice as indicators of mutagenic activity. 
As reported earlier, in studies of the first year (and in earlier experi-
ments) indications were that mutagen induced polygenic mutations, that is 
mutations of minor effects, do have an influence upon the means and the 
variances of some quantitative traits under some conditions. Some traits 
appeared to be of particular usefulness while others showed no effect of 
mutagenic activity. It was also found that effects due to mutagenic treat-
ment could be detected in both the F1 and F2 generation progeny of males 
(6) 
Table 2. Dominant lethality parameters with standard errors and sample sizes 
of Replicate A and B series (DBA/2J strain) females and their Fl young. Females 
belonging to the two experimental and a single negative control group were mated 
for a period of seven days immediately following treatment, thus represent effects 
of mutagenic agent upon spermatozoa. 
Replicate A 
Live Scars/2 	2.09 
Dead Scars/ 2 	.13 
Total Scars/ 2 	2.23 






TEM dose, mg. /kg. 
.10 
2.20 + .41(35) 
.60 + 	.15(35) 
2.80 + .49(35) 
2.25 + .49(20) _ 
of body weight 
.20 
.61 + .16(61) 
.20 + 	.07(61) _ 
.80 + .18(61) 
.95 + .30(19) 
Total Weaned! ? 4.86 + .67( 7) 3.60 + .74( 5) 2(1) 
Percent Dead Scars 
of Total , 	5.8 21.4 24.5 
Percent Perinatal 
Losses 29.2 44.1 51.4 
Replicate B 
Live Scars! ? 2.29 + .65(24) .47 + .19(32) .38 + .12(61) 
Dead Scars/2 .29 + .11(24) .13 + .07(32) .07 + .03(61) 
Total Scars!? 2.58 + .70(24) .59 + 	.21(32) .44 + .14(61) 
Total Live Births!? 4.00 + .84(10) 1.57 + .48( 7) .45 + .25(11) 
Total Weaned!? 5.67 + .61( 6) 3(1) 0 
Percent Dead Scars 
of Total 11.3 21.1 14.8 
Percent Perinatal 
Losses 27.3 26.7 78.3 
(7) 
Table 3. Dominant lethality parameters with standard errors and sample sizes of 
Replicate A and B series BALB/cby females and their F 1 young. Females belonging 
to the two experimental and a single negative control group were mated for a period 
of seven days immediately following treatment, thus represent effects of mutagenic 
agent upon spermatozoa. 
TEM dose, mg./kg. of body weight 
0 	 .10 .20 
Replicate A 
Live Scars/ c 	 8.19 + .84(21) 3.50 + .63(32) 1.37 + .29(59) 
Dead Scars/ 9 	 .19 + .09(21) .69 + .25(32) .71 + .19(59) 
Total Scars/ 2 	 8.38 + .84(21) 4.19 + 	.68(32) _ 2.08 + .39(59) 
Total Live Births/ 9 	6.74 + .74(19) 3.75 + .55(20) 1.38 + .27(24) 
Total Weaned/ 9 	6.94 +.68(18) _ 4.29 + .50(17) _ 2.14 + .25(14) 
Percent Dead Scars 
of Total 2.3 16.4 46.7 
Percent Perinatal Losses 25.6 33.0 59.3 
Replicate B 
Live Scars/2 	 8.71 + .87(14) 2.69 + .64(29) 1.27 + .31(59) 
Dead Scars/ 9 	 .07 + .07(14) .62 + .22(29) .78 + .16(59) 
Total Scars/ 2 	 8.78 + .87(14) 3.31 + .72(29) 2.05 + .41(59) 
Total Live Births/ 	7.46 + .60(13) 3.86 ± .58(14) 1.58 ± 	.39(24) 
Total Weaned/ 9 	7.46 + .60(13) 4.42 + .50(12) 2.69 + 	.46(13) 
Percent Dead Scars 
of Total .8 18.8 38.0 
Percent Perinatal -Losses 20.5 30.8 50.7 
( 8 ) 
Table 4. Dominant lethality parameters with standard errors and sample sizes of 
Replicate A and B series C3H/HeJ females and their F 1 young. Females belonging to 
the two experimental and a single negative control group were mated for a period of 
seven days immediately following treatment, thus represent effects of mutagenic 
agent upon spermatozoa. - 
Replicate A 
TEM dose, mg./kg. of body weight 
0 	 .10 .20 
Live Scars/ ? 1.86 + .78(22) 2.65 + .62(31) 1.62 + .34(60) 
Dead Scars/ ? .18 + .18(22) .03 + .03(31) .10 + .06(60) 
Total Scars/? 2.05 + .82(22) 2.68 + .62(31) 1.72 + .35(60) 
Total Live Births/ ? 6.60 + 1.78(5) 3.75 + .85(12) 1.74 + .52(19) 
Total Weaned/ 8.25 + 	.85(4) 5.20 + .37( 5) 4.43 + .48( 7) 
Percent Dead Scars 
of Total 8.9 2.6 5.8 
Percent Perinatal Losses 19.5 45.1 66.0 
Replicate B 
Live Scars/? 2.32 + .76(19) 2.77 + .62(31) 2.06 + .37(64) 
Dead Scars/-9 .11 + .11(19) .16 + .08(31) .05 + .03(64) 
Total Scars/ 2.42 + .78(19) 2.94 + .66(31) 2.11 + .38(64) 
Total Live Births/ 3.71 + .78( 7) 2.92 + .69(13) 1.42 + .40(24) 
Total Weaned/? 4.33 + .56( 6) 4.13 + .69( 8) 4.14 + .40( 7) 
Percent Dead Scars 
of Total 4.3 5.5 2.2 
Percent Perinatal Losses 	40.9 
	
55.8 	 74.2 
(9) 
subjected to mutagenic treatment. Experiments completed the second year 
supported certain conclusions arrived at in the first year; other traits 
were found to be not so broadly useful as had been hoped. Some traits 
which had not appeared to be of particular usefulness in the first year's 
experiment showed greater promise in the second year. 	One trait not 
employed in the first year, brain weight, proved to be of particular in-
terest in experiments of the second year. 
While information from either generation may be of interest as an in-
dicator of genetic damage resulting from mutagenic treatment, in general, 
effects observed in the F2 generation are more certainly attributable to a 
genetic basis than those of the F1 generation. Even so, genetic causation 
is an entirely reasonable hypothetical explanation of observed F1 generation 
effects. However, the possibility of certain kinds of relayed toxic effects 
cannot be absolutely ruled out. 
During the past year, an effort was made to examine the effects of muta-
genic treatment on two new strains of inbred mice, employing the same experi-
mental design that had been employed in earlier years with strain ABA/2J. 
As indicated above, these strains were BALB/cByJ and C3H/HeJ. The necess-
ity of obtaining reasonably large numbers of all three strains at the same 
time caused a significant delay in initiation of experiments, and data 
have been analyzed only for the effects of mutagenic agents on spermatozoa 
in the Fl generation. These results are presented in the analyses to follow. 
Analyses of the effects of mutagen on the F2 generation of spermatozoan 
treated germ cells and upon the F 1 and F2 generations of spermatogonial 
treatments will be dealt with in subsequent reports. 
Effects of Mutagen on Spermatozoa: F
1 Generation 
The productivity of strain DBA/2J in experiments of the current year 
was considerably poorer than had been projected with the result that little 
usable data are available for comparison of treatment effects in F1 genera-
tion animals. Since these animals will serve as parents for F2 progeny, it 
is likely that little data will be available also for these comparisons. 
Hopefully, there will be more useful data available for spermatogonial treat-
ment effects, particularly since dominant lethal effects will be of negli-
gible importance in these matings. 
Strain C3H/HeJ, which is being employed for the first time in these 
experiments, also proved to be not entirely satisfactory in regard to its 
productivity, although some comparisons of interest did emerge. Inasmuch 
as modest numbers of individuals are available in each treatment group, it 
is anticipated that numbers available for analysis in the F2 generation will 
be much more nearly satisfactory, as will numbers available in the sperma-
togonial treatment groups, F1 and F2 generation. The most exciting results 
of this year have hinged upon the very high productivity of strain BALB/cByJ. 
While there has not been time to subject these data to computer analysis, 
which will include the critical partitioning of the effects of litter size, 
the results to be presented below have been analyzed by ANOVA and by Student's 
(1 0) 
t-test where appropriate. 
The most exciting results to emerge indicate that strain BALB/cByJ  
shows a linear increase in body weight with increasing mutagen dose. 
Differences among means were highly significant (p < Al)  based upon a 
factorial ANOVA. This result is the same as was reported for strain DBA/ 
2J in experiments of the first and second year. With respect to the time 
of development of the righting response, most exciting results were also 
found. With strain BALB/cByJ the time of development of the righting re-
sponse increased with increasing_ mutagen dose in a roughly linear manner, 
and the differences proved to be significant by factorial ANOVA. This 
same result was also found in the experiments of the second year (but not 
those of the first) for strain DBA/2J. This same pattern can be visualized 
in the experiments of the first year with DBA/2J, but the differences among 
groups were not significant. 
An interesting pattern was observed with respect to the defecation 
portion of the open field test in strain BALB/cByJ which,however,proved to 
be not significant based upon factorial ANOVA. The pattern involved a 
consistent decrease in number of fecal pellets deposited per unit of time 
with increasing dose in both males and females when replicates were com-
bined. The hypothesis that the decrease in means with increasing dose may 
be real will be tested more adequately by the experiments of the third year 
in which larger numbers will be involved. 
Tables 5 through 10 present the data acquired for all three strains 
with respect to the six quantitative traits examined. Variation in mean  
body weight for all three strains examined is shown in Table 5. Means, 
standard errors of the mean and sample sizes are presented for each re-
plicate, sex and dose group. For strain BALB/cByJ, differences between 
sexes proved to be significantly different (p < .01) by factorial ANOVA. 
Inasmuch as differences between replicates were not significant for either 
sex, replicates were combined for analysis. Of interest is the fact that 
the mean values for even the lowest dose group, sexes compared separately, 
are highly significantly increased over control values on the basis of a 
2-tailed t-test. In spite of the fact that body weight is known to be 
affected by a number of environmental variables, it is clear that under the 
controlled laboratory conditions employed with both the BALB/cByJ and 
the DBA/2J strains, this trait exhibits sufficiently low variation and 
the response to mutagenic effect is sufficiently high so that it provides 
a superb test for the effect of a suspected mutagenic agent. We would 
recommend that the BALB/cByJ strain be used in such tests because of the 
very high productivity of the animal. 
With respect to strains C3H, results are not clear, very likely due to 
the small numbers involved. In replicate A, there appears to be an indica-
tion of the same response observed in BALB/cByJ and, in earlier experiments, 
with DBA/2J. However the results in replicate B follow a different pattern 
in which the low mutagen dose appears to induce a decrease in body weight 
followed by an increase in body weight at the higher dose level. Parenthe-
tically, the increases in body weight for replicate A are significant for 
both dose groups, sexes considered separately, on the basis of a 2-tailed 
Table 5. Effect of TEM dose on body weight of F1 progeny of treated male 
parents in inbred strains BALB/cByJ, C 3H/HeJ and DBA/2J. Males were 
treated at the spermatozoan germ cell stage. Standard errors are pro-




0.1 mg/hg 0.2 mg/hg 
Rep Ad' 18.23 + .23 (62) 19.52 + 	.26 (33) 20.77 + .57 _ (12) 
Rep B e 18.40 + .23 (42) 19.75 + .30 (29) 20.02 + .30 (15) 
Combined d' 18.30 + .16 _ (104) 19.63 + .20 (62)* 20.35 + .30 _ (27);* 
Rep A9 16.36 + .20 (63) 17.17 + .24 (40) 18.25 + .47 (18) 
Rep B52 16.66 + .19 (59) 17.30 + .19 (32) 17.64 + .24 (27) 
Combined 2 16.51 +.14 (122) 17.23 + .16 (72)** 17.89 + .24 (45)** 
B. C 3H 
Rep Ad' 16.97 + .35 (22) 19.46 + .32 (11)** 19.89 + .20 (11)** 
Rep B e 19.38 + .49 (13) 18.52 + .34 (15) 19.22 + .37 (13) 
Rep A? 14.87 + .33 (11) 15.86 + .33 (15)* 16.18 + .22 (19)* 
Rep B? 16.07 + .25 (13) 15.01 + .52 (18) 15.83 + .91 (16) 
C. DBA 
Rep Ad' 15.53 + .41 (22) 13.71 + 1.03 ( 	7) ( 	2) 
Rep 	Bc-?' 15.79 + .42 (24) ( 	0) ( 	0) 
Rep A? 15.00 + .35 (12) 13.79 + 	.65 (11) ( 	0) 
Rep B 14.78 + .38 (10) ( 	 1) ( 	0) 
* In comparison with control, p < .05 
** In comparison with control, p< .01 
(12) 
t-test. In replicate B, observed differences are not significant, and it 
is entirely likely that an experiment involving larger numbers would have 
shown the same results found for the'other two strains. 
With respect to strain DBA/2J, only replicate A had F1 young in a 
dose group other than control, but even here the numbers were too low to 
be meaningful. For males of replicate A, the differences between the low 
dose group and control are not significant based upon a 2-tailed t-test; 
for females of replicate A the differences between means are significant 
(p< 5%). Obviously, where such small numbers are involved, the likelihood 
of a Type II error is not negligible. Since this result is in conflict 
with results of earlier experiments where much larger numbers were in-
volved, we suspect that this is precisely what has happened. 
In regard to the time of development of the righting response (see 
Table 6) results obtained with strain BALB/cByJ are persuasive and are 
particularly interesting in that they parallel the results obtained with 
strain DBA/2J in experiments of the second year. Differences between sexes 
only approached significance based upon a factorial ANOVA (.05< "p < .10). 
However, the differences due to treatment proved to be highly significant 
(p -c ".001). The pattern that emerges indicates an increase in the length 
of time between birth and development of the righting response (a decrease 
in rate of development) with increasing mutagen dose. Although differences 
between the low dose means and those of controls are not as clearly differ-
ent as was the case with body weight, for each sex differences would be 
significant (p 4: .05) on the basis of a 1-tails:' t-test. Based upon a 
2-tailed t-test, the difference between the control and low dose means 
approaches significance for males replicates combined. The same difference 
is highly significant for females. For both sexes the difference between 
the high dose group and control, replicates combined, is highly significant 
(p< .01). This trait is unquestionably of great potential usefulness in 
detecting mutagenic activity, particularly when used in conjunction with 
body weight at weaning. While results with large numbers using strain 
DBA/2J in the experiments of the second year showed very similar effects, 
strain BALB/cByJ would clearly be the strain of choice in mutagenicity 
tests because of its greater productivity. 
Data obtained for strain DBA/2J in the present experiment are based upon 
such limited numbers that the results are not of great usefulness. There was 
a face value increase in developmental time with increasing dose for both 
sexes of replicate A, but sample sizes are such as to make meaningful con-
clusions impossible. With respect to strain C3H, a very interesting pheno-
menon was observed which may be meaningful in spite of the small numbers 
involved, if not useful. For both sexes in both replicates there was ob-
served an increase in rate of development, a decrease in the length of time 
between birth and the righting response, at the lowest TEM dose. Differ-
ences between replicates were not significant. Accordingly replicates were 
combined. The difference between the means of the low close group and those 
of control proved to be nonsignificant for males (p 	.15) but highly signi- 
ficant for females (p< '.01) on the basis of a 2-tailed t-test. At the 
highest dose developmental time remained lower than that of controls but 
(13) 
Table 6. Effect of TEM dose on time of development of the righting re-
sponse of the F 1 progeny of treated male parents in inbred strains BALB/ 
cByJ, C3H/HeJ and DBA/2J. Males were treated at the spermatozoan germ 





0.1 mg/hg 	 0.2 mg/hg 
Rep A o" 	9.52 + .14 (62) 	9.73 + .31 (33) 	10.75 + .68 (12) 
Rep B e 9.16 + .24 (24) 	9.89 + .28 (29) 	10.53 + .52 (15) 
Combined d' 	9.38 + .13 (104) 9.81 + .21 (62) 10.63 + .42 (27)* 
Rep A 2 	9.76 + .21 (63) 	10.60 + .24 (40) 	11.44 + .41 (18) 
Rep B9 9.29 + .23 (59) 10.25 + .24 (32) 10.48 + .49 (27) 




Rep A g, 	7.73 + .29 (22) 	7.09 + .37 (11) 	7.64 + .51 (11) _  
Rep Be 7.85 + .32 (13) 	7.40 + .36 (15) 	7.00 + .45 (13)  
Combined ̀ r 	7.77 +.21 (35) 	7.27 + .26 (26) 	7.29 + .34 (24) _   
Rep A.9 	8.64 +.31 (11) 6.93 + .33 (15) 7.65 + .37 (20)  
Rep B9 7.77 +.50 (13) 	7.00 + .32 (18) 	7.00 + .43 (16) _ 	 _ 	 _ 
Combined 9 	8.17 + .31 (24) 6.97 +.23 (33)** 7.36 + .28 (36) 
C. DBA 
Rep A d, 	7.77 + .31 (22) 	8.00 + .63 ( 8) 	9.50 + .5 (2) 
Rep Be 	8.50 + .31 (24) 	11.00 + 	0 ( 2) 	 (0) 
Rep A 9 	8.25 + .39 (12) 	8.82 + .42 (11) 	 (0) 
Rep B9 8.30 + .30 (10) 	 ( 1) 	 (0) 
* In comparison with control, p< .01 
(14) 
appeared to increase slightly above the low dose group. The interesting 
suggestion that emerges from these data is that the fitness of strain 
C3H F1 young may have been increased slightly, as judged by an increased 
rate of development, by the genetic variance induced at the low mutagen 
dose. While this hypothetical effect might or might not be of usefulness 
in the detection of mutagenic effects, the implications for the broader 
significance of mutagen induced genetic variance are very important. A 
similar effect was observed in the experiments of the prior year with 
respect to the low dose group employing strain DBA/2J. In our report of 
those results we noted that "...the increase in rate of development, i.e. 
reduction in time of development of the righting response, associated with 
the low mutagen dose group approaches significance in comparisons with 
the control. We have observed this pattern before in respect to other 
traits, and it may well be real." In the same experiments, among the F2 
generation young of the spermatozoan treated group the increase in rate of 
development (decrease in time of development) of the righting response for 
the low TEM dose group was even more strikingly demonstrated. With sexes 
and replicates combined a multiple range test indicated that the difference 
between the low dose group and control means was significant. 
We reported then and we still feel that the simplest interpretation 
of these results is that the slightest amount of mutagen induced variation 
has the effect of shortening developmental time appreciably in some highly 
inbred mice strains. With increasing mutagen effect, i.e., genetic damage, 
developmental times are not so strikingly reduced or may be increased. 
This interpretation is based upon the assumption that a very limited amount 
of mutagen induced polygenic variance may provide a genetic buffering effect 
that results in more rapid development. With increasing mutagenic damage, 
however, the cumulative effects of the deleterious mutations will gradually 
mask the buffering effects of polygenic mutations. Rate of development is 
a phenomenon closely related to fitness, and it might be predicted that other 
fitness traits would show a similar pattern where the direction of "bad" 
or "good" effect can be guessed in a relatively straightforward manner. 
With respect to the defecation portion of the open field test, the 
results that emerged, while not significant, are interesting and will be 
tested in future experiments (Table 7). With strain BALB/cByJ differences 
between replicates were not significant. Accordingly, replicates were com-
bined and a factorial ANOVA (sex by dose) was carried out to determine if 
an apparent increase in defecation rate with increasing mutagen dose was 
real. While the differences between sexes proved to be significant (p < 
.025), differences due to mutagen dose were not (p 	.15). Experiments 
currently in progress and to be conducted in the coming year may well de-
monstrate a mutagenic effect with respect to this trait. Nevertheless, it 
seems likely that the numbers required to demonstrate significance will 
make the trait somewhat less useful than body weight and righting response. 
There were indications in strain C3H of a reduction in defecation rate 
with increasing mutagen dose but the differences are so modest and the 
numbers so low that meaningful comparisons are not possible (Table 7). 
Experiments with defecation rate in strain DBA/2J failed to show differ-
ences among dose groups, although a highly significant difference between 
(15) 
Table 7. Effect of TEM on the defecation portion of the open field test 
of F1 progeny of treated male parents in inbred strains BALB/cByJ, C3H/ 
HeJ and DBA/2J. Males were treated at the spermatozoan gerM cell stage. 








B. C 3H 
Rep A 6 
 Rep B d 
Combined 
Rep A 9 
Rep B 9 
Combined 9 
C. DBA 
Rep A d 
Rep B 
Rep A 9 


















+ .27 	( 67) 
+.30 ( 42) _ 
+ .21 	(109) _ 
+.28 	( 63) 
+ .23 	( 59) 
+ .18 	(122) 
+ .37 	( 22) 
+ 	.26 	( 13) _ 
+ .25 	( 35) 
+ 	.58 	( 11) 
+ .31 	( 13) 
+ .31 	( 24) 
+ .49 	( 22) 
+ .38 	( 24) 
+ .51 	( 12) 
+ .39 	( 10) 
TEM dose 
0.1 mg/kg 
4.09 + .42 	(33) 
5.07 + .37 	(29) 
4.55 + .29 	(62) _ 
4.15 4 	.34 	(40) 
3.59 + .33 	(32) 
3.90 + 	.24 	(72) 
3.27 + .59 	(11) 
3.20 + .47 	(15) 
3.23 +.36 	(26) 
2.73 + 	.49 	(15) 
2.83 + .23 	(18) 
2.79 + .25 	(33) 
4.00 + 1.05 	(7) 
(2) 
2.00 + 	.65(11) 
( 	 1) 
0.2 mg/kg 
	
3.75 + .35 	(12) 
4.60 + .49 (1 5)_ 
4.22 + .32 	(27) 
3.61 + .49 	(18) 
3.81 + .26 	(27) 
3.73 + 	.25 	(45) 
3.09 + .49 	(11) 
3.36 + .29 	(14) 
3.24 + .27 	(25) _ 
2.90 + .35 	(20) _ 
3.07 + 	.43 	(14) _ 




( 	 0) 
(16) 
sexes was found in experiments of the past year. As can -be seen in Table 
7, the numbers available for strain DBA/2J in experiments of the present 
year are not adequate to provide meaningful conclusions. 
With respect to hematocrit, results of experiments of the present year 
are shown in Table 8. For strain BALB/cByJ the pattern of means that 
emerges is erratic. While two of the differences between means are signifi-
cant on the basis of a 2-tailed t-test, it would be difficult to interpret 
both of the significant differences as meaningful biologically. In experi-
ments of the past two years employing strain DBA/2J, it was observed that 
the hematocrit reading was always higher in the middle and high mutagen 
doses than in the control. In only one comparison was a significant differ-
ence found, but the pattern was consistent. In the experiments of the pre-
sent year involving BALB/cByJ, the high mutagen dose is associated with a 
higher hematocrit level for males and females of replicate A, but only males 
in replicate B show the same trend. By contrast, females show a significant 
reduction in hematocrit level (p< .05) in the highest dose group. The 
hematocrit pattern determined for strain C3H is quite interesting in that 
it is reminiscent of the results with righting response. With replicates 
combined, both males and females show a reduction in the. lowest TEM dose 
group below controls followed by an increase in the high dose group to a 
level above controls. Based upon a 2-tailed t-test analysis, replicates 
combined, the decrease in hematocrit from control to low dose mean is not 
significant for either sex (although the same difference is found in both 
sexes of each replicate), but the increase from low dose group to high dose 
group is highly significant. Again, while this pattern may not be parti-
cularly useful for the purpose of ascertaining mutagenic activity, it is 
of great interest as it suggests something about the phenotypic effect of 
small amounts of mutagen induced genetic variance. 
Again, the data from the strain DBA/2j are too limited to say more than 
that the means are not in conflict with results of experiments of the prior 
years. 
Data acquired with respect to tail length are represented in Table 9. 
Unlike earlier results with strain DBA/2J in which variation in tail length 
appeared to be strongly positively correlated with variation in body weight, 
no effect could be observed in strain BALB/cByJ in tail length variation 
in spite of the clear evidence of mutagenic effect on body weight. The 
results obtained in strain C3H are quite interesting although the small 
sample sizes prevent the unequivocal demonstration of effects that may be 
present (Table 9). However, in each sex of both replicates, tail length 
is reduced in the low TEM dose group below control and increased above the 
low TEM dose group in the high TEM dose group. A factorial analysis of 
variance, sex by dose, replicates combined, indicates that the reduction in 
tail length in the low TEM dose group is highly significant (F1, 115 ' 10.13; 
p< .005). The high dose groups are not significantly different from con-
trols, but the increase over the low dose group is significant (F1, 117 ' 
4.12; p< .05). In view of the modest numbers involved in these com-
parisons, it is entirely possible that strain C3H, employing tail length 
as a trait, could prove to be particularly sensitive in the detection of 
very low level mutagenic activity. Unfortunately, present plans do not 
(17) 
Table 8. Effect of TEM dose on hematocrit in F1 progeny of treated male 
parents in inbred strains BALB/cByJ, C3H/HeJ and DBA/2J. Males were 
treated at the spermatozoan germ cell stage. Standard errors are provided 




0.1 mg/kg 0.2 mg/kg 
Rep A d' 49.06 + .15 (62) 49.48 + .28 (33) 50.50 + .58 (12)* 
Rep B 49.64 + .25 (42) 48.93 + .21 (28) 49.87 + .46 (15) 
Rep A? 48.54 1 	.15 (63) 48.45 + .23 (40) 48.89 + .31 (18) 
Rep B ? 49.50 + .21 (32) 48.44 + .17 (32) 48.07 + .18 (27)* 
B. CH 
Rep A e 45.91 + .29 (22) 45.82 + .38 (11) 46.64 + .39 (11) 
Rep B e 46.54 + .45 (13) 45.87 + .35 (15) 47.23 + .50 (13) 
Combined e 46.14 + .25 (35) 45.85 + .25 (26) 46.96 + .32 (24)** 
Rep A? 46.30 + .47 (10) 46.00 + .45 (15) 46.70 + .25 (20) 
Rep B ? 46.08 + .29 (13) 45.39 + .29 (18) 46.40 + .31 (15) 
Combined ? 46.17 + .26 (23) 45.67 + .26 (33) 46.57 + .19 (35)** 
C. DBA 
Rep A d 47.77 + .20 (22) 48.00 + .37 ( 	6) 48.00 + 1.0 ( 	2) 
Rep B d' 48.17 + .33 (24) 50.50 + .50 ( 2) ( 	0) 
Rep A ? 47.17 + .30 (12) 46.73 -I- 	.45 (11) ( 	 0) 
Rep B ? 46.90 + .43 (10) ( 1) ( 	 0) 
* In comparisons with control, p< .05 
** In comparisons with low dose group, p< .01 
(18) 
Table 9. Effect of TEM dose on tail length of F 1 progeny of treated male 
parents in inbred strains BALB/cByJ, C3H/HeJ and DBA/2J. Males were 
treated at the spermatozoan germ cell stage. Standard errors are provided 




0.1 mg/kg 0.2 mg/kg 
Rep A d' 83.44 + .31 (61) 83.22 + .66 (27) 82.67 + 1.40 (12) 
Rep B 82.15 + .40 (41) 81.52 + .27 (29) 83.00 + 	.47 (15) 
Rep A 81.31 + .33 (35) 81.90 + .35 (40) 82.41 + 	.45 (17) 
Rep B 81.26 + .23 (58) 81.47 + .26 (32) 81.15 + 	.40 (26) 
B. C3H 
Rep A d' 80.59 + .60 (22) 78.55 + .61 (11) 78.91 + 	.79 _ (11) 
Rep B 78.42 + .69 (12) 77.60 +.58 _ (15) 78.38 + 	.63 - (13) 
Combined o 79.82 + .49 (34) 78.00 + .43 (26)** 78.63 + 	.49 (24)* 
Rep A 79.80 + .49 _ (10) 78.47 + .80 _ (15) 79.40 + 	.50 (20) 
Rep B? 77.92 + .67 (12) 76.61 + .66 (18) 77.64 + 	.43 (14) 
Combined 78.77 + .46 (22) 77.45 + .53 (33)** 78.68 + 	.37 _ (34)* 
C. DBA 
Rep Ad' 73.82 + .55 (17) 74.40 + .68 (15) 
Rep Be 76.00 + .48 (18) ( 	1) 
Rep A? 75.12 + .58 ( 	8) 73.57 + .84 ( 	7) 
Rep B 74.33 + .95 ( 	6) ( 	1) 
* In comparisons with low dose group, p< .05 
** In comparisons with control, p< 
(19) 
permit the retesting of this exciting possibility. 
Data on variation in tail length in strain DBA/2J are also provided 
in Table 9 but, as with other traits, the small numbers available do not 
permit meaningful conclusions. 
Finally, with respect to brain weight, a trait which looked particu-
larly exciting in the experiments of the second year with strain DBA/2J, 
effects in BALB/cByJ were found for males, replicates combined, but not 
for females (Table 10). In males, both the low and the high TEM dose 
groups exhibited significantly higher brain weights than the control based 
upon a 2-tailed t-test. In females, however, differences among groups 
were not significant. It may be noted that numbers are lower in analysis 
of brain weight than for other traits. This is because some males were 
employed in translocation tests and were too old by the time the tests. had 
been completed'to have their brain weights included. Another factor, some 
error variance with respect to brain weight is added because of the necess-
ity of letting females wean their litters. Thus infertile females may have 
their brain weights taken at 14 weeks of age, while females carrying young 
to weaning may be 17 weeks of age or older. The variance introduced by 
this problem may well account for the lack of significance among dose groups 
in females in contrast with the highly significant differences among males 
in spite of even lower numbers. Of course, it would be quite reasonable 
to employ a test involving brain weights of males only in strain BALB/cByJ 
as an adjunct to the body weight and righting response traits already de-
monstrated. With respect to strain C3H (where some males were also in-
volved in translocation tests and where the weaning problem with females 
also existed) the small numbers involved make meaningful conclusions im-
possible. The same is true with respect to strain DBA/2J in which numbers 
are even lower that is usually the case. 
Discussion. The conclusion6 of major importance that emerge from these 
results with respect to the F1 young of three inbred mouse strains include 
the conclusion that strain BALB/cByJ not only exhibits a response to muta-
genic action in certain of its quantitative traits,but that it is suffi-
ciently highly productive to be employed economically as a test animal  in 
detecting mutagenic activity at relatively modest levels. It is emphasized 
that the kinds of mutations that are involved are what have been termed 
polygenic mutations, that is mutations of very slight effect which may be 
passed on from one to the next generation and,thus,be cumulative in their 
effects over time. By and large, most other mutagenic assays in common usage 
do not detect this very important type of lesion. 
The most important developments of these experiments are that the  
effects of mutagenic treatment on the traits body weight at weaning and time 
of the development of the righting response in strain BALB/cByJ can he most  
useful as indicators of mutagenic activity of suspect compounds. Employed 
in conjunction with the less strikingly affected defecation portion of the 
open field test and brain weight in male progeny only, it seems relatively 
certain that the basis for a very straightforward test of mutagenicity is at 
hand. 
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Table 10. Effect of TEM dose on brain weight of F1 progeny of treated 
male parents in inbred strains BALB/cByJ, C3H/HeJ and DBA/2J. Males 
were treated at the spermatozoan gerffi cell stage. Standard errors are 
provided and sample size is given in parentheses. 
TEM dose 
O. C3H 
Rep A d' 





Rep B d' 
Rep A? 
Rep B? 
mg/kg 	 0.1 mg/kg 	 0.2 mg/kg 
476.20 + 1.76 ( 60) 481.82 + 2.32 (22) 	498.00 + 8.25 ( 5) 
469.83 + 3.49 ( 36) 479.22 + 1.96 (23) 472.78 + 3.08 ( 9) 
473.81 + 1.73 ( 96) 480.49 + 1.51 (45)** 481.79 + 4.75 (14)** 
487.84 + 2.23 ( 58) 494.72 + 2.32 (37) 	479.82 + 6.28 (11) _ 	 _  
481.59 + 1.95 ( 58) 478.31 + 5.75 (32) 484.46 + 3.58 (26) _ -  
484.72 + 1.54 (116) 487.10 + 3.08 (69) 	483.08 + 3.11 (37) _  
441.36 + 2.36 ( 14) 442.43 + 4.62 ( 7) 	440.14 + 6.34 ( 7) 
436.18 + 2.98 ( 11) 435.40 + 3.86 (10) 440.29 + 4.70 ( 7) 
447.70 + 2.97 ( 10) 446.07 + 3.80 (15) 	444.79 + 2.65 (19) 
449.08 + 3.23 ( 12) 439.39 + 6.41 (18) 439.50 + 2.75 (14) 
417.81 + 1.92 ( 21) 396.80 + 13.63( 5) 
413.50 + 2.36 ( 22) 	 ( 0) 
427.13 + 1.84 ( 8) 429.91 + 2.96 (11) 
	
( 0) 
426.70 + 3.11 ( 10) 	 ( 1) ( 0) 
A. BALB 






** In comparisons with control, p< .01 
Respectfully submitted, 
/7,..,P0.44-iteavor- 
W. Crenshaw, Jr. 
ject Director 
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The interesting parallel in strain C3H evident in several traits (time 
of development of the righting response, hematocrit level and tail length), 
involving a decrease below control in trait value at the low mutagen dose 
level followed by an increase in trait value at the high mutagen dose level, 
is very interesting from the standpoint of basic genetic significance. While 
usefulness as an indicator of mutagenic activity is not clearly indicated, 
potential usefulness in ascertaining very low mutagenic activity cannot be 
ignored. 
As indicated above, this report is of necessity limited to F 1 genera-
tion results. It is entirely possible that the data we are now acquiring 
with respect to strain C3H and BALB/cByJ.for F 2 generation young and, par-
ticularly, for spermatogonial treatment effects may be most exciting based, 
as they will be, upon greater numbers of animals. 
With respect to plans for the year now in progress, the data analyzed 
in this report as well as data on F2 young in the analysis of spermatozoan 
treatment effect and F1 and F2 generation progeny in spermatogonial treat-
ment effects will be submitted to complete computer'analysis. This will 
include partitioning of the effects of litter size in addition to the 
examination of differences in means due to sex, treatment and replicate. 
Early in the past year, as soon as it was evident that our productivity 
of F1 young was going to be quite low, we made a decision to initiate a 
second experiment during the year involving the BALB/cByJ strain carried 
to F1 young only. These data will become available shortly and will pro-
vide a timely test of our results reported on here for strain BALB/cByJ. 
With respect to plans for the experiments of the final year of the 
contract just beginning, employing the same design employed in past years 
and including all the traits employed in the past year, it is proposed 
that we examine the effects of TEM on the single strain BALB/cByJ in a 
concerted effort to demonstrate as conclusively as possible the usefulness 
of quantitative traits as indicators of mutagenic effect. In the interests 
of having test groups as large as possible, we plan to employ mutagen doses 
of 0, .1 and .2 mg of TEM per kg of body weight as in the past year. 
As reported in the last semi-annual report, results of our first two 
years experiments provided substantial evidence that a late dominant lethal 
(perinatal) effect originally observed by Soares was responsible for a sig-
nificant number of deaths in treated groups. Dr. Jack Favor had developed 
supporting evidence in the course of his doctoral research. These results 
have been submitted for publication as a manuscript with resulting favorable 
recommendations for publication. The manuscript is currently being revised 
for resubmission. 
JWCJr:dm 
REPORT OF PROGRESS FOR RESEARCH CONTRACT NIEHS NO. NO1-ES-5-2135 
June 25, 1978 through December 25, 1978 
In the Report of Progress for the period ending June 25, 1978, 
preliminary analyses of the dominant lethal and quantitative trait data 
of Experiment III were included. Because of the difficulty of obtaining 
the numbers required of the strains being tested, the experiment was 
initiated late, and data collection was not completed by the end of the 
contract year. Experiment IV, a limited repetition of part of Experiment 
III, had been set up later in that same period. An outline of that experiment, 
including numbers.of animals and a schedule of matings,was also included 
in the last Report of Progress. Detailed statistical analyses are now 
available for the quantitative data of Experiment III, and these results 
will be presented in the second part of the present document. The first 
part of this document will be devoted to the description of Experiment V 
initiated in the present year. 
Experiment V. This experiment is devoted primarily to the effects of 
a mutagenic agent in determining the expression of quantitative traits in 
a single strain of inbred mouse, BALB/cByJ. As pointed out in the last 
semi-annual report, a decision had been made by the Principal Investigator 
and Contract Officer to devote total effort in the final contract year to 
the testing of this highly productive strain. As in the series of pre-
ceding experiments, triethylene melamine (TEM) was the mutagenic agent 
employed. Again, in order to maximize the number of animals in each group 
only two doses (.1 and .2 mg TEM per kilogram of body weight) were employed 
in addition to a control group. As has been the practice since Experiment II, 
the number of matings set in each dose group was adjusted to compensate for 
dominant lethal effects of treatment in the high dose groups in such a way 
that similar numbers of F1 progeny would be produced in all groups. TEM 
treatment effects will be tested on spermatozoanand spermatogonial stages 
of spermatogenesis in progeny of the F 1 and F2 generations. 
The quantitative traits which are being studied in Experiment V to 
determine the effect of mutagenic treatment on the F
1 
and F2 generation progeny 
of treated males include: 1) time of development of the righting response, 
2) body weight at weaning, 3) the defecation portion of the open field test, 
4) tail length at seven weeks of age, 5) hematocrit at seven weeks, and 
6) brain weight at approximately 13 1/2 weeks of age. In addition to these 
continuously varying traits, productivity traits are also being studied to 
determine if treatment has been effective. These traits include 1) percent 
dead implantation scars of total scars, 2) total implantation scars, 
3) percent females born, 4) total young born, 5) percent females weaned and 
6) total young weaned. Traits 1 and 2 which are based upon inspection of 
uterine scars in parental generation females were collected for F1 generation 
young only. Other productivity traits were obtained in both F1 and F2 
 generations. 
Design of Experiment. In Experiment V, female parents used to assess 
the effects of treatment at different germ cell stages were assigned to 
one of six replicates. Replicates A, B and C, carried out two weeks apart, 
consisted of females mated to males which had been exposed to mutagenic 
treatment immediately prior to mating, thus involving mutagenized spermatozoa. 
These matings involved trios of females mated with each male. Replicates D, 
E and F were temporally separated replicate groups of females which were 
mated to males which had been exposed to mutagenic treatment over eight 
weeks prior to establishment of mating. Accordingly, the germ cells involved 
were mutagenized as spermatogonial cells. In these latter replicates, the 
spacing was irregular for technical reasons with about two and one-half 
weeks elapsing between Replicates D and E and about six weeks separating 
E and F. Replicates A, B and C involved a total of 214 male mice of the 
BALB/cByJ strain. In order to maximize numbers of matings, males were 
selected from three different age groups involved and varied from 13 to 19 
weeks at treatment. Care was taken to assure that all age groups were 
approximately equally represented in the control and treatment groups. The 
three replicates were also approximately equal in numbers of matings involved. 
In Replicate D crosses, thirty males were each mated with two females 
for a period of two weeks. In like manner, thirty males were mated each 
with two Replicate E females for a period of two weeks. Replicate F will be 
established with similar numbers of males about January 10, 1979. In total, 
about 175 females will be involved in testing the effects of mutagenic 
treatment on spermatogonial stage germ cells. 
As has been general practice, females of matings involved in spermatozoa 
treatment tests were isolated from each other 10 days after the initiation 
of matings and checked daily for the presence of a litter through day 21 after 
the termination of matings. Young were sexed and marked by toe clipping for 
identification at birth. Starting on day 5, progeny were checked for the 
ability to right (righting response) and were checked daily until the trait 
appeared. All animals were weaned at four weeks of age, at which time body 
weight and sex were recorded, and indiiriduals were permanently marked by 
coded ear punching. The defecation portion of the field test was conducted 
on mice at five weeks of age, while tail length and hematocrit measures were 
taken for mice at approximately seven weeks of age. 
At the present time, F1  young of Replicates A and B have been weaned and 
the fecal test has been conducted for them. The young of Replicate C are due 
to be weaned early in January. The young of Replicate D have been weaned and 
the fecal tests conducted for them, and the young of Replicate E are scheduled 
to be weaned early in January. As was pointed out above, Replicate-F matings 
have not yet been established. 
It is planned that matings of F
1 individuals to produce F 2 progeny will 
be established for all replicates between eleven and twelve weeks of age. 
Pair crosses will be established between individuals taken randomly, except 
that sibling crosses will be precluded, within dose and replicate. Three 
replicates of spermatozoan treatment groups and three of spermatogonial 
treatment groups will be established by the progeny of the same parental 
replicate groups. Table 1 summarizes the scheduling of parental and F 1 
 generation matings. 
Table 1. Schedule of Matings for Parental Generation 
Replicate 
VA VB VC VD VE VF 
Fem,2.es received 	8/9/78 8/30/78 9/20/78 9/13/78 10/4/78 10/25/78 
Matings 10/19/78 11/1/78 11/13/78 10/26/78 11/14/78 to be est. 1/10/79 
Matings separated 10/26/78 11/8/78 11/20/78 11/9/78 11/28/78 to be sep. 1/24/79 
The mutagenic treatment consisted of intraperitoneal injection of 
triethylene melamine dissolved in .50 cc Hank's balanced salt solution pre-
pared immediately prior to injection. Control males received the same quantity 
of carrier only. Doses were based on the mean body weight of a random sample 
of the mice to be treated. Where males of different ages were employed, mean 
body weights were established for each of the different age groups involved. 
As indicated above, different numbers of matings were established for each 
dose group to compensate for dominant lethal effects in the higher doses of 
spermatozoan treatment groups and in order to produce similar numbers of 
F1 progeny. The total number of males treated in Replicates A, B and C 
combined, in-_the dose groups 0.0, .1 and .2 mg/kg of body weight were 
respectively 37, 62 and 115. All animals were identified by a coded number 
so that observations were blind with respect to dose. Because dominant 
lethal effects in spermatogonial treatment groups are virtually absent, 
Replicates D, E and F dose groups were established with approximately 30 males 
employed in each dose group for all three replicates combined. 
II 
Results:(A) Dominant Lethality, Experiment III.  Preliminary discussions 
of dominant lethal variation among the three strains compared in Experiment III 
(viz. DBA/2J, BALB/cByJ and C3H/HeJ)were presented in the most recent semi-
annual report. We now have statistical analyses to support the tentative 
conclusions of that report. 
It was reported in the previous Report of Progress that "while total 
live scars tend to decrease with increasing dose for both DBA/2J and BALB/cByJ, 
strain C3H/HeJ showed an increase in live scars between controls and the 
lowest mutagenic dose followed by a drop to a level below that of controls 
for the highest mutagenic dose". Analyses of total scars was carried out by 
ANOVA after square root transformation. As expected, differences between 
means due to dose were highly significant (p< .001), but the strain x dose 
interaction that should have geen produced by the unusual performance of 
strain C3H/HeJ at high dose was not significant (p - .195). Differences among 
strains were highly significant (p< .001). Differences between replicates 
were negligible. 
With respect to the traditional measurement of dominant lethality, 
percent dead scars of total scars, it was reported that "the BALB/cByJ strain 
exhibits a clear increase from a very low control value to a very high 
value with the highest mutagen dose supported by closely parallel and 
regular replicate responses. Strain C3H/HeJ is remarkable in that clear 
evidence of dominant lethality by the traditional measure is lacking. In 
both replicates the highest mutagen dos shows a face value decrease in 
percent dead scars of total, but all differences between experimental 
groups and control are slight and show no evidence of a dominant lethal 
effect." Percent dead scars of total were analyzed by ANOVA after 
arc sine transformation of data with the following results. The differences 
among strains were indeed highly significant (p< .001) due evidently to 
the performances of BALB/cByJ and DBA/2J. 
Data from Experiments I and II are a part of a paper by Favor, Soares, 
and Crenshaw demonstrating a late dominant lethal effect in mice. This 
paper has been accepted for publication by the journal Mutation Research, 
with publication expected in the near future. As reported in the last Report 
of Progress, the results of Experiment III support our conclusions based 
upon earlier experiments, but the detailed statistical analyses have not 
yet been completed. Tables 2, 3 and 4 of the last Report of Progress submitted 
gave details of important dominant lethal parameters for all three strains. 
While some differences have emerged in the more detailed statistical analyses, 
the original tables are essentially correct. 
Quantitative Traits, Experiment III. The numbers of animals involved in 
the present experiment and the amount and complexity of data acquired in 
Experiment III and subsequently have prevented the complete statistical 
analyses of all data as of the present moment. The data that we have analyzed 
make significant: contributions toward our understanding of a number of factors 
involved in the use of quantitative traits in the assessment of mutagenic 
damage. For the first time our sample sizes have been sufficiently great 
so . as to provide us with some definite conclusions and, perhaps equally 
important, they provide patterns of response that, while not necessarily 
significant, suggest meaningful genetic mechanisms that could account for 
the effect. Numbers of DBA/2J strain mice are too limited to make much 
sense in the present analyses. Accordingly, we will limit discussions 
below to strains BALB/cByJ and C3H/HeJ for the F 1 generation groups repre- 
senting mutagenized spermatozoa and, for BALB/cByJ only, groups representing 
germ cells treated as spermatogonia. 
Time of Development of the Righting Response. It was reported in the 
most recent Report of Progress that preliminary analyses of data revealed 
interesting responses in the time of development of the righting response 
to doses of the mutagen TEM in both strains BALB/cByJ and C3H/HeJ, but that 
the responses were remarkably different in the two strains. In BALB/cByJ, in 
both replicates and both sexes, there was a more or less linear increase in 
the time of development of the righting response with increasing mutagen 
dose. One way analyses of variance comparisons showed highly significant 
differences between the control and the highest dose group in males and 
between controls and both mutagen doses in females. Subsequently, 
employing covariance techniques, these data were adjusted for variation 
in litter size. While the pattern of an increase in time of development 
of the righting response with increasing dose remains the same, differences 
among dose groups were no longer significant. 
Thus, much of the variance between dose groups in the raw data is attributable 
to litter size effects. An examination of the righting response in spermatogonial 
treatment groups reveals precisely the same pattern, an increase in time 
of development of the righting response with increasing dose. The differences 
between control and the experimental groups are not as great, but the sample 
size is nearly three times larger than that in the spermatozoan treatment 
group tested. Again, the differences among dose groups are not significant, 
but the suggestion is clear that mutagen induced variance in strain BALB/cByJ 
appears to slow down the rate of development at least as measured by time of 
development of the righting response. As might have been expected, the 
effect is not great in spermatogonial treatment groups, where some of the 
variance might have been eliminated, as it is in spermatozoan treatment 
groups. Inasmuch as the numbers involved are moderately large, it may be 
concluded that righting response would not be a useful trait to employ if 
BALB/cByJ were the strain being used. Fortunately, there are in progress 
two experiments that may provide additional evidence on the question. 
The effects of triethylene melamine on strain C3H/HeJ were remarkably 
different from that of BALB/cByJ. As we reported in the last Report of 
Progress, strain C3H revealed a reduction in time of development of the 
righting response in mutagenized groups, but these differences were significant 
only for females at the low dose group. In contrast with the results of 
covariation for litter size found in strain BALB/cByJ, the effects of 
covariation were not significant in C3H/HeJ but, adjusting for litter size, 
differences among dose groups were highly significant (p < .001). From 
Table 2 it can be seen that the effect of mutagenic action was to decrease 
in similar manner the time of development of the righting response in both 
dose groups, with the control being significantly different - from both. 
Apparently the effect of mutagen induced variation at the dose levels involved 
is to increase the rate of development in strain C3H/HeJ. As was pointed out 
in the most recent Report of Progress, "a similar effect was observed in the 
experiments of the prior year with respect to the low dose group employing 
strain DBA/2J." We also noted in an earlier Report of Progress that 
	the increase in the rate of development, i.e. reduction in time of 
group approaches significance in comparisons with control. We have observed 
this pattern before in respect to other traits, and it may well be real." 
We continue to feel that the simplest interpretations of these results is that 
Table 2. Effect of TEM dose on time of development in days of the righting 
response of the F1 progeny of treated male parents in inbred strains BALB/cByJ 
and C31-1111eJ. Males were treated at the spermatozoan or spermatogonial cell 
stages. 	Sample sizes are given in parentheses. 	Means have been adjusted 
for the effects of litter size by covariance. Sexes and replicates are 
combined for simplicity. 
Strain 	Stage 	Significance 	0 mg/kg 	0.1 mg/kg 	0.2 mg/kg 
BALB Spermatogonia n.s. 8.95 (376) 8.97 (458) 9.11 (419) 
BALB Spermatozoa n.s. 9.84 (226) 9.88 (134) 10.07 (72) 
C3H Spermatozoa p< 	.001 8.25 ( 59 ) 7.04 (59) 7.09 (60) 
the slightest amount of mutagen induced variation has the effect of 
shortening developmental time appreciably in some highly inbred mice 
strains. With increasing mutagen effect, i.e. genetic damage, developmental 
traits are not so strikingly reduced or may be increased. This inter-
pretation is based upon the assumption that a very limited amount of 
mutagen induced polygenic variance in a highly inbred strain may provide a 
genetic buffering effect that results in more rapid development. With 
increasing mutagen damage, however, the cumulative effects of the 
deleterious mutations will gradually mask the buffering effects of 
polygenic mutations. Rate of development is a phenomena closely related 
to fitness, and it might be predicted that other fitness traits would show 
a similar pattern where the direction of "bad" or "good" effect can be 
guessed in a relatively straightforward manner." By this interpretation 
it is suggested that BALB/cByJ is somewhat better balanced genetically than 
C3H/HeJ and that the general effect of added variance on the former is 
deleterious and reduces rate of development. By contrast, strain C3H is 
interpreted as being less well balanced genetically, perhaps more highly 
inbred or, at least, less well balanced, and is "improved" by added genetic 
variation as indicated by an increase in rateof development. It will be 
most interesting to study the effects on spermatogonial mutagenized stages 
in C3H which will be forthcoming shortly. It can be predicted that a 
similar effect would occur. That is, an increase in rateof development 
in mutagenized groups relative to controls. Whether the effect would be 
greater or lesser than in spermatozoan treatment groups cannot be predicted 
from the data available. From a purely practical viewpoint if the results  
with C3H/HeJ can be confirmed, considering the modest numbers involved, this  
strain employing the time of development of the righting response trait, 
would be extraordinarily sensitive as an indicator of mutagenic activity. 
Body Weight at Weaning. In the last Report of Progress it was reported 
that there were highly significant increases in body weight in mutagenized 
groups in strain BALB/cByJ and in Replicate A (Replicate B was not available) 
of strain C3H/HeJ. These conclusions were drawn prior to adjustment for 
litter size effect. Table 3 shows the results after adjustment for litter 
size. It can be seen that, after adjustment for litter size, differences 
among groups were no longer significant. Indeed, the direction of difference 
in means was actually reversed in strain BALB/cByJ. In strain C3H/HeJ the 
direction of differences remains the same as prior to adjustment for litter 
size. Means, adjusted for litter size, are shown for the spermatogonial 
stages in strain BALB/cByJ. The differences among means proved to be highly 
significant (p < .001) based upon a factorial ANOVA with both replicates of 
both sexes showing the same tendency for mutagenized groups to have greater 
body weights than controls. Combining replicates and comparing sexes 
separately, only the high mutagen dose group in females was significantly 
greater than control (p < .001), but in males both low and high dose groups 
were highly significantly greater than controls (p < .001 in both cases). 
The latter comparisons are based upon t-test analyses. 
Table 3. Effect of TEM dose on body weight at weaning of F i progeny of 
treated male parents in inbred strains BALB/cByJ and C3H/HeA. Males were 
treated at the spermatozoan or spermatogonial germ stages. Sample sizes 
are given in parentheses. Means have been adjusted for the effects of 
litter size by covariance. Sexes and replicates are combined for simplicity. 
Strain Stage Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
BALB Spermatogonia p< 	.001 16.49 (376) 16.87 (458) 17.06 (419) 
BALE Spermatozoa n.s. 18.00 (226) 17.83 (134) 17.67 (72) 
C3H Spermatozoa n.s. 16.93 (59) 16.97 (59) 17.36 (60) 
The lack of significant differences among the groups in spermatozoan 
treated groups may be attributed most simply to small sample sizes. The 
fact that very large sample sizes are associated with the significant differ-
ences in spermatogonial treatment groups lends greater confidence to the 
results. Fortunately, an additional experiment already in progress will 
provide a test: of these conclusions. As has been pointed out previously, 
the fact that this approach may detect differences in the spermatogonial stages  
is particularly exciting in view of the difficulty of measurements of 
mutagenic effect generally for this stage. 
Tail Length at Seven Weeks of Age. Remarkably, highly significant 
differences were found among dose groups in spermatogonial stage treated 
groups in strain BALB/cByJ, but not among treatment groups in spermatozoan 
treated stages. (Table 4). The sample sizes were considerably greater in the 
spermatogonial groups, as were the differences between the several means. 
Table 4. Effect of TEM dose on tail length at seven weeks of age of 
F, progeny of treated male parents in inbred strains BALB/cByJ and C3H/HeJ. 
MAles were treated at the spermatozoan or spermatogonial germ cell stages. 
Sample sizes are given in parentheses. Means have been adjusted for the 
effects of litter size by covariance, and sexes and replicates are combined, 
except as noted. 
Strain Stage 	Significance mg/kg 0.1 mg/kg 0.2 mg/kg 
BALB Spermatogonia p< .001 81.88 (366) 82.57 (441) 82.51 (406) 
BALB Spermatozoa n.s. 82.04 (222) 82.26 (128) 82.07 (70) 
C3H Spermatozoa p< 	.05 79.01 (56) 77.91 (59) 78.90 (58) 
C3H Rep A 80.68 ± .58 (22) 78.55 ± .61 (11) 78.91 ± .79 (11) 
9 Rep B 78.42 ± .69 (12) 77.60 ± .58 (15) 78.29 ± .59 (14) 
cr Rep A 79.80 ± .49 (10) 78.47 ± .80 (15) 79.40 ± .51 (20) 
Rep B 78.17 ± .57 (12) 76.61 ± 	.66 (18) 77.69 ± .46 (13) 
The effect of mutagen treatment was to increase tail length for both dose 
groups, but not in a linear manner. The simplest interpretation of the 
difference in response in the two different germ cell stage groups is that 
the mutagen induced genetic variance is filtered through spermatogenesis in 
spermatogonial test groups. Therefore, presumably mostly lesions of minor 
effect are left, with the effect of increasing tail length. The more 
extensive and more numerous (and likely more damaging) induced variance 
in spermatozoan stages has produced appreciable effects in the direction 
of shortening and perhaps also lengthening the tail. These conclusions 
are based upon means adjusted for variation in litter size. It is of 
interest that variance due to litter size was not significant with respect 
to spermatozoan stage cell treatment but was significant (p - .025) in 
regard to spermatogonial stage group tests. 
With respect to strain C3H/HeJ, significant differences were found 
(p - .03) among groups after adjustment for litter size in spite of the 
relatively small sample sizes involved (See Table 4). The effect of the 
mutagen induced variance was to reduce tail length in the low dose group 
followed by an increase to a level very slightly below that of controls in 
the high dose group. Raw data are also provided in. Table 4 for both replicates 
and both sexes to demonstrate the impressive parallel in all four groups in 
this general pattern. Not surprisingly, a factorial analysis of variance 
of the unadjusted data provided a similar conclusion to that based upon 
data adjusted for litter size with tail lengths in the low dose group 
highly significantly below those of controls, and the high dose group 
significantly above the low dose group, but not significantly different 
from controls. This is a pattern that we have seen before in strain DBA/2J. 
It would be highly desirable to repeat this experiment with C3H/HeJ. It is  
evident that, if real, the high sensitivity of this strain in spermatozoan  
stage tests would make it extraordinarily useful and economical as a test  
animal employing the system presently being developed to determine mutagenic  
effect through quantitative trait changes. While there were highly 
significant effects of litter size on tail length (p < .001), the pattern 
of variation remained very similar before and after such adjustment, and the 
significance of differences among groups remained. 
Hematocrit at Seven Weeks of Age. It is convenient to focus upon the 
effect of mutagenic treatment upon strain C3H/HeJ first because of the 
similarity in pattern of response in hematocrit to that found for tail length 
(Table 5). After adjustment for litter size by covariance, the differences 
among spermatozoa treated group means were highly significant (p < .002). 
Again there was found a pattern of reduction in hematocrit in the low dose 
group below that of controls followed by an increase in hematocrit in the high 
dose group to approximately the level of the mean. While there was a signif-
icant effect of litter size (p < .05), adjustment for litter size did not 
alter significantly this pattern. The same pattern of reduction in mean at 
low dose followed by increase in mean at high dose was found in both sexes 
of both replicates. Unadjusted means are presented in Table 5 to show this 
remarkable and persuasive pattern. The usefulness of this strain for possibly  
detecting very slight mutagenic effects is emphasized. While these results do 
require confirmation, one cannot ignore the potential for the strain considering 
the small number of organisms employed and the remarkable effect on mean 
differences. 
Table 5. Effect of TEM dose on hematocrit at seven weeks of age of F1 
progeny of treated male parents in inbred strains BALB/cByJ and C3H/HeJ. 
Males were treated at the spermatozoan or spermatogonial germ cell stages. 
Sample sizes are given in parentheses. Means have been adjusted for the 
effects of litter size by covariance, and sexes and replicates are combined, 
except as noted. 




0.1 mg/kg 	0.2 mg/kg  




48.86 (437) 48.63 (410) 




48.85 (133) 49.28 (72) 
C3H 	Spermatozoa 	p < .002 	 46.30 (58) 
	
45.71 (59) 	46.61 (59) 
C3H 	Rep A 
	
45.91 ± .29 (22) 	45.82 ± .38 (11) 46.64 ± .39 (11) 
Rep B 46.54 ± .45 (13) 45.87 ± .35 (15) 47.21 ± .46 (14) 
Rep A 
	
46.30 ± .47 (10) 	46.00 ± .45 (15) 46.70 ± .25 (20) 
Rep B 46.08 ± .29 (13) 45.39 ± .29 (18) 46.36 ± .33 (14) 
The effects of mutagenic treatment on strain BALB/cByJ are interesting 
but less clear cut. In neither case are there significant differences among 
means after adjustment for litter size. In each case effects of litter size 
only approached significance (.05 < p < .10). Similarily, effects of dose on 
differences among means only approached significance. In the case of 
spermatozoan test groups p - .11. With respect to spermatogonial groups, 
p - .08, and both sexes of both replicates showed a slight increase in hematocrit 
in the low dose group. In the high dose group, males of both replicates and 
females of one showed a similar decrease below controls in hematocrit. Females 
of the other replicate showed, by contrast, an increase in hematocrit. Clearly, 
no simple biological explanation emerges to account for such a pattern in 
spite of appreciable sample sizes. The pattern for strain BALB/cByJ 
spermatozoan test groups is similarly complex and was analyzed in the last 
Report of Progress. Means adjusted for litter size have been appended in the 
present report (Table 5) and show virtually no change in the low dose group in 
comparisons with controls. However, there was an appreciable increase in the 
high dose group over controls (and the low dose group) in respect to hematocrit. 
An interesting parallel with the results observed in spermatogonial test groups 
is that three of four sex/replicate groups showed an increase in hematocrit 
in the high dose group, while females of one replicate showed an equally 
appreciable decrease. This is the reverse of the pattern observed for 
spermatogonia, and is equally difficult to explain biologically. 
We conclude that with respect to hematocrit, strain C3H/HeJ shows 
promise while BALB/cByJ does not, especially when one considers the very 
small numbers involved in the former as compared with the great numbers 
involved in the latter. 
Defecation Portion of the Open Field Test. 	As indicated in the last 
Report of Progress, differences among groups in strain C3H/HeJ were not 
significant. There were no confounding effects of litter size nor were 
there replicate/dose/sex interactions. It is simply that the means were 
so slightly different and the sample sizes so small that me.lningful patterns 
are not evident. Combining sexes and replicates and adjusting for variation 
in litter size, the means showed a pattern of slight decrease in fecal rate 
in the low dose group relative to controls followed by increase in the high 
dose group to approximately the control level. Since this pattern has 
been observed before, it would be desirable to look at defecation rate in 
C3H spermatozoan treatment groups where larger numbers are involved. It 
may very well be real. 
Table 6. Effect of TEM dose on defecation rate at five weeks of age in F 1 
 progeny of treated male parents in inbred strain BALB/cByJ. Males were 
treated at the spermatozoan and spermatogonial germ cell stages. Sample 
sizes are given in parentheses. Means have been adjusted for the effects 
of litter size by covariance, and sexes and replicates are combined. 
Strain Stage Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
BALB Spermatogonia p< 	.05 4.03 	(376) 4.36 	(458) 4.38 	(417) 
BALB Spermatozoa p - .20 4.53 	(226) 4.18 	(134) 3.92 	(72) 
The data with respect to BALB/cByJ are, by contrast, considerably 
more interesting. With respect to the spermatozoan treatment group, 
differences between means are sufficiently great and the pattern of response 
among replicates and sexes sufficiently consistent as to suggest reality 
(Table 6). Fortunately, two additional experiments already in progress will 
provide further data to confirm or reject the evident pattern. Litter size 
effects were appreciable but not significant, and, except for a highly 
significant difference between sexes, there were no other significant inter- 
actions. The pattern that emerges, grouping sexes and replicates and adjusting 
for litter size effects, involves a reduction in defecation rate that is 
roughly linear for the two dose groups as compared with controls. While there 
is some irregularity in this pattern when sexes and replicates are compared 
seperately, combining replicates but treating sexes seperately, the pattern 
that emerges for males and females alike is a roughly linear reduction in 
defecation rate from control through low to high dose group. This latter 
comment is based upon comparisons of unadjusted means which are affected 
only slightly as a result of litter size adjustment. 
In the spermatogonial treatment groups with the much larger sample 
sizes involved significant differences among dose groups, after adjust-
ment for litter size effects, were found (p < .05). Effects of litter 
size were appreciable, but not significant. There was a highly significant 
difference between sexes, but significant interactions were not found. 
Most interestingly, the pattern that emerges is of an increase in means 
from the control group to treated groups, which are themselves approximately 
equal. While, at first glance it might appear that mutagen induced 
variance in spermatozoan germ cell stages should not be the opposite 
in effect of mutagen induced variance in spermatogonial germ cell stages, 
it is not entirely unreasonable that this is the case. It seems quite 
likely that mutations induced in spermatozoa may be much more numerous 
and involve a wider variety of lesions than mutations induced in spermatogonia 
and surviving the process of spermatogenesis, which would very likely 
include lesions of considerably reduced effect individually. In an 
experiment presently in progress, results will be obtained to test this 
initial conclusion, but the numbers leave little doubt as to the likelihood 
that the effect is real. 
Brain Weight at Approximately Thirteen Weeks of Age. As reported in 
the last Report of Progress numbers were too small in strain C3H 
comparisons to permit any conclusions as to effect of mutagenic agent on 
brain size. It was pointed out that two major factors interfered with 
conducting a fair test of the brain weight trait. One of these has to do 
with the necessity of retaining females until they carried their young to 
weaning which introduced an element of age variation from thirteen to 
seventeen weeks of age or even older for some females. Similarly some 
males were involved in translocation tests to determine the effect of 
translocations upon quantitative traits. Thus, numbers of males were 
necessarily reduced. Although there were considerably greater numbers in 
the spermatozoan groups for strain BALB/cByJ than for strain C3H/HeJ, there 
is some evidence that the effect of age variance in females complicates 
considerably the interpretation of data acquired. As might have been 
expected, there was a highly significant effect of the litter size on 
brain weight. Similarly, there were highly significant differences 
between replicates and sexes. Even more unhappily, there was a highly 
significant replicate x dose x sex interaction. In spite of all this, 
the differences among the groups due to dose approached significance 
(p < .20), but the adjusted means are so strikingly different from the 
unadjusted means as to suggest the need for a more critical analysis of 
the data. Fortunately, two other experiments are already in progress 
which will shed light upon this complicated analysis. 
Table 7. Effect of TEM dose on brain weight at approximately thirteen 
weeks of age in F
1 
progeny of treated male parents in inbred strain 
BALB/cByJ treated at the spermatogonial germ cell stage. Sample sizes 
are given in parentheses. Means have been adjusted for the effects of 
litter size by covariance, and sexes and replicates are combined. 
Strain 	Stage 	 Significance 	0 mg/kg 	0.1 mg/kg 	0.2 mg/kg  
BALB 	Spermatogonia 	p < .01 	473.04 (350) 476.14 (420) 474.85 (389) 
The spermatogonial test groups for strain BALB/cByJ were much more 
satisfying. There were highly significant effects of litter size which, 
however, produced very modest changes in the dose mean values. There 
were also highly significant differences between replicates and between 
sexes. In spite of highly significant group x sex and significant dose 
x sex interactions, differences among groups remain highly significant. 
After adjustment for litter size, and combining sexes and replicates, 
the mean pattern reflects an appreciable increase from control to low 
dose group followed by a modest decrease to the highest dose group which 
is still appreciably above the control level. As a matter of fact, the 
most consistent element of the patterns observed, i.e. in both sexes of 
both replicates, is a modest increase in brain size in high dose groups 
with respect to controls. There is some variation in the low dose groups 
with males tending to show considerable increases in brain weight relative 
to controls. In females the mean response is more nearly linear with low 
dose group brain weights lying somewhere between those of controls and 
high dose group brain weights. However, in one replicate treated group 
responses were very nearly equal; in the other low dose group brain weights 
were below those of controls. This variation in response among females 
undoubtly is responsible for the replicate x sex and dose x sex interaction. 
The differences between control and low dose groups within females would 
not be significant for either replicate,nor is the difference between the 
female low dose group response in Replicate C significantly different from 
that in Replicate D. The simplest interpretation, then, is that there 
appears to be a linear response in females, but, in males, an increase to 
low dose group followed by a decrease to high dose group. In spite of 
these complications, the brain weight trait would still appear to be 
quite useful employing strain BALB/cByJ in the detection of strong 
mutagenic effect or, employing males only, as a sensitive detector of 
mutagenic effect. Fortunately, there is an additional experiment in 
progress which will permit us to evaluate more completely the importance 
of female variation in the present experiment. 
Discussion. Detailed statistical analyses of the data, particularly 
in regard to results adjusted for litter size effects, have revealed that 
early optimism for the usefulness of strain BALB/cByJ was not realized. 
Nevertheless, the large numbers of organisms produced by this highly 
productive strain provide the basis for some very useful effects on quan-
titative traits particularly, and quite interestingly, in spermatogonial 
treatment groups. In this regard, highly significant and approximately 
linear increases in body weight with increasing mutagen dose were found 
after adjustment for the effects of litter size. Similarily, a highly 
significant though non-linear increase in tail length in mutagenized 
groups was found after adjustment for the effects of litter size. The 
increases resulting from both doses were approximately the same. This 
same pattern was observed in defecation rate where a significant increase 
between the control and each dose group was found, but in which the 
differences between the two mutagen doses were negligible. Finally, with 
respect to brain weight, highly significant differences were found among 
dose groups with an increase from control to low dose group followed by 
an appreciable decrease in the highest dose group. This pattern may be 
accounted for on the basis of modest amounts of induced genetic variance 
producing an effect in one direction, with excessive amounts producing a 
reversal of direction. 
With_respect to BALB/cByJ spermatozoan test groups, while no 
significant results were obtained (after adjustment for litter size effects) 
interesting patterns were observed with respect to several characters, viz. 
body weight, hematocrit, and defecation rate, and the differences among means 
approached significance in some cases. Two additional experiments are 
underway with strain BALB/cByJ which will provide a test of these observed 
patterns. Inasmuch as the sample sizes in the spermatogonial stage groups 
were nearly two and one-half times as large as those of spermatozoan test 
groups, it is quite possible that some of the differences observed may 
become significant in the additional experiments being conducted. One 
of these experiments will also include a spermatogonial stage group. Thus 
these results also will be tested. 
With respect to strain C3H/HeJ, statistical analyses of the spermatozoan 
stage only are available at the moment. These are most exciting and 
suggest that it would be highly desirable to continue exploration of this 
strain as a potential animal of choice in a mutagenic assay test using 
quantitative traits. With respect to two characters, time of development 
of the righting response and hematocrit, highly significant differences 
among dose groups were found in spite of sample sizes on the order of 
sixty animals per dose group. The pattern in each of these two traits 
showed a decrease in measure at the low dose level followed by an increase 
to approximately the control level in the high dose group. This identical 
pattern was also found in tail length which was accompanied by a significant 
difference among means. These statistical indications of significance 
were all found after adjustment for litter size effects. It seems 
reasonable to expect that, while strain C3H/HeJ might not be too 
reliable as an indicator of high mutagenic activity, it may provide an 
extremely sensitive indicator in that it responds very strongly to low 
levels of mutagenic activity. Since confirmation of these results is 
of great importance before they can provide the basis for a useful 
assay system, the potential usefulness of this organism makes it very 
desirable to do so. Statistical analyses of the spermatogonial stage 
results for strain C3H/HeJ have not yet been completed, but on the 
assumption that limited amounts of induced genetic variance produce 
major effects, it can be predicted that results with the spermatogonial 
stage will be most interesting. 
With respect to plans for the year now in progress, we will 
continue to acquire data on Experiment V, the final experiment to be 
carried out under this research contract. These data will be submitted 
to complete statistical analyses including partitioning of the effects of 
litter size in addition to the examination of differences in means due 
to sex, treatment, replicate and interactions of these factors. 
We are also continuing the analyses of results of data acquired in 
Experiment III and Experiment IV, the latter a limited test involving 
repetition of the initial stages of Experiment III only. 
Finally a collaborative effort between Dr. Eugene Soares, Dr. John 
Favor and the undersigned with respect to a late dominant lethal 
(perinatal) effect in mice has been accepted for publication by 
Mutation Research and should be out very shortly. This study was based 
upon results of Experiments I and II in this series and upon separate 
studies by Soares and Favor carried out earlier. 
Respectfully submitted, 
 John W. Crenshaw, Jr. 
Project Director 
FINAL REPORT FOR RESEARCH CONTRACT NIEHS NO. NO1-ES-5-2135 
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In the last two Reports of Progress for the year ending 
December 25, 1978, three experiments (III, IV and V) were dealt with 
in part. The primary reason for this incomplete treatment was that we 
initiated experiments with a highly productive inbred mouse strain, 
BALB/cByJ. This decision produced some very exciting results but cramped 
our facilities to the extent that we were forced to alter original schedules 
for the completion of experiments. This delay also lead to our request 
for an extension of the contract without funds. 
Experiment III has been described in detail, and statistical analyses 
of the dominant lethal results and the mutagenic effects on quantative 
traits have been described for the F1 generation groups representing muta-
genized spermatozoa and spermatogonia. In this final report we will com-
plete the discussion of results on quantitative trait analysis for Exper-
iment III :Eor the F2 generation groups representing both mutagenized 
spermatozoa and spermatogonia. 
Experiment IV, representing a limited repetition of Experiment III, 
including only F1 generation groups treated as spermato=m, has been out-
lined previously. Statistical analyses of dominant lethal data and the 
results of quantitative trait analyses will be presented here. 
Finally, Experiment V was outlined in the previous Report of Progress 
in respect to experimental design, numbers of parental animals and a 
schedule o:E matings up to but not including the establishment of F1 crosses. 
Mating schedules for this experiment, dominant lethal data and the results 
of quantitative trait analyses will be added in the present report. 
The three experiments to be discussed in this report are devoted 
primarily to the effects of a single mutagenic agent in altering the 
expression of quantitative traits in the inbred mouse strain, BALB/cByJ. 
In Experiment III, two other inbred mouse strains were also considered 
(DBA/2J and C3H/HeJ), but the numbers of young produced by these strains 
were so low as to provide results that must be confirmed to be useful. 
In all three experiments the mutagenic agent employed was triethylenemelamine 
(TEM). In order to maximize the number of animals in each group, only 
two doses (.1 and .2 mg TEM per kilogram of body weight) were employed 
in addition to a control group. In all these experiments the number of 
matings set in each dose group was adjusted to compensate for dominant 
lethal effects of treatment in the high dose groups in such a way that 
similar numbers of F1 progeny would be ptoduced in all treatment groups. 
Treatment effects were tested in spermatozoan and spermatogonial stages 
of spermatogenesis in progeny of the F 1 and F2 generations, except that 
in Experiment IV only F1 generation spermatozoan treated young were produced. 
In all three experiments, the quantitative traits studied to determine 
the effects of mutagenic treatment were: 1) time of development of the 
righting response, 2) body weight at weaning, 3) the defecation portion 
of the open field test, 4) tail length at seven weeks of age, 5) hematocrit 
at seven weeks, and 6) brain weight. The time at which brain weights 
were taken was variable depending upon the desirability of obtaining data 
which precluded the early sacrifice of an individual. However in Experiments 
IV and V brain weights were taken at approximately 15 weeks of age for 
males and approximately 19 weeks of age for females. 
In addition to the continuously varing traits listed above, productivity 
traits were also studied to determine if treatment had been effective. 
These traits included: 1) percent dead implantation scars of total scars, 
2) total implantation scars, 3) percent females born, 4) total young born, 
5) percent females weaned and 6) total young weaned. Traits 1 and 2, 
which are based upon inspection of uterine scars in parent -n1 generation 
females, were analyzed for F1 generation young only. Other productivity 
traits were studied in both F1 and F2 generations. 
As has been general practice, females of crosses involved in sperma-
tozoan treatment tests were isolated from each other ten days after the 
initiation of matings and checked daily for the presence of a litter through 
day 21 after the termination of matings. Young were sexed and marked 
by toe clipping for identification at birth. Starting on day 5, progeny 
were checked for the ability to right themselves and were checked daily 
until the trait appeared. All animals were weaned at four weeks of age, 
at which time body weight and sex were recorded, and individuals were 
permanently marked by coded ear punching. The defecation portion of the 
field test was conducted on mice at five weeks of age; tail length and 
hematocrit measures were taken for mice at approximately seven weeks of 
age. As indicated above, brain weights were taken at about 15 weeks 
of age for males and at about 19 weeks of age for females. 
For all experiments, the mutagenic treatment consisted of intraperi-
toneal injection of triethylenemelamine carried in .25 cc Hank's balanced 
salt solution prepared immediately prior to injection. Control males 
received the same quantity of carrier only. Doses were based on the mean 
body weight of a random sample of the mice to be treated. 
Results: Quantitative Traits, Experiment III. Results of analyses 
of data for both spermatozoan and spermatogonial treated groups of the 
F1 generation were considered in the last Report of Progress. In this 
report, analyses of data with respect to the F2 generation for sperma-
tozoan and spermatogonial treated groups for strain BALB/cByJ will be 
discussed. Where meaningful comparisons can be made, the results of earlier 
analyses have been repeated. 
2 
Time of Development of the Righting Response. In the last Report 
of Progress no significant differences were reported among dose groups 
for this trait for either spermatozoan or spermatogonial series of the 
F1 generation. However, in both cases it was noted that there was a roughly 
linear increase in the time of development of the righting response with 
increasing mutagen dose. In the F2 generation of the spermatozoan treated 
group the same situation obtains, i.e., there is an increase in time of 
development of the righting response with increasing dose. Again the 
relationship is roughly linear and the differences are not significant 
(p < .10). 
With respect to the spermatogonial treated series in the F2 generation, 
differences among dose groups were not significant. Interestingly, the 
pattern is not consistent with that observed in other germ cell/generation 
groups. The face value differences among means involve a very slight increase 
in time of development of the righting response from the control to the 
low dose group followed by an appreciable decrease in time of development 
of righting response between the low dose and high dose group. As indicated ' 
earlier, "it may be concluded that righting response would not be a useful 
trait to employ if BALB/cByJ were the strain being used." 
Body Weight at Weaning. 	In the most recent Report of Progress It 
was reported that when means were adjusted for litter size there were 
highly significant differences (p <-005) among the F1 spermatogonial 
dose groups, but differences among dose group means in the Fl generation 
spermatozoan treatment series were not significant. Table 1 is taken 
in part from this source but includes, in addition, datat for the F2 genera-
tion spermatozoan and spermatogonial treatment groups. As may be seen, 
significant differences were found among dose group means for both of 
these treatment groups, with the more impressive differences being found 
among the spermatogonial treatment means. 
* * * 
Table 1. 	Effect of TEM dose on body weight at weaning of F1 and F2 
progeny of treated male parents in inbred strain BALB/cByJ in Experiment III. 
Males were treated at the spermatozoan or spermatogonial germ cell stages. 
Sample sizes are given in parentheses. Means have been adjusted for the 
effects of litter size by covariance. Sexes and replicates are combined 
for simplicity. 
Strain Stage Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
BALB F1 Spermatozoa n.s. 18.00 (226) 17.83 (134) 17.67 (72) 
BALB F2 Spermatozoa p < .05 17.17 (641) 17.45 (270) 17.10 (98) 
BALB F1 Spermatogonia p < .005 16.49 (376) 16.87 (458) 17.06 (419) 
BALB F2 Spermatogonia p < .01 16.84 (462) 17.17 (466) 17.11 (509) 
The results indicate that body weight may be a very useful character 
employing BALB/cByJ, with appreciable increases in body weight expected 
from relatively weak mutagenic doses in the F2 generation only of 
the spermatozoan treatment group but in the Fl and F2 generation groups 
of spermatogonial treated groups. As has been pointed out previously, 
the fact that this approach detects differences in the spermatogonial 
stages is particularly exciting in view of the difficulty of measurement 
of mutagenic effect generally for this stage. The biological significance 
of these results will be discussed at greater length later in this report. 
Tail Length at Seven Weeks of Age. As stated in the last Report of 
Progress there were no significant differences among dose group means in 
the F1 generation spermatozoan treatment group, but highly significant 
differences were found among dose groups in the F1 generation spermatogonial 
treatment group (Table 2). The same pattern emerges in the F2 generation 
groups in that the spermatozoan treatment groups show no significant differ-
ences, while the spermatogonial groups show significant differences that 
closely parallel those of the F1 spermatogonial group in pattern. In each 
case there is an impressive increase in length of tail in the low dose 
groups with respect to the tail length mean in controls. This is followed 
by a slight, nonsignificant, reduction in tail length at the highest dose 
level in both the F1 and F2 spermatogonial groups. This parallels precisely 
the pattern for the same groups in body weight. The close correspondence 
between tail length effect and body weight effect has been observed in 
a number of other experiments in this series. Although it seems likely 
that body weight and tail length are associated and not independent, the 
two traits employed together would increase reliability of conclusion when 
they pointed in the same direction. 
* * * 
Table 2. Effect of TEM dose on tail length at seven weeks of age of Fl 
and F2 progeny of treated male parents in inbred strain BALB/cByJ in 
Experiment III. Males were treated at the spermatozoan or spermatogonial 
germ cell stages. Sample sizes are given in parentheses. Means have been 
adjusted for the effects of litter size by covariance, and sexes and rep-
licates are combined. 
Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
n.s. 82.04 (222) 82.26 (128) 82.07 (70) 
n.s. 80.88 (613) 80.92 (264) 80.66 (96) 
p < 	.001 81.88 (366) 82.57 (441) 82.51 (406) 
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Hematocrit at Seven Weeks of Age. In the most recent Report of Progress 
it was reported with respect to the F1 generation test groups that differences 
among treatment group means were significant for neither spermatozoan nor 
spermatogonial treated series. However, in both cases factorial analyses 
of variance indicated that the observed differences did approach significance 
(p - .10). Analysis of F2 generation groups revealed highly significant 
differences among dose group means in the spermatogonial series; differences 
among dose means in the spermatozoan series, however, were not significant 
(Table 3). 	The pattern observed in the F2 spermatogonial series indicates 
very little difference between the low dose group and controls but a 
significant decrease in hematocrit in the high dose group. Inasmuch as 
other traits (body weight and tail length) of usefulness in detecting muta-
genic effects have been of greatest importance in the detection of low 
dose effects, the hematocrit trait may be of value in detecting the effects 
of more highly mutagenic agents. 
Table 3. Effect of TEM dose on hematocrit at seven weeks of age of F1 
 and F2 progeny of treated male parents in inbred strain BALB/cBy in 
Experiment III. Males were treated at the spermatozoan or spermatogonial 
germ cell stages. Sample sizes are given in parentheses. Means have been 
adjusted for the effects of litter size by covariance, and sexes and 
replicates are combined. 
Strain 	Stage 	Significance 0 mg/kg 	0.1 mg/kg 	0.2 mg/kg 
BALB F1 Spermatozoa 	p 	.11(n.s.) 48.88 (226) 	48.85 (133) 49.28 (72) 
BALB F2 Spermatozoa n.s. 	48.78 (635) 48.65 (263) 48.90 (97) 
BALB 	F1 Spermatogonia p 	.08(n.s.) 48.73 (365) 	48.86 (437) 48.63 (410) 
BALB F2 Spermatogonia p < .005 	48.85 (453) 48.82 (463) 48.51 (507) 
The hematocrit analyses exhibit closely parallel response patterns 
of the F1 and F2 generation effects, both for the spermatogonial group 
and for the spermatozoan group. With respect to the spermatogonial groups 
the difference between means for the control and low dose group is quite 
modest in each case and is followed by a much more impressive decrease 
in hematocrit at the highest dose group. By contrast, in the spermatozoan 
groups, both the F1 and F2 generation means exhibit slight reductions 
from control to low dose groups followed by modest increases in hematocrit 
at the highest dose level. 
Defecation Portion of the Open Field Test. In the Last Report of 
Progress significant differences were found among dose group means only 
for the F1 generation spermatogonial series. However, differences between 
means in the F 1 spermatozoan series were sufficiently great and the pattern 
of response among replicates and sexes sufficiently consistent as to suggest 
that the differences might well be real. In the F2 generation results no 
significant differences were found among dose group means for either the 
spermatozoan or spermatogonial treatment series, but differences between 
means were appreciable leading to approaches to significance in both cases 
(Table 4). 
* * * 
Table 4. Effect of TEM dose on defecation rate at five weeks of age in 
F1 and F2 progeny of treated male parents in inbred strain BALB/cByJ in 
Experiment III. Males were treated at the spermatoaoan and spermatogonial 
germ cell stages. Sample sizes are given in parentheses. Means have been 
adjusted for the effects of litter size by covariance, and sexes and rep-
licates are combined. 
Strain 	Stage 	Significance 	0 mg/kg 	0.1 mg/kg 	0.2 mg/kg  
BALB F1 Spermatozoa 	p - .20 	4.53 (226) 4.18 (134) 	3.92 (72) 
BALB F2 Spermatozoa p - .19 4.17 (641) 4.37 (270) 4.52 (98) 
BALB F1 Spermatogonia 	p < .05 	4.03 (376) 4.36 (458) 	4.38 (417) 
BALB F2 Spermatogonia p - .24 4.70 (462) 4.94 (466) 4.79 (509) 
The dose response patterns that emerge are not consistent among the 
germ cell stage treatment/generation groups, but they are interesting and 
may well reflect real response patterns. In the F1 generation spermatozoan 
groups, defecation rate decreases in a roughly linear fashion with increasing 
dose. By contrast, in the F2 generation spermatozoan treatment group, 
defecation rate increases in a roughly linear fashion with increasing dose. 
With respect to spermatogonial series treatment, in the F1 generation there 
is a pattern involving an increase in defecation rate among treated groups 
relative to controls, and the differences are significant. However the 
difference between the two treatment groups is negligible. Finally, in 
the F2 generation spermatogonial series, there is a face value increase 
in defecation rate from the control group to the low dose group followed 
by a modest decrease. 
Brain Weight at Fifteen to Nineteen Weeks of Age. In previous reports 
we have reported on brain weights at "Approximately Thirteen Weeks of Age". 
It turns out that this figure is, in practice, much closer to fifteen weeks 
of age for males and nineteen weeks of age for females. In the last Report 
of Progress, we provided the results of analysis of brain weights in the 
Fl generation spermatogonial group where highly significant differences 
were found involving an increase in brain weight from control to low dose 
group followed by a modest decrease in brain weight at the higher dose. 
Mean values were not provided for the F1 generation spermatozoan groups 
because differences among dose groups were not significant. Means for both 
groups are presented here in Table 5 in order to show the patterns involved. 
* * * 
Table 5.  Effect of TEM dose on brain weight at approximately thirteen weeks 
of age in F1 and F2 progeny of treated male parents in inbred strain BALB/cByJ 
treated at the spermatozoan and spermatogonial germ cell stages. Sample 
sizes are given in parentheses. Means have been adjusted for the effects of 
litter size by covariance, and sexes and replicates are combined. 
Strain 
	
Stage 	Significance 	0 mg/kg 	0.1 mg/kg 	0.2 mg/kg  
BALB F1 Spermatozoa 	n.s. 	482.11 (212) 481.84 (114) 476.64 (51) 
BALB 	F2 Spermatozoa p - .01 472.46 (630) 475.72 (266) 473.78 (94) 
BALB Fl Spermatogonia p < .01 	473.04 (350) 476.14 (420) 474.85 (389) 
BALB F2 Spermatogonia p < .001 464.32 (459) 465.88 (464) 468.29 (506) 
It can be seen that the F1 spermatozoan pattern reflects a very modest drop 
in brain size from the control to the low dose group followed by a more 
impressive decrease in brain weight in the high dose group. For both of 
the F2 generation groups, differences among dose groups proved to be highly 
significant, and the patterns are quite interesting. For the F2 spermatozoan 
dose groups, there is an increase in brain weight from control to low dose 
group followed by a modest decrease in the high dose group, the mean brain 
weight of which is still appreciably greater than control. The relationship 
of F2 to F1 spermatozoan results for brain weight parallels very closely 
that for body weight in that in both, there are more or less linear decreases 
in weight (non-significant) with increasing mutagenic dose in F1 generation 
results followed by significant increases from control to low dose group 
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in the F2 generation results. The parallel continues to high dose groups 
where brain weight decreased (only slightly) while body weight decreased 
(appreciably). In the F2 spermatogonial groups there is a modest increase 
from control to low dose group followed by an impressive increase to the 
high dose group. The numbers involved and the improbability that such 
differences could be due to chance alone leave little doubt as to the reality 
of these differences. 
Results: Dominant Lethality, Experiment IV.  Data obtained on dominant 
lethal parameters for the A and B replicates in Experiment IV are outlined 
in Table 6. These results parallel quite closely the results obtained in 
* * * 
Table 6. Dominant lethality parameters with standard errors and sample size 
of Replicate A and B series BALB/cByJ females and their F1 young in Experiment 
IV. Females belonging to the two experimental and a single negative control 
group were mated for a period of seven days immediately following treatment, 
thus represent effects of mutagenic agent upon spermatozoa. 
Replicate 	A 
TEM dose, mg/kg of body weight 
0 .10 .20 
Live Scars/ 9 4.60 ± 1.12 (20) 3.04 ± .74 (25) .97 	± 	.21 (70) 
Dead Scars/ 9 .35 ± 	.22 (20) .80 ± .23 (25) .46 	± .14 (70) 
Total Scars!? 4.95.± 1.14 (20) 3.84 ± .87 (25) 1.43 	± .30 (70) 
Total Live Births!? 6.73 ± 	.85 (11) 3.14 ± .63 (14) 1.67 ± .36 (21) 
Total Weaned/ 9 6.27 ± .92 (11) 3.14 ± .63 (14) 1.43 	± .28 (21) 
Percent of Dead Scars 
of Total 7.1 21.8 32.2 
Percent Perinatal 
Losses 19.6 42.1 48.5 
Replicate 	B 
Live Scars/ 9 5.00 ± 	.94 (19) 2.54 ± .53 (28) 1.84 	± .35 (68) 
Dead Scars/9 .47 ± .19 (19) .50 ± .17 (28) .46 	± .11 (68) 
Total Scars/9 5.47 ± 	.97 (19) 3.04 ± .63 (28) 2.29 	± .41 (68) 
Total Live Births/9 4.87 ± .69 (15) 3.27 ± .40 (15) 2.86 	± .48 (28) 
Total Weaned/9 4.87 ± 	.69 (15) 3.27 ± .40 (15) 2.79 	± .48 (28) 
Percent Dead Scars 
of Total 8.6 16.4 20.1 
Percent Perinatal 
Losses 23.2 31.0 36.0 
Experiment III and demonstrate quite clearly that administration of mutagenic 
agents was effective. Data on live scars, dead scars and total scars repre-
sent numbers per treated female. It can be seen that, as has been found 
in the past, number of live scars per female decreases more or less linearly 
with increasing dose as do total scars per female. Dead scars per female, 
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by contrast, tend to show an increase from control to the lower dose 
followed by a decrease. Statistical analyses of scar data were carried 
out by ANOVA; these were based upon numbers of pregnant females (i.e. 
having uterine scars) within each group. Analysis of total scars was 
carried out on data after square root transformation. As expected, 
differences among means due to dose were highly significant (p < .001). 
Differences between replicates were not significant nor were group x 
dose interactions. A factorial analysis of the percent dead scars of 
total scars, carried out after arc sine transformation, revealed that 
the differences among dose groups were significant (p 	.014). Again, 
there were no significant differences between replicates, and the group 
x dose interaction was not significant. As has been found in the past, 
considering only females with scars for this analysis, increase in percent 
dead scars and in percent perinatal losses from control to both treated 
groups was impressive, but the difference between treated groups itself 
was not. It is generally felt that the number of zygotes lost continues 
to increase with higher doses, but that an increasing proportion of the 
losses at high mutagenic exposures are made up of pre—implantation losses 
which are not represented by uterine scars. 
Results: Quantitative Traits, Experiment IV. 	The primary value 
of this repetition is the demonstration that, as was reported for Experiment 
III, spermatozoan treated F1 generation young are not of particular use-
fulness in the detection of mutagenic activity. This is true with respect 
to all traits. 
Time of Development of the Righting Response. As was the case in 
Experiment III, no significant differences due to dose were found. Contrary 
to what was found in Experiment III, there was a roughly linear decrease 
in the time of development of the righting response with increasing mutagen 
dose in Experiment IV. 
Body Weight at Weaning. Paralleling the results of Experiment III, 
differences due to dose among F1 progeny of spermatozoan treated groups 
were not significant. Parallel elements in the dose means are limited 
to a decrease in body weight below controls at the highest mutagenic dose 
in both experiments. However, the approaches to significance are so slight 
that nothing would be gained by combining the two experiments. 
Tail Length at Seven Weeks of Age. The parallel with Experiment 
III continues with no significant differences among dose groups observed 
in the F1 generation spermatozoan treated groups. There is an interesting 
parallel in that in both experiments, after adjustment for litter size, 
there is an increase in tail length from control to low dose group followed 
by a modest decrease. Again, however, approaches to significance in both 
experiments are so slight as to suggest coincidence in the parallel results. 
Hematocrit at Seven Weeks of Age. Again, as was the case in Experiment 
III, hematocrit differences due to dose were not significant. There was 
observed an element of similarity in the two experiments in that very 
slight reductions were found from control to low dose group followed by 
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an increase of some magnitude in the high dose group. Again, it is 
estimated that statistical significance would not be achieved by combining,  
the two experiments in a factorial analysis. 
Defecation Portion of the Open Field Test. Differences among means 
approached significance more closely than in other traits in the series 
(p 	.16), and differences among means in Experiment III also approached 
significance rather closely (p - .11). However, the patterns of distri- 
bution of means is not similar in the two experiments. There was reported 
a more or :Less linear decrease in defecation rate with increasing dose 
in Experiment III, whereas in Experiment IV there is an increase from 
controls to both dose groups, with the high dose group mean being slightly 
higher than the low dose group. 
Brain Weight at Fifteen to Nineteen Weeks of Age. As with other 
traits in F1 generation spermatozoan test groups, significant differences 
due to dose were not found in either Experiment III or Experiment IV. 
Similarity in pattern of mean distribution exists only in that brain weights 
of treated group progeny were reduced below control means. Differences 
among means were considerably less in Experiment IV than in Experiment III. 
Experiment V: Methods. As outlined in detail in the Report of Progress 
for the period June 25, 1978 through December 25, 1978, mice of the parental 
generation were assigned to one of six replicates. The first three of 
these, carried out two weeks apart, involved mutagenized spermatozoa. 
These matings involved trios of females mated with each ramie. The remaining 
three replicates involved mutagenized spermatogonial cells, the mutagenic 
treatment having been administered over eight weeks prior to establishment 
of matings. A schedule of matings was included in the Report of Progress. 
All matings had been carried out at that time except those for the final 
replicate, F, which was established on January 8, 1979 instead of January 
10, 1979 as planned. In this experiment, in order to maximize number 
of matings, males were selected from three different age groups and varied 
from thirteen to nineteen weeks at treatment. Care was taken to assure 
that all age groups were approximately equally represented in the control 
and different treatment groups. 
A schedule of matings of Fl generation crosses is provided in Table 7. 
Pairs and trios of females were mated with single males (in addition to 
pair matings) in order to use all available females. The numbers of females 
* * * 
Table 7. Schedule of Matings of F1 Generation Crosses in Experiment V. 
Replicate 	 A 	BC 	D 	E 	Y 
Matings Established 2/8/79 2/22/79 3/5/79 2/14/79 3/15/79 5/1/79 
Matings Separated 2/22/79 3/8/79 3/19/79 3/28/79 3/29/79 5/15/79 
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and males involved in F1 generation crosses are shown in Table 8. Crosses 
were established between individuals taken randomly within dose and replicate, 
except that sibling crosses were precluded. 
	
* * 	* 
Table 8. Numbers of females and males involved in F 1 generation crosses in 
Experiment V. Where females available within a group outnumbered males, 
pairs or trios of females were mated with males as necessary to exploit all 
females. Otherwise pair matings were employed. 
Spermatozoa Treated 	 Spermatogonia Treated  
Replicate: 	A 	 B 	 C D 	 E 	 F 
5Vcr ?id ?id 	 ?Le ?id. ?id, 
control 	52/52 	52/36 	70/62 	25/25 	46/31 	45/38 
.1 mg/kg 81/74 85/85 73/73 63/52 51/38 57/23 
.2 mg/kg 	81/67 	96/85 	91/69 	52/46 	40/40 	41/35 
Results: Dominant Lethality, Experiment V. Three replicates (A, B & C) 
were employed in Experiment V examining the effects of mutagenic action 
upon spermatozoa. The data obtained on dominant lethal parameters for these 
three replicates are outlined in Table 9. In general, these results parallel 
quite closely those obtained in earlier experiments, particularly those 
in which strain BALB/cByJ mice have been employed. In Replicate B total 
scars, which usually decrease from control to the low level dose, actually 
showed a modest increase. However, the higher dose revealed a substantial 
reduction in total scars that is characteristic of the dominant lethal test. 
In Replicate C there was observed a drop in percent dead scars of total 
from the control to the low mutagen dose. However, dead scars are a low 
frequency phenomenon, and a modest change can produce a sizable effect upon 
percentage dead scars of total. Inasmuch as total scars show a very straight-
forward linear decrease with increasing dose as expected, it seems likely 
that the low percentage of dead scars in the low dose group is most simply 
attributable to chance variation. In general, it can be said that live 
scars and total scars tend to decrease with increasing dose. Dead scars, 
by contrast, tend to show an increase from control to low dose group. The 
change from low dose to high dose group is unpredictable. Statistical analysis 
of dead scars as a percentage of total scars were carried out by ANOVA 
following arc sine transformation. Differences among dose groups were found 
to be highly significant (p - .002). Differences among replicates also 
proved to be highly significant (p < .001), probably due to the aberrant 
figure recorded for Replicate C described above. Group X dose interactions 
were not significant. Inspection of the differences between dose group 
means revealed that the increase in percent dead scars of total was rather 
modest from control to low dose group, but considerably greater from low 
dose to high dose group. Analysis of total scars was carried out after 
square root transformation of data. Differences among dose groups proved 
to be highly significant (p < .001). There was found a clear linear trend 
of decreasing total scars with increasing mutagen dose in Replicates A and 
C. While the data of Replicate B were not sufficiently different to affect 
the statistical results, they probably were responsible for a significant 
dose x group interaction (p - .024). It may be recalled that differences 
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Table 9. Dominant lethality parameters with standard errors and sample 
sizes of Replicate A, B and C series BALB/cByJ females and their F1 young 
in Experiment V. Females belonging to the two experimental and a single 





were mated for a period of seven days immediately 
represent effects of mutagenic agent 
TEM dose, mg/kg of body weight 
upon 
.20 0 .10 
Live Scars/2 5.07 ± 	.94 (27) 4.15 	± 	.60 (59) 2.19 ± .30 (112) 
Dead Scars/2 .22 ± 	.15 .42 	± 	.18 .66 ± .13 (112) 
Total Scars/9 5.30 ± 	.97 (27) 4.58 	± 	.62 (59) 2.85 ± 	.34 (112) 
Total Live Births!? 7.40 ± 	.70 (15) 4.91 	± 	.51 (32) 2.76 ± .38 (55) 
Total Weaned!? 7.00 ± 	.68 (15) 4.84 	± 	.37 (32) 2.71 ± 	.30 (55) 
Percent Dead Scars 
of Total 4.2 9.2 23.2 
Percent Perinatal 
Losses 19.0 35.9 38.0 
Replicate B 
Live Scars/9 3.65 ± 	.81 (34) 3.64 	± 	.51 (59) 2.57 ± .33 (115) 
Dead Scars!? .06 ± 	.04 (34) .27 	± 	.09 (59) .40 ± .04 (115) 
Total Scars!? 3.71 ± 	.81 (34) 3.92 	± 	.54 (59) 2.97 ± .36 (115) 
Total Live Births!? 6.25 ± 	.70 (16) 5.14 	± 	.47 (36) 3.92 ± .32 (51) 
Total Weaned/ 2 5.56 ± 	.55 (16) 4.83 	± 	.38 (36) 3.65 ± 	.28 (51) 
Percent Dead Scars 
of Total 1.6 6.9 13.5 
Percent Perinatal 
Losses 28.2 14.0 32.4 
Replicate C 
Live Scars!? 4.77 ± 	.74 (44) 3.69 	± 	.57 (59) 2.59 ± .35 (103) 
Dead Scars!? .43 ± 	.15 (44) .15 	± 	.05 (59) .34 ± .09 (103) 
Total Scars/2 	5.20 ± 	.75 (44) 3.85 	± 	.59 (59) 2.93 ± .37 (103) 
Total Live Births!? 5.81 ± 	.52 (26) 5.81 	± 	.49 (27) 3.73 ± .38 (44) 
Total Weaned!? 5.58 ± 	.45 (26) 5.70 	± 	.43 (27) 3.41 ± .33 (44) 
Percent Dead Scars 
of Total 8.3 3.9 11.6 
Percent Perinatal 
Losses 28.1 28.0 38.6 
among means in total scars due to dose were highly significant in Experiment 
IV where dead scars decreased in linear fashion with increasing dose in 
both replicates. Differences among replicates were not significant. In 
spite of the irregularities present, the analyses of total scars and of 
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dead scars as a percent of total scars indicate clearly that the mutagenic 
agent was effective. 
Results: Quantitative Traits, Experiment V. I. Spermatozoan Treatment,  
F1 Progeny. The results of the analysis of quantitative traits in F1 
progeny of males in which germ cells were mutagenized as spermatozoa are 
of value for only a few traits. For these traits, differences among means 
are significant and often they parallel the results found in Experiments 
III & IV involving the same strain and mutagen doses. It should be born 
in mind that this experiment involves sample sizes 50% larger than the 
combined numbers of those involved in Experiments III & IV. In total, 
data were obtained from nearly 1300 young in the spermatozoan treatment group 
of Experiment V. Three of the traits involved (body weight at weaning, 
tail length at seven weeks and hematocrit at seven weeks) would be expected 
to be of usefulness in detecting mutagenic effects. 
Time of Development of the Righting Response. As was found in 
Experiments III & IV no significant differences due to dose were found. 
Further, the pattern of distribution of dose means is quite different 
in Experiment III from the patterns of Experiments IV & V which are strongly 
parallel. In Experiment V with its relatively large sample size the 
difference among doses approaches significance (p 	.12). For practical 
purposes, however, this would not appear to be a very useful trait in the 
ascertainment of mutagenic damage in F1 generation young where spermatozoan 
treatment is involved. 
Body Weight at Weaning. In Experiments III & IV differences among 
dose groups were not significant. However, with the much larger sample 
size of Experiment V, differences among dose groups are highly significant 
(p - .005) after adjustment for litter size (Table 10). There is also a 
highly significant difference between sexes and among replicates. However, 
none of the interactions between group, dose and sex is significant. 
* 	* 	* 
Table 10. Effect of TEM dose on body weight at weaning of F1 progeny of 
treated male parents in inbred strain BALB/cByJ in Experiments III, IV and 
V. Males were treated at the spermatozoan germ cell stage. Sample sizes 
are given in parentheses. Means have been adjusted for the effects of 
litter size by covariance. Sexes and replicates are combined for simplicity. 
Experiment Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
III n.s. 18.00 (226) 17.83 (134) 17.67 (72) 
IV n.s. 18.18 (143) 18.27 (97) 18.13 (109) 
V p < .005 16.28 (317) 16.66 (488) 16.28 (490) 
Inasmuch as there is no difference between means of the control and high 
dose groups after adjustment for litter size, it follows that the low dose 
mean is highly significantly greater than both the control and high dose 
means. The numbers are sufficiently large in this experiment to leave 
little doubt as to this result. Further, the results of Experiment IV show 
12 
the same pattern, that is an increase from control to low dose mean followed 
by a decrease to high dose mean. However, the differences among means 
in Experiment IV are of considerably lesser magnitude than are the differences 
among Experiment V means. In Experiment III there is a drop in body weight 
from low dose mean to high dose mean that is quite similar in magnitude 
to that of Experiment IV, but there is, contrary to the results of the 
other two experiments, a drop in mean body weight from control mean to 
low dose mean. As was indicated earlier the differences among means in 
Experiments III & IV did not approach significance. It is emphasized that 
the discussions above pertain to means adjusted for litter size by covariance. 
With respect to the raw data, there is a more or less linear increase in 
body size from control to low dose group followed by virtually no change 
to high dose group. The maintenance of such high body weight in the high 
dose group is probably largely attributable to the reduced mean litter 
sizes with increasing mutagen dose. 
As was indicated above, from a purely practical viewpoint, to employ 
this trait as an indicator of mutagenic activity, experiments should be 
designed involving multiple replicates and based upon totals of 300 to 
500 F1 young in the control and each test group. 
Tail Length at Seven Weeks of Age. As was pointed out above there 
were close parallels between the results of Experiments III & IV, although 
differences among dose group means were not significant. Experiment V exhibits 
the identical pattern and is associated with a highly significant difference 
(p < .002) among dose group means after adjustment for the effects of litter 
size by covariance (Table 11). Undoubtedly, the large sample sizes 
(300 to 500 in each group) and an increased magnitude in the difference 
between means contributed to the statistical significance. 
* * * 
Table 11. Effect of TEM dose on tail length at seven weeks of age of F1 
progeny of treated male parents in inbred strain BALB/cBy3 in Experiments 
III, IV and V. Males were treated at the spermatozoan germ cell stage. 
Sample sizes are given in parentheses. Means have been adjusted for the 
effects of litter size by covariance, and,sexes and replicates are combined 
for simplicity. 
Experiment Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
III n.s. 82.04 (222) 82.26 (128) 82.07 (70) 
IV n.s. 82.18 (129) 82.51 (95) 82.41 (103) 
V p < .002 81.12 (303) 81.75 (472) 81.09 (467) 
There is usually a close correlation between body weight and tail 
length. This correlation is quite clear in Experiments IV & V. If body 
weights in Experiment III had been closely correlated with tail length 
(they were not), the parallelism found in Experiment IV & V with regard 
to body weight would have been even more strongly supported. 
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After adjustment for litter size, tail length was found to increase 
from the control to the low dose group, but to decrease to about the level 
of control in the high dose group; this is the same pattern that was found 
with respect to body weight at weaning in Experiments IV & V. Returning 
to tail length in Experiment V, there are highly significant differences 
among replicates and, as expected, highly significant differences between 
sexes. However, none of the interactions between replicate, dose and sex 
was significant. 
From the existing evidence, this trait would appear to be most useful 
in the detection of mutagenic damage in F1 progeny of males in which germ 
cells were mutagenized as spermatozoa. In combination with the body weight 
at weaning trait, reliability of the test would be increased. Nevertheless, 
substantial numbers (300 to 500) of F1 young would be required to demonstrate 
effects with confidence. 
Hematocrit at Seven Weeks of Age. The "element of similarity" in 
respect to hematocrit in Experiments III & IV referred to above are also 
present in Experiment V. That is to say, there is a reduction in hematocrit 
from control to low dose group followed by an increase of the same magnitude 
above the control in the high dose group (Table 12). Thus, the difference 
between low and high dose group means is about twice as great as the differ-
ence between the control and either dose group mean. While the differences 
among groups are highly significant (p < .01), the level 4of significance 
is due largely to the magnitude of the difference between treated group 
means. This trait would be of usefulness in detecting mutagenic damage, 
particularly in combination with the tail length and body weight traits. 
In addition to significant differences among replicates and between sexes, 
there were found highly significant replicate by sex (p < .002) and dose 
x sex (p < .005) interactions. Table 12 shows the dose group means after 
adjustment for litter size for the three experiments considered. 
* * * 
Table 12. Effect of TEM dose on hematocrit at seven weeks of age of F1 
progeny of treated male parents in inbred strain BALB/cByJ in Experiments 
III, IV and V. Males were treated at the spermatozoan germ cell stage. 
Sample sizes are given in parentheses. Means have been adjusted for the 
effects of litter size by covariance, and sexes and replicates are combined 
for simplicity. 
Experiment 	Significance 	0 mg/kg 	0.1 mg/kg 	0.2 mg/kg  
III 	p -.11 (n.s.) 	48.88 (226) 
IV n.s. 	48.56 (129) 







Defecation Portion of the Open Field Test. This trait would appear 
for practical purposes to be of negligible value in the detection of muta-
genic effects in F1 generation progeny of males where mutagenic treatment 
is directed at spermatozoa. Although all three experiments exhibited 
differences among means that approached significance (..1. < p < .2) the 
patterns emerging are in striking contrast with one another. As indicated 
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above, Experiments III & IV were quite different from one another. The 
results of Experiment V add to the diversity by showing an increase from 
control to low dose rate like that in Experiment IV followed by a decrease 
from low to high dose rate comparable to that in Experiment III. It seems 
reasonable to suppose that some of the differences between means may well 
be real, but the factors producing the differences need not be those being 
tested. 
Brain Weight at Fifteen to Nineteen Weeks of Age. As in the case 
of the previous trait, brain weight would not appear to be of practical 
value in the determination of mutagenic damage involving F1 progeny of 
treated males where germ cells are mutagenized at the spermatozoan stage. 
As in the case of Experiments III & IV no significant differences were 
found among dose group means. While the patterns of dose group means was 
parallel in Experiments III & IV, with brain weights of treated groups 
generally falling below control means, this is reversed in Experiment V 
where brain weights of treated groups are greater than those of controls. 
Results: Quantitative Traits, Experiment V. II. Spermatozoan Treatment, _ 
F9 Progeny. Results obtained in the F2 generation of spermatozoan treated 
germ cells are, from a purely practical viewpoint, even less useful than 
those in the F1 generation where there were at least a few very exciting 
traits. There are some very interesting evidences of heritability implicit 
in some of the results to be discussed below, but the likelihood that this 
would be a good stage to employ in testing for mutagenicity is not impressive. 
Time of Development of the Righting Response. 	As was found in 
Experiments III, IV and V in the F1 generation and in Experiment III in 
F2 generation results there were no significant differences among groups. 
It is worth pointing out a parallel between the results in Experiment III 
of Fl and F2 generation trends. In both, there was observed a more or 
less linear increase in the time of development of the righting response 
with increasing dose. Differences among means did not approach significance 
in the F1 generation results but did so in the F2 generation results 
(p - .10). It is also of interest that in the spermatogonial F1 generation 
results in Experiment III, a similar parallelism exists. This will be 
discussed below. It should be borne in mind that male parents of the 
spermatozoan F1 progeny were also parents of Fl spermatogonial progeny. 
However, in one case it would have been the spermatozoan stage cells affected, 
but in the other spermatogonial cells would have been involved. The sim-
ilarity of these test results carried out at quite different times is quite 
provocative. 
Body Weight at Weaning. Differences among dose groups in Experiment 
V were not significant (p - .22) but they are quite interesting in that 
they parallel very closely the results of the F2 generation spermatozoan 
test group in Experiment III where differences among means were significant 
(p - .05). In both groups there is an increase in body weight from control 
to low dose groups after adjustment for the effects of litter size by 
covariance. At the higher dose, the results of Experiments III & V are 
not closely parallel in that there is no difference between the low and 
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high dose group means in Experiment V, but there is a significant drop 
from low dose to high dose group mean in Experiment III. The inconsistency 
of response in high dose means will be seen again in our consideration 
of spermatogonial groups. 
It may be recalled that in the F1 spermatozoan test groups in Exper-
iment III there was found a non-significant linear decrease in body weight 
means from control through the low dose to the high dose group that is 
at variance with other observations with respect to the effect of mutagenic 
dose on body weight at weaning. It is worth noting that this effect did 
not appear to be heritable, and it is of even greater interest that before 
adjustment for litter size there were highly significant increases in 
body weight in both sexes of both replicates from control to low dose 
group and to high dose group. Why the adjustments for litter size resulted 
in such a remarkable difference primarily in the control and high dose 
group means is difficult to guess, but these data will be examined in 
greater detail at a later date. 
From a practical viewpoint, body weight at weaning in the F2 generation 
of the spermatozoan treatment group would not be a good trait to employ 
in testing for mutagenic effect, but it is about as, good as any. 
Tail Length at Seven Weeks of Age. In Experiment V, differences among 
groups were not significant, nor were they significant in the comparable 
F2 generation of the spermatozoan treatment group in Experiment III. 
The only parallel in the results of the two different experiments is that 
there was a decrease in mean tail length from control to high dose group 
mean in both experiments, and the decrease is of approximately the same 
magnitude in each experiment. In the low dose groups, the mean is slightly 
above control in Experiment III, appreciably below the control mean in 
Experiment V. It may be recalled that in the F1 generation spermatozoan 
treatment groups in all three experiments (III, IV & V) there was an impress- , 
ive increase from control to low dose group mean followed by a similarly 
impressive decrease to high dose group mean. However, differences among 
tail length means were not significant except in the case of Experiment V 
(p < .002). Thus, it might be said that the pattern in the F2 generation 
spermatozoan treatment in Experiment III is reminiscent of the F1 generation 
spermatozoan test group results except that the increase from control 
to low dose group mean is very slight, while the subsequent decrease is 
several times as great. In Experiment V, it is of interest that the usually 
observed strong correlation between body weight and tail length is not 
evident. As with the body weight trait, it may be said that tail length 
is not a good trait to test for mutagenicity in the spermatozoan treatment 
stage in the F2 generation. 
Hematocrit at Seven Weeks of Age. 	This trait is probably the most 
interesting in this particular germ cell stage test group because of the 
parallels that exist with the same germ cell stage in Experiment III and 
with Experiments III, IV & V in the F1 generation spermatozoan treatment 
groups. 
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In Experiment V differences among groups approach significance 
(p 	.055). The most important element in common in all five of the sets 
of results cited above is a drop from control to low dose group. In all 
experiments except V, there is a face value increase from low dose group 
to high dose group mean, not significant in Experiment III, F2 sperma- 
tozoan test group, but approaching significance in Experiment III, Fl 
spermatozoan test group (p - .11). In the F1 generation spermatozoan 
test group in Experiment IV the increase was not significant, but it was 
highly significant in Experiment V (p < .01). 
While these evidences go a long way toward establishing the reality 
of the differences dealt with, the numbers required to demonstrate a signif-
icant effect would not lead one to conclude that this is a useful trait 
for the ascertainment of mutagenic effect in an F2 generation spermatozoan 
treated test group. 
Defecation Portion of the Open Field Test.  Differences among groups 
in Experiment V are not significant. From an academic viewpoint it is 
of interest that there is a face value increase from control to low dose 
group followed by a decrease from low to high dose group mean as was found 
in the F1 generation spermatozoan test group in Experiment.V. In the F2 
generation spermatozoan test group, Experiments III & V have in common 
only an increase from control to low dose group means. In general, it 
may be said that none of the spermatozoan groups tested for this test in 
either experiment has revealed significant differences among dose group 
means. 
Brain Weight at Fifteen to Nineteen Weeks of Age. In Experiment V 
differences among means are not significant, and the distribution of means 
in Experiments III & V are in remarkable contrast to one another. In 
Experiment III differences among means proved to be highly significant 
based upon increases in both treated groups over the control mean (see 
Table 5). In the Experiment V results, there is an interesting parallel 
between F2 spermatozoan and Fl spermatozoan treatment groups in that there 
is a decrease from control values to both low and high dose group means, 
but in neither case were there significant differences among means. 
It is clear that brain weight would not be a useful trait for the 
ascertainment of mutagenic damage in F2 generation spermatozoan treated 
groups. 
In sumniary, if it is desirable to ascertain with confidence the herita-
bility of mutagenic effects by testing an F2 generation, spermatozoan 
treatment would not be recommended employing BALB/cBy3 as an experimental 
strain. 
Results: Quantitative Traits, Experiment V. III. Spermatogonial  
Treatment, Fl Progeny. In Experiment V, in spermatogonial treatment groups, 
significant differences due to dose were found with respect to every trait 
examined with the exception of brain weight. As indicated above in Experi-
ment IV, there was no comparable treatment group. However, there were 
reported above results from a comparable group in Experiment III, and 
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comparisons will be made in the discussion below with respect to specific 
traits. It may be recalled that significant differences among dose groups 
were found in all except two traits in Experiment III. These were time 
of development of the righting response and hematocrit. With respect 
to three traits, significant differences among dose groups were found 
in both Experiments III & V, and the dose mean differences that are signif-
icant in both experiments are parallel. It is of particular interest 
that these parallel differences were found with respect to the control 
and low dose treatment group means. These three traits are: body weight 
at weaning, tail length at seven weeks and defecation portion of the open 
field test. 
Time of Development of the Righting Response.  In Experiment III with 
sample sizes exceeding 1200, no significant differences were observed 
among dose groups as reported above. In contrast, in Experiment V with 
less impressive sample sizes totaling some 750 young, highly significant 
differences were found among dose groups (p < .01) after adjustment for 
litter size by covariance. There was observed a linear decrease in the 
time of development (increase in rate) of the righting response with increase 
in mutagen dose. There were also highly significant differences (p < .001) 
among the three replicates and a significant group x dose interaction 
(p < .05). In Experiment III there were also highly significant differences 
(p < .001) between replicate means but no significant interactions or 
other complications. 
It can only be concluded that factors other than those being tested 
may have major effect upon the time of development of the righting response. 
In general, it may be said that all of the three replicates in Experiment V 
exhibited greater mean righting response times than those observed in 
Experiment III. Of course, changes in food or water quality, or subtle 
environmental changes of which we are not aware could be responsible for 
the general differences between times of development of the righting response 
or the differences in response to mutagenic agent observed in the two 
experiments. It seems evident that until such factors can be identified 
and controlled, this trait will not be particularly reliable for the detec-
tion of mutagenic effects in F1 generation young of males treated at the 
spermatogonial germ cell stage. An equally evident conclusion is that 
the time of development of the righting response may be affected by mutagenic 
treatment. Interestingly, the highly significant decrease in time of 
development of the righting response with increasing mutagen dose parallels 
closely the results of the F1 generation spermatozoan test groups (p - .12), 
but not those of the F2 spermatozoan groups. 
Body Weight at Weaning. 	In Experiment III it may be recalled that 
highly significant differences among dose group means (p < .001) were found 
in this treatment stage after adjustment for litter size by covariance. 
These differences were based upon a roughly linear increase in body size 
with increasing mutagen dose. In Experiment V significant differences 
were also found among dose group means (p < .025) after adjustment for 
litter size (Table 13). This statistical significance is due primarily 
to an increase in mean from control to low dose group that parallels very 
closely the difference between control and low dose group in Experiment III. 
* 	* 	* 
Table 13. Effect of TEM dose on body weight at weaning of F1 and F2 
progeny of treated male parents in inbred strain BALB/cByJ in Experiments 
III and V. Males were treated at the spermatogonial germ cell stage. 
Sample sizes are given in parentheses. Means have been adjusted for the 
effects of litter size by covariance. Sexes and replicates are combined 
for simplicity. 
Experiment Generation Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
III F1 p < .001 16.49 (376) 16.87 (458) 17.06 (419) 
V F1 p 	-. .025 15.53 (221) 16.03 (287) 15.81 (258) 
III F2 p < .01 16.84 (462) 17.17 (466) 17.11 (509) 
V F2 p < .05 15.78 (515) 15.86 (617) 15.56 (581) 
In contrast to the situation in Experiment III, there is a decrease in body 
weight between the low and high dose group means which, however, is not 
significant. Similarly the difference between low and high dose means in 
Experiment: III is not significant. Thus, the general conclusion that may 
be drawn from these two experiments, III and V, is than body weight at weaning, 
adjusted for litter size by covariance, increases with mutagenic treatment. 
However, the effect of doubling the mutagenic dose while not entirely clear, 
appears to be other than linear. 
It seems likely that this trait, particularly in combination with 
that to be discussed next, tail length at seven weeks of age, could be 
quite useful in providing a very sensitive method for the detection of 
mutagenic damage in spermatogonia. This is particularly important when 
it is considered that very few mammalian tests are effective in the detection 
of spermatogonial damage. Since it is in spermatogonial cells that mutagenic 
damage may accumulate, the usefulness of this assay could be very great. 
Cytogenic techniques may also be employed to detect mutagenic damage in 
spermatogonial cells. Whether this assay is comparable in sensitivity 
to such techniques can only be determined by direct comparison, but if 
the effects we have measured are based upon polygenic variation as seems 
most probable, sensitivity of this assay could prove to be very great indeed. 
Tail Length at Seven Weeks of Age. The parallel between the results 
of Experiments III & V are impressive. After adjustment for the effects 
of litter size by covariance, differences among means based upon factorial 
ANOVA were highly significant (p < .005) in Experiment III. In Experiment 
V, differences among means after comparable analysis were also highly sig-
nificant, (p < .001). In both experiments there is a parallel increase 
in magnitude from control to low dose group mean followed by a decrease 
of considerably lesser magnitude in high dose group means (Table 14). 
The similarity in the distribution of tail length means and the means for 
body weight is quite clear, and this has been observed on a number of 
occasions in other experiments involving the same and other inbred strains. 
In this particular case, tail length seems to have provided a more reliable 
measure of mutagenic effect than body weight at weaning. However, the cor- 
related results of both traits provide an indication of even greater reliability. 
J. 	* 	* 
Table 14. Effect of TEM dose on tail length at seven weeks of age of F 1 
 and F2 progeny of treated male parents in inbred strain BALBLeByJ in 
Experiments III and V. Males were treated at the spermatogonial germ cell 
stage. Sample sizes are given in parentheses. Means have been adjusted 
for the effects of litter size by covariance, and sexes and replicates 
are combined for simplicity. 
Experiment Generation Significance 0 mg/kg 	0.1 mg/kg 	0.2 mg/kg  
III F1 p < 	.001 81.88 (366) 82.57 (441) 82.51 (406) 
V F1 p < .005 79.64 (217) 80.47 (262) 79.93 (238) 
III F2 p < 	.05 79.60 (436) 79.96 (449) 78.89 (486) 
V F2 n.s. 81.72 (500) 81.85 (583) 81.75 (535) 
In both Experiments III and V, differences between the sexes with 
respect to tail length are, as usual, highly significant (p < .001) and 
differences between replicates (Experiment III) and among replicates (Ex-
periment V) are significant. In both experiments there is an interesting 
indication of a dose x sex interaction, significant in Experiment III 
(p 	.02), but only approaching significance in Experiment V (p < .10). 
As with body weight at weaning the effect of doubling the mutagenic dose 
is not to produce more of the effect of a single dose. It appears that 
tail length, adjusted for litter size by covariance, increases with mutagenic 
treatment. However, the effect of increasing mutagenic doses is other 
than linear and may actually result in a reversal of direction of effect. 
This has been observed many times with a number of traits, and it seems 
quite likely that it is real. 
Hematocrit at Seven Weeks of Age. 	The similarities that exist between 
Experiments III & V with respect to hematocrit are not based upon differences 
that are significant. However, the observed increase in hematocrit from 
control to low dose group mean may very well be real. In Experiment III, 
differences among groups only approached significance (p < .10),but the 
greatest difference was that between the two dose group means. In Experiment 
V, there are highly significant differences among groups (p < .001), but 
both low and high dose group means are greater than the control group mean, 
and there appears to be a roughly linear increase in hematocrit with in-
creasing dose (Table 15). 
* * * 
Table 15. Effect of TEM dose on hematocrit at seven weeks of age of F/ 
progeny of treated male parents in inbred strain BALB/cByJ in Experiments 
III and V. Males were treated at the spermatogonial germ cell stage. 
Sample sizes are given in parentheses. Means have been adjusted for the 
effects of litter size by covariance, and sexes and replicates are 
combined for simplicity. 
Experiment 	Significance 	0 mg/kg 
	
0.1 mg/kg 	0.2 mg/kg 
p < .10 (n.s.) 48.73 (365) 
	
48.86 (437) 48.63 (410) 




In view of the limited response, if real, of hematocrit to low mutagen 
doses and the variable response to high dose treatment in this germ cell 
stage, hematocrit would not seem to be a very likely prospect for the effi-
cient ascertainment of mutagenic damage. 
Defecation Portion of the Open Field Test. Next to the tail length 
and body weight traits, defecation rate exhibited the most interesting 
parallels of any in the spermatogonial F1 generation results (Table 16). 
In both experiments (III and V) differences among means were significant 
(.01 < p < .05). Although there did not appear to be significant variation 
due to litter size, the factorial ANOVA was carried out after adjustment 
for whatever litter size effects existed. In both experiments there were 
highly significant differences between sexes. In Experiment III there 
was no significant difference between replicates, but in Experiment V 
differences among replicates were highly significant. In neither experiment 
were any interactions significant. 
* * * 
Table 16. Effect of TEM dose on defecation rate at. five weeks of age in 
F1 and F2 progeny of treated male parents in inbred strain BALB/cBy3 in 
Experiments III and V. Males were treated at the spermatogonial germ cell 
stage. Sample sizes are given in parentheses. Means have been adjusted 
for the effects of litter size by covariance, and sexes and replicates are 
combined. 
Experiment Generation Significance 0 mg/kg 	0.1 mg/kg 	0.2 mg/kg 
III 	F1 	p < .05 	4.03 (376) 	4.36 (.458) 	4.38 (417) 
V F1 p -. .01 4.10 (229) 4.38 (299) 3.84 (258) 
III 	F2 	 n.s. 	4.70 (462) 	4.94 (466) 	4.79 (509) 
V F2 n.s. 3.74 (521) 3.83 (619) 3.74 (581) 
As with the body weight and tail length traits, there are important 
parallels between the control and low dose group means. Also as with the 
body weight and tail length traits, the low dose and high dose group rela-
tionships are dissimilar. It is of interest that there is a highly signif-
icant drop from low dose group to high dose group in Experiment V which 
parallels the face value change of the body weight and tail length traits 
in the same experiment. In contrast, in Experiment III, the difference 
between low and high dose group means is not significant, and varies in 
the three traits from slight increases in fecal deposition rate and body 
weight to a slight decrease in tail length. In view of the close parallel 
of defecation rate, body weight and tail length traits, it is reasonable 
to suggest that all three traits employed together would provide an element 
of reliability of results that could be most useful. 
Brain Weight at Fifteen to Nineteen Weeks of Age. This trait, which 
appeared to have interesting potential in work with other strains and in 
the same germ cell stage treatment group with BALB/clay.1 in Experiment III, 
failed to show significant differences among means in Experiment V (Table 
17). In contrast with the highly significant increase from control to 
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* * * 
Table 17. Effect of TEM dose on brain weight at approximately fifteen 
(males)to nineteen (females) weeks of age in F1 progeny of male parents 
in inbred strain BALB/cByJ treated at the spermatogonial germ cell stage. 
Results of Experiments III and V are included. Sample sizes are given in 
parentheses. Means have been adjusted for the effects of litter size by 
covariance, and sexes and replicates are combined. 
Experiment Generation Significance 0 mg/kg 0.1 mg/kg 0.2 mg/kg 
III F1 p < 	.01 473.04 (350) 476.14 (420) 474.85 (389) 
V F1 n.s. 457.05 (210) 455.66 (288) 455.68 (251) 
III F2 p < 	.001 464.32 (459) 465.88 (464) 468.29 (506) 
V F2 p < 	.001 442.22 (506) 444.87 (607) 447.69 (551) 
low dose group mean in Experiment III, there was a face value decrease 
from control to low dose group mean in Experiment V. From these data it 
is clear that a consistent effect cannot be expected, and brain weight 
would not be a trait of choice employing strain BALB/cByJ in an F1 generation 
test of spermatogonial damage. 
Results: Quantitative Traits, Experiment V. IV. Spermatogonial Treatment,  
F2 Progeny. In general, in spermatogonial test groups, the results of 
tests involving F2 progeny are almost as useful and quite as exciting as 
those involving Fl progeny. Tests involving spermatozoan test groups, either 
F1 or F2 generation, have been far less interesting. In these latter groups, 
except for three traits (body weight at weaning, tail length at seven weeks 
and hematocrit at seven weeks, and these only in the F 1 spermatozoan test 
groups), there have really been few traits that would appear to be of potential 
usefulness in the practical ascertainment of mutagenic damage- However, 
in striking contrast, most traits exhibited significant differences among 
dose groups in one or the other experiment in F1 spermatogonial test groups, 
and three, body weight at weaning, tail length at seven weeks and defecation 
rate showed parallel effects in pattern in Experiments III and V, primarily 
with respect to differences between control and low mutagen dose groups. 
With respect to F2 generation spermatogonial tests Experiment III results 
were discussed above. In experiment V, three traits stand out in exhibiting, 
as in Experiment III, significant differences among means and in having 
parallels with the mean distributions of Experiment III. These are, perhaps 
curiously, body weight at weaning, hematocrit at seven weeks and brain weight 
at fifteen to nineteen weeks of age. But, perhaps equally important, the 
defecation rate and tail length traits, which showed such impressive effects 
of mutagenic treatment in F1 spermatogonial test groups, offer strong support 
for those conclusions by demonstrating very similar mean distribution patterns 
in F2 results. The lack of significant differences seems largely a result 
of decreased magnitude of the differences between means. It will be attempted 
in this section to tie together meaningful comparisons not only of Experiments 
III and V, but also meaningful comparisons of F1 and F2 spermatogonial 
results. 
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Time of Development of the Righting Response. In Experiment V, there 
were not found significant differences among means and, in fact, such dif-
ferences were of lesser magnitude than in any other germ cell stage/generation 
group tested. It may be recalled that there were highly significant dif-
ferences among means in the F1 generation spermatogonial tests based upon 
a roughly linear decrease in time of the development (increase in devel-
opmental rate) of the righting response . with increasing mutagen dose. 
There seems to be little doubt as to the reality of the differences found 
in that experiment, but either the responsible genetic variance was lost, 
or the appropriate environment to foster the development of the differences 
observed did not exist, when the F2 generation experiments were conducted, 
or both. Further, Fl spermatogonial test results from Experiment III, reported 
above, did not support the F1 spermatogonial results of Experiment V, and 
the F2 generation results in Experiment III only support those of Experiment 
V in exhibiting very modest differences among means and no particular pattern 
of response. 
The righting response trait, at least insofar as strain BALB/cByJ 
is concerned, is not a very useful trait to employ in the ascertainment 
of mutagenic damage. 
Body Weight at Weaning. In Experiment V differences among means were 
found to be significant as they were in Experiment III in spermatogonial, 
F2 generation tests (Table 13). It will be recalled that there were also 
significant: differences among means in both Experiments III & V in the 
F1 generation spermatogonial test groups. However, the primary importance 
of the F2 spermatogonial generation results does not lie in their usefulness 
for the ascertainment of genetic damage, but in the evidence they provide 
for heritability of effect. The Fl generation spermatogonial stage tests 
would serve far better for detection of mutagenic effects. The mean dis-
tribution patterns seen in the F2 tests are nicely derivable genetically 
from those found in the F1 tests. There are increases in the F2 generation 
tests from control to low dose group in both experiments. This difference 
is not significant in Experiment V, although it is in Experiment II/. 
In the F1 generation spermatogonial tests, the increase from control to 
low dose group was impressive and significant in both experiments. In 
Experiment V, Fl generation results, there was evident an appreciable 
drop from low to high dose group, and this same trend is present in the 
F2 spermatogonial results and the difference is significant. One interesting 
difference: the high dose group in Experiment V Fl was appreciably above 
control, while in the F2 results the same group is appreciably below control. 
However, there is a decrease from low dose mean to high dose mean in both 
F1 and F2 generation results. The relationship between the high dose means 
of Experiment III & V remains approximately the same in the F1 and F2 gen-
eration results (see Figure 1A). 
These patterns just described have close similarities to mean distri-
bution patterns for spermatozoan results in both the F1 and F2 generation 
with the notable exception that, in Experiment III of the F/ generation, 
there was an apparent linear decrease in body weight with increasing mutagen 











Figure 1. Effect of triethylenemelamine dose on body weight at weaning 
and tail length at seven weeks in F1 and F2 generation progeny of treated 
males of inbred strain BALB/cByJ in Experiments III, IV and V. Effects 
of treatment on spermatozoa and spermatogonia are shown. Sexes and repli-
cates are combined for simplicity. Probability figures shown are taken 
from factorial ANOVA results for each experiment and refer to significance 
of differences among means within an experiment. 
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Tail Length at Seven Weeks of Age. Differences among means due to 
dose in Experiment V, F2 generation spermatogonial results were not signif-
icant, but the pattern of distribution of means is very similar to what 
it was in the F1 generation spermatogonial results as well as to the results 
of Experiment III in both F1 and F2 generation spermatogonial tests. This 
pattern involves an increase from control to low dose group followed by 
a less pronounced decrease to the high dose group. In all spermatogonial 
► 
	
	 tests except this, significant differences among tail length means were 
recorded. These results are important in that they provide evidence of 
heritability with the magnitude of the differences among means reduced 
in F2 generation results. In the F2 spermatogonial results of Experiment 
III, the mean distribution pattern is similar to that in EXperiment V, 
and the magnitude of the differences among means are reduced, but the increase 
from control to low dose group is significant (Table 14). 
Only one of the spermatozoan tests, that for the F1 generation in 
Experiment V, resulted in significant differences among means, and these 
were impressively so. In this test, there was also found the generally 
observed increase from control to low dose group mean followed by a decrease 
to the high dose group mean. The distribution of means for all tests, 
spermatogonial and spermatozoan, are graphed for ease of visualization 
in Figure 1B. 
Hematocrit at Seven Weeks of Age. In Experiment V, differences among 
dose group means were significant, with the significance itself due primarily 
to an increase from control to low dose group in the F2 spermatogonial 
results. In F1 generation spermatogonial results of the same experiment 
there were highly significant differences among means and an increase from 
control to low dose group comparable in magnitude to that in the F2 results. 
With respect to the response in the high dose group, results are quite 
dissimilar in the F1 and F2 generations. In the former, there was a highly 
significant increase from low to high dose group; in the F2 generation 
results there was a decrease. As has been pointed out previously, high 
dose group results do appear to be erratic and unpredictable. 
Elements of concordance between the results of Experiment III and V 
are present, but not very useful. In F1 generation results of Experiment 
III there was found the same increase from control to low dose group that 
was found in Experiment V. However, unlike the results of Experiment V, 
there was a non-significant decrease from low dose to high dose group means. 
In F2 generation results, by contrast, Experiments III and V are alike 
in exhibiting decreases from low to high dose group means. However, in 
Experiment III there was recorded a slight decrease from control to low 
dose group mean as opposed to the significant increase found in Experiment V. 
Everything considered, while there may be elements of similarity based 
upon heritability, hematocrit, in strain BALB/cByJ, would not appear to 
be useful either in providing persuasive evidence of heritability of mutagen 
induced variance or, for practical purposes, in the ascertainment of genetic 
damage. Even so, the impressive levels of significance involved in certain 
differences do indicate that effects of mutagenic treatment exist, but 
they appear to be unpredictable. 
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Defecation Portion of the Open Field Test. The results of Experiment 
V in the F2 generation of the spermatogonial test are quite comparable 
to those of Experiment III not only in that there are no significant dif-
ferences between means, but also in the close parallel in distribution 
of means. In both experiments there is an increase from control to low 
dose mean followed by a decrease from low to high dose mean. As has been 
noted with respect to other traits, this is the same pattern found in F1 
generation spermatogonial results (with the exception of one data point) 
except that the differences between F2 generation means are much reduced. 
Inasmuch as the differences among means in the F1 results were significant 
in both experiments III and V, it is reasonable to suppose that the effects 
are heritable but with reduced degree of expression in the F2 generation. 
For purely practical purposes the defecation rate trait would not 
appear to be of usefulness in an F2 generation spermatogonial test to 
ascertain mutagenic damage. 
Brain Weight at Fifteen to Nineteen Weeks of Age. Results obtained 
with this trait are clearly the most useful of those obtained in the F2 
generation of the spermatogonial tests. As with the results of Experiment 
III, there are highly significant differences among means (p < .001), and 
the results of Experiment V parallel precisely those of Experiment III 
in that there is a linear increase from control to low dose group continuing 
on to high dose group. The magnitude of the increases in both experiments 
are quite comparable (Table 17). 
It is concluded that brain weight can provide a very sensitive measure 
of mutations induced at multiple loci by a mutagenic agent in the F2 gen-
eration progeny of treated males. It should be pointed out that results 
with F1 young may have been distorted to an appreciable extent by the 
necessity of permitting females to rear their young to weaning before taking 
the brain weight of the females themselves. This introduced a variable 
that may be partioned out by a more detailed analysis. Most importantly, 
however, this factor does not intrude into the measurement of brain weight 
of the F2 progeny because there was no intention to produce an F3 generation 
and no need to distribute brain weight measurements over an excessively 
broad span of ages. 
Discussion. The purpose of these experiments has to determine the 
usefulness of the cumulative effects of mutations induced by a powerful 
mutagenic agent, triethylenemelamine, in bringing about changes in means 
of a series of traits of a continuously varying nature and, therefore, 
likely determined by genes at multiple loci. 
Dominant lethal effects have been studied in the F1 generation of 
every experiment conducted primarily to assure that the mutagenic agent 
employed had been effective, and also to provide a standard by which any 
polygenic effects observed might be compared. Suffice it to say that in 
every experiment conducted, highly significant dominant lethal effects 
were observed, thus indicating that potent mutagenic agent had been success-




a hitherto undescribed late dominant lethal effect, the results of which 
have been published (Favor, Soares and Crenshaw, Mutation Research, 54 
(1978) 333--342). This dominant lethal effect was found to occur at about 
the time o: parturition and to vary directly with increase in mutagen dose. 
In the discussion of specific effects below, we have concentrated 
upon a single mouse inbred strain, BALB/cByJ, primarily because the last 
three experiments were conducted with this strain because of its very 
high productivity. Some of the other strains studied probably exhibited 
much greater mutagenic effects, but the poor productivity of the strains 
could make it considerably more expensive to conduct experiments of the 
size required to demonstrate mutagenic effect. In fact, it is not known 
that the economics of the situation would favor use of the BALB strain 
employed, but indications from preliminary studies made it seem most likely 
that this would be the case. Nevertheless, the other strains studied, 
Strain C3H/HeJ and DBA/2J, showed clear indications of response, some similar, 
some different, to the same mutation dose and employing the same traits. 
One generalization may be stated that may be of some usefulness with 
respect to sample sizes required to demonstrate statistical significance 
in most groups in these studies. In general, in order to provide a base 
sufficient for useful statistical analysis of the data developed for the 
traits recommended below, on the order of 400 to 500 young will be required 
for each control and experimental group in an experiment. These numbers 
may be produced by combining two or three replicates, but the replicates 
should be carried out in reasonably close temporal succession. 
Although it has not been specifically stated in the discussion of 
every trait in the report above, the statistical analyses carried out are 
always factorial analyses of variance (dose x replicate x sex). In every 
case, dose/group means have been adjusted by covariance for the effects 
of litter size, even if the effects of litter size could not be shown to 
be significant. 
In view of the goal of these experiments, it has been far more important 
to demonstrate repeatable effects than to demonstrate rectilinear relationship 
between increasing mutagenic dose and degree of effect. An interesting 
fact that has emerged, that appears to be repeatable and that appears from 
a number of evidences to be heritable, is variation in the direction of 
response with the two different doses employed. While rectilinear response 
was observed in some traits, quite often traits were found to increase 
above control at the low dose level and to decrease back toward or beyond 
control level at the high dose. The opposite was also observed for other 
traits, that is to say decreased response occurred at the low dose level 
relative to control, followed by a return toward or even above control 
level at the high dose. It does not strain the imagination to develop 
hypotheses to account for this sort of response. For the body weight trait, 
for example, it is reasonable to suppose that a heterotic effect may obtain 
at low mutagen dose, or simply that allelic mutants for increased body 
size tend to be dominant over those for decreased body size. Either mechanism 
could account for increases in body size at low mutagen doses. However, 
it is clear that if enough mutations are induced, as by a doubled mutagenic 
dose, the net effect on the development of the organism may be sufficiently 
detrimental as to lead to a general reduction in body size or failure to 
develop the same body size at the time weights are taken. 
Turning to a specific consideration of the traits of importance in 
each generation of the two germ cell stages tested, we will consider first 
F1 generation responses in those tests in which germ cells were treated 
as spermatozoa. It may be recalled that only three traits proved to be 
potentially useful in reflecting effects of the mutagenic agent. However, 
the economic significance of this stage is very great inasmuch as experiments 
can be run in a relatively short time, about six months. (F1 spermatogonial 
tests would require an additional 2 months and F2 spermatozoan tests require 
approximately a year.) 
In Experiment V, with over 300 young involved in the control group 
and between 450 and 500 in each of the experimental groups, there were 
highly significant differences among dose groups with respect to both body 
weight and tail length. In both traits there was an increase from control 
to low dose group followed by a decrease to high dose group. With respect 
to both traits the low dose mean was highly significantly greater than 
either the control or the high dose mean. Accordingly, it is suggested  
that these two traits, in combination, would be quite useful in the detection  
of the effects of agents of relatively low mutagenicity. With respect 
to the same germ cell/generation test in Experiments III and IV, differences 
among means were not significant, in part because of relatively low numbers. 
(Both experiments combined included less than 1300 mice.) However, the 
distribution of means in both experiments follows the same pattern as that 
in Experiment V with respect to tail length, and the pattern of means in 
Experiment IV paralleled that in Experiment V with respect to body weight. 
Hematocrit also proved to be useful in Experiment V as an indicator 
of mutagenic damage. In this case, there was a modest reduction (non—sig- 
nificant) from control to low dose treatment group followed by an appreciable 
increase (highly significant) between low - and high dose group means. Although 
differences among means were not significant for the comparable germ cell 
stage/generation tests in Experiments III and IV, the pattern of distribution 
of means offers precise support for the results of Experiment V with its 
much larger numbers. It is our interpretation, that hematocrit might be  
particularly useful in the ascertainment of the effects of agents of rela-
tively high mutagenicity. In every case the reduction from control to 
low dose was relatively modest, and the subsequent increase to high level 
dose mean somewhat greater. 
We conclude that the traits body weight at weaning, tail length at  
seven weeks and hematocrit at seven weeks may prove to be quite useful  
in the detection of mutagenic effects over a broad range of dosages, employing  
the strain BALB/cByJ in adequate numbers, in an F1 generation test involving  
mutagenized spermatozoa. 
* * 	* 
Results of the analysis of data on F2 generation young in the sper-
matozoan treated series indicate that this is not a particularly useful 
stage for in the detection of mutagenic effects.  
With respect to body weight, evidence of heritability of the increase 
from control to low dose group followed by a decrease to high dose group 
was found :Ln Experiment III, and the differences among means were significant 
(p < .05), in spite of relatively modest numbers. (There were approximately 
650 young :Ln the control group, 270 in the low dose and 100 in the high 
dose group.) That numbers are not the problem, however, is indicated by 
the results of Experiment V in which about 750 young were tabulated each 
for control and high dose group and over 1000 for the low dose group. 
In this experiment, heritability of the Fl generation effect of increase 
from control to low dose group was indicated, but there was no subsequent 
decrease to the high dose group as in the F1 generation- None of these 
differences however were significant in Experiment V. 
With respect to the hematocrit trait, heritability of effect was sug 
gested by the results of both Experiments III and V in that there was a 
drop from control to low dose group paralleling that of the Fi generation 
results. In Experiment V, with the very large numbers involved, this 
difference approached significance (p - .055). Also paralleling the F1 
results, there was an increase from low dose group to high dose group in 
Experiment III (not significant) but not in Experiment V.. 
In spite of the often inconclusive results of analyses. of our data 
on brain weight, the impressive results to be discussed below with respect 
to spermatogonial effects suggests that prospects for this trait may be 
explored a bit further before being discarded as a trait suitable for sper-
matozoan testing. In the first place, there has been a problem of variation 
in time of acquisition of brain weight due, in females, to the necessity 
of permitting F1 females to rear their young to weaning prior to taking 
brain weights. In males also, in F1 generation results, brain weights 
have been postponed for some males while tests for evidence of trans-
locations were carried out. More detailed analyses of our data will be 
carried out with appropriate partitioning of these variables as time permits. 
In our F2 generation spermatozoan germ cell stage test, in Experiment III, 
there was a highly significant increase in brain weight from control to 
low dose group, paralleling a significant increase in body weight in the 
same experiment (there was also a non-significant decrease from low to 
high dose group, also paralleling a decrease in body weight). However, 
this mean distribution pattern received no support from the results of 
Experiment V in which very large numbers were involved. It is worth noting, 
however, that the F2 generation spermatozoan results in Experiment V with 
respect to brain weight showed interesting similarities, suggesting heri-
tability, to the Fl generation spermatozoan results. Clearly, at this 
stage of development, brain weight would not appear to be a useful trait 
for the detection of mutagenic damage in spermatozoan test groups. 
29 
* 	* 	* 
The results of both of the spermatogonial generation  tests are exciting,  
and show considerable promise for use in the detection of mutagenic activity.  
On the one hand, it is of particular interest that mutations induced in 
spermatogonial cells are relatively easily detectable, because there are 
not many tests available in mammalian systems in which spermatogonial damage 
can be detected. The question as to why this might be so in our test when 
spermatozoan damage is not so easily detected is an interesting one. It 
is suggested that for most of the traits employed, it may be that mutations 
induced in spermatozoa may be so much more dramatic in their effect in 
both directions that erratic results eliminate the general trends which 
may be evident in spermatogonial damage, where far less dramatic mutations 
only may survive repair or elimination. 
The F1 generation spermatogonial germ cell stage results were far 
and away the most exciting and useful of any obtained. With respect to  
three traits, body weight at weaning, tail length at seven weeks and the  
defecation portion of the open field test, significant differences were  
found to exist among means in both Experiments III and V, and the dose  
mean differences that were significant in both experiments were parallel.  
With respect to body weight at weaning, there were increases in body 
weight from control to low dose groups in both Experiments III and V, highly 
significant in the former, significant in the latter. In both experiments, 
differences between low and high dose groups are not significant. In Exper-
iment III there was recorded a face value increase; in Experiment V, a 
decrease. 
Closely paralleling these body weight patterns, there were highly 
significant increases in tail length in both Experiments III and V between 
the control and low dose groups. In both experiments there were decreases 
from low dose to high dose groups, but these differences were not significant. 
It is of particular interest that the numbers involved in this particular 
germ cell stage/generation test were relatively modest. In Experiment 
III, numbers ranged from about 370 in the control group to between 360 
and 410 in the experimental test groups. In Experiment V, the numbers 
were even lower, ranging from about 220 in the control groups to between 
240 to 260 in the experimental groups. 
Employing the traits body weight at weaning and tail length at seven  
weeks in a spermatozoan and a spermatogonial, F1 generation test, there  
exists in the approach under investigation here a powerful mechanism for  
the demonstration of mutagenic effects, particularly with relatively low  
potency mutagenic agents.  
The defecation portion of the open field test also revealed significant 
increases from control to low dose group, paralleling the body weight and 
tail length traits, in both Experiments III and V. While the levels of 
significance in these experiments were not as impressive (.01 < p < .05) 
as in the body weight and tail length traits, incorporation of this trait 
would add an additional degree of confidence to an Fl spermatogonial test. 
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The parallelism with the body weight and tail length traits extends to 
the relationship between low dose and high dose group means, but in an 
interestingly different way. In Experiment V with respect to all three 
traits, body weight, tail length and fecal rate, there was observed a decrease 
from low dose to high dose group. In Experiment III some similarity was 
found in that there is little difference between low and high dose group 
means for all three traits. In body weight there is a modest increase 
from low to high dose; in tail length there was a modest decrease from 
low to high, and in fecal rate there was very little difference. 
As indicated above, the F2 generation spermatogonial germ cell stage 
test was not nearly so impressive in the kinds of conclusions it provided 
as were the F1 generation spermatogonial tests. This was true in spite 
of considerably greater numbers (450 to 600 in most test groups). However, 
some of the most interesting results with respect to heritability were  
developed in this group, and brain weight proved to be a remarkably exciting  
and useful trait in contrast to what it had been in other groups.  
With respect to the brain weight trait, there proved to be a highly 
significant more or less linear increase in brain weight with increasing 
mutagen dose in both Experiments III and V, and the mean distribution patterns 
are quite similar in both experiments. It is probably not just coincidental 
that this was an F2 generation test and one in which brain weights could 
be taken over a relatively short span of time in the life of the experimental 
animal. Everything considered, this germ cell stage/generation group would 
not be one of choice if the primary interest were the confident ascertainment 
of mutagenic damage. However, brain weight stands out as the best choice 
of traits if it were desirable, on other grounds, to test mutagenic effect 
in the F2 generation of mutagen induced spermatogonial damage. It seems 
likely that spermatogonial mutagenesis generally results in fewer unrepaired 
mutations as well as mutations of a less dramatic and extensive nature 
than is the case in spermatozoan mutagenesis. It further seems likely 
that even this damage may be somewhat diluted by selection in transmission 
from the F1 to the F2 generation. Accordingly, it is concluded that very 
slight increases (with increases in mutagenic dose) in the frequency of 
mutations (themselves of very slight effect) results in an increase in 
brain weight in strain BALB/cByJ. It is reasonable to suppose that the 
reduction in brain weight size often observed (but not as a significant 
effect in our experiments) may be real and may result from an increase 
in the frequency of mutations generally or in the frequency of mutations 
having a generally deleterious effect upon brain development. 
The hematocrit trait in F2 spermatogonial results was of interest 
in that there were differences among means in both Experiments III and 
V (respectively p < .005 and p < .05). However, the parallel aspect of 
the mean distributions lies only in a reduction from low to high dose group. 
This difference is means is highly significant in Experiment III, but not in 
Experiment V. There was an impressive increase in Experiment V from control 
to low dose. group but little difference between control and low dose group 
in Experiment III. 
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One other trait, body weight at weaning, revealed differences among 
means in both Experiments III and V. These were highly significant 
(p < .01) in Experiment III, based largely upon an increase from control 
to low dose group, and significant (p < .05) in Experiment V, with the 
significance based largely upon a decrease from low to high dose group 
mean. However, in both cases there is an increase from control to low 
dose group followed by a decrease from low to high dose group. The magnitude 
of the differences are such that this would not appear to be a highly reliable " 
trait in the ascertainment of mutagenic damage in this germ cell/generation 
test group. Nevertheless, the pattern provides evidence for heritability 
of the increase from control to low dose group. 
4. 
Also of interest in respect to heritability are the tail length and 
fecal rate traits, although significant differences among means are limited 
to the tail length trait in Experiment V. Of greater importance, the traits 
tail length and fecal rate in both Experiments III and V show patterns 
that parallel precisely the body weight trait in Experiments III and V, 
and all three reinforce a general heritability of the pattern found in 
the F1 spermatogonial test results. More specifically, in both experiments, 
for all three traits, there is an increase from control to low dose group 
that is significant always in the F1 spermatogonial test results but only 
half the time in the F2 spermatogonial test results. The magnitude of  
the difference between control and low dose group means is uniformally  
lesser in the F7 spermatogonial results than in Fl spermatogonial results,  
as might be expected if the genetic variance were diluted as by natural  
selection in the passage from one to the next generation.  
4.4 
* * 	* 
As a final note it is emphasized that we have concentrated in this 
report upon those traits in which highly significant differences among 
means were found in at least one test and where there was support of direc-
tion of change of means in other tests. For obvious reasons, consistency 
of change of direction as a mutagenic effect is important in the development 
of confidence in this approach. However, the pioneering nature of this 
effort is emphasized. When one is dealing with the numbers of organisms 
dealt with in this study, there is a high level of confidence that those 
differences between dose group means that are highly significant really 
do reflect real differences due at least in part to mutagenic effects 
induced. It is perfectly reasonable to suppose that these differences, 
based as they are upon different mutagenic events are real effects. Of 
course unnoticed environmental differences between replicates, even in 
our carefully controlled animal colony rooms, could lead to different 
effects based upon interaction of genotype and environment. 
The nature of the statistical analyses employed (factorial analysis 
of variance considering the effects of variation in mutagenic dose, sex 
of organism and in temporally spaced replicates, in addition to a parti-
tioning out of the effects of litter size by covariance) is a highly 
sophisticated tool. The use of traits that are known to vary easily with 
environmental effects as, for example, body weight, has been criticized. 
However, it is clear that the critics do not appreciate that the fundamental 
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nature of the analysis of variance technique is to compare variation within 
dose/sex/replicate group with that variation fOund to exist between groups. 
Our animals have been carefully coded so that the investigators and workers 
are not aware of the dose group to which a given individual belongs. 
Further, all dose groups are distributed randomly within the same colony 
rooms. They receive the same food, the same water and are handled by 
the same assistants. Clearly environmental factors may vary in time, and 
this is very likely a major source of the variation that has been recorded 
in this study between replicates. But environmental factors that are 
known to affect a given trait are absolutely the same, insofar as they 
can be controlled, for all animals within an experimental replicate. 
If our statistical analysis says the trait is a good one, it is a good 
one irrespective of philosophical opinion to the contrary. The proof 
of the pudding, in such case, clearly lies in the eating thereof. 
We have emphasized the practical approach in these studies. It is 
felt that justification has been provided for the investigative employment 
and for further theoretical exploration of this general approach. These 
most promising tests would be based upon the traits outlined above in 
the F1 generation of spermatogonial treatment and of spermatozoan treatment, 
with the greater reliability at this time resting with the former. At 
present, this approach appears to be more useful in the detection of very 
slight mutagenic damage than of great mutagenic damage, but further inves-
tigation, perhaps involving additional traits, may well reveal some that 
will be affected only by higher mutagenic doses. There wxere indications 
that some other inbred strains, for example C3H/HeJ, would bear further 
investigation. Although considerably less productive thaw} the strain 
reported upon here, there were evidences that mutagenic events might be 
more strongly reflected for some traits in this strain than in the strain 
receiving primary attention. 
Respectfully Submitted 
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